| patient_id,diagnosis_year,age_at_diagnosis,sex,fitzpatrick_skin_type,melanoma_subtype,primary_site,family_history_melanoma_flag,prior_melanoma_flag,uv_exposure_index,tanning_bed_use_flag,immunosuppression_flag,ecog_performance_status,breslow_thickness_mm,ulceration_flag,mitotic_rate_per_mm2,t_stage,slnb_performed_flag,slnb_result,slnb_positive_flag,lymph_node_count_positive,in_transit_metastasis_flag,n_stage,m_stage,ldh_uln_ratio,overall_ajcc_stage,distant_metastasis_flag,braf_mutation_status,braf_v600_flag,nras_mutation_flag,kit_mutation_flag,nf1_mutation_flag,pten_loss_flag,cdkn2a_loss_flag,gnaq_mutation_flag,gna11_mutation_flag,tmb_mutations_per_mb,tmb_high_flag,pd_l1_cps,ctdna_vaf_pct,msi_status,surgery_type,excision_margin_cm,surgical_margin_status,margin_to_tumor_distance_mm,complete_lymph_node_dissection_flag,reconstruction_type,wound_complication_flag,time_to_surgery_days,re_excision_flag,immunotherapy_flag,ici_regimen,ici_line,ici_cycles_administered,best_overall_response_ici,ici_pfs_months,ici_pfs_event_flag,irAE_any_grade_flag,irAE_grade_3_4_flag,irAE_organ_system,irAE_colitis_flag,irAE_pneumonitis_flag,irAE_hypophysitis_flag,irAE_thyroid_flag,immunotherapy_discontinuation_flag,steroid_for_irAE_flag,hyperprogression_flag,targeted_therapy_flag,targeted_regimen,combo_braf_mek_flag,best_overall_response_targeted,targeted_pfs_months,targeted_pfs_event_flag,acquired_resistance_flag,resistance_mechanism,cutaneous_squamous_cell_ca_flag,metastasis_site_lung,metastasis_site_liver,metastasis_site_brain,metastasis_site_bone,metastasis_site_gi,metastasis_site_adrenal,metastasis_site_soft_tissue,metastasis_site_distant_lymph,metastasis_count,oligometastatic_flag,brain_metastasis_count,brain_metastasis_size_max_cm,visceral_metastasis_flag,time_to_first_metastasis_months,radiation_flag,radiation_site,adjuvant_ici_flag,adjuvant_regimen,intralesional_therapy_flag,overall_survival_months,os_event_flag,recurrence_free_survival_months,rfs_event_flag,duration_of_response_months,time_to_next_treatment_months,cause_of_death,sku,generator_version,seed |
| MEL-0000001,2018,66,Female,2,NM,Trunk,0,0,9.2,0,0,0,7.92,1,3.0,T4b,1,Micrometastasis,1,0,0,N0,M0,1.0,IIC,0,WT,0,0,0,0,1,1,0,0,26.7,1,100,4.43,MSS,Wide_Local_Excision,1.9,R0,4.9,0,Primary_Closure,1,57,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,174.4,1,110.47,0,0.0,5.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000002,2021,58,Male,4,SSM,Trunk,0,0,7.8,0,0,0,1.37,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.65,IIA,0,V600E,1,0,0,0,0,0,0,0,14.3,1,23,3.04,MSS,Wide_Local_Excision,1.4,R0,1.3,0,Primary_Closure,0,29,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,27.88,1,0.0,10.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000003,2021,62,Male,3,LMM,HeadNeck,0,0,4.7,1,0,1,0.42,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.25,IB,0,WT,0,0,0,0,0,0,0,0,18.7,1,49,0.13,MSS,Wide_Local_Excision,1.3,R0,3.3,0,Skin_Graft,0,49,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,160.3,1,63.87,1,0.0,12.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000004,2021,69,Female,2,SSM,UpperExtremity,0,0,5.2,1,0,1,1.11,0,3.0,T2a,1,Micrometastasis,1,1,0,N1a,M0,0.58,IIIA,0,V600E,1,0,0,0,0,0,0,0,15.3,1,9,1.63,MSS,Wide_Local_Excision,1.7,R0,4.8,0,Primary_Closure,0,120,0,1,Pembrolizumab_mono,1L,9,PR,9.82,1,0,0,None,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,SD,1.33,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,22.8,0,None,1,Nivolumab,0,240.0,0,240.0,1,16.24,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000005,2020,44,Male,3,SSM,Trunk,1,0,7.5,0,0,1,1.37,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.36,IIA,0,V600E,1,0,0,0,1,0,0,0,17.6,1,29,0.72,MSS,Wide_Local_Excision,1.4,R0,2.7,0,Flap,0,38,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,143.49,1,143.49,1,0.0,8.2,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000006,2019,40,Male,5,UM,Uveal,0,0,5.3,0,0,1,0.54,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.11,IA,0,WT,0,0,0,0,0,0,1,0,8.2,0,7,4.92,MSS,Wide_Local_Excision,0.8,R0,7.6,1,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,69.23,1,69.23,1,0.0,5.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000007,2021,35,Male,2,NM,UpperExtremity,0,0,2.3,0,0,1,2.72,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.44,IIB,0,WT,0,0,0,0,0,1,0,0,10.1,1,21,4.64,MSS,Wide_Local_Excision,1.9,R0,10.0,0,None,0,14,0,1,Pembrolizumab_mono,2L,32,SD,26.01,1,1,1,Endocrine,0,0,0,1,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,240.0,0,34.33,1,0.0,32.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000008,2023,62,Male,2,NM,Trunk,0,0,6.4,0,0,0,1.31,0,1.0,T2a,1,Negative,0,0,0,N0,M1d_1,1.05,IV,1,WT,0,0,0,0,1,0,0,0,15.2,1,10,2.59,MSS,Wide_Local_Excision,1.7,R0,1.0,0,Flap,0,62,0,1,Pembrolizumab_mono,1L,9,PR,0.13,1,1,1,Hepatic,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,1,0,1,0,0,0,0,0,2,1,1,1.2,1,0.3,0,None,0,None,0,1.82,0,1.82,1,5.43,8.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000009,2018,59,Male,6,SSM,LowerExtremity,0,0,3.5,0,0,1,1.84,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.8,IIA,0,WT,0,1,0,0,0,0,0,0,3.1,0,8,0.76,MSS,Wide_Local_Excision,1.7,R0,3.7,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,127.09,1,127.09,1,0.0,11.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000010,2019,47,Female,3,SSM,LowerExtremity,0,0,9.7,0,0,0,1.35,1,2.0,T2b,1,Negative,0,0,0,N0,M0,0.86,IIB,0,WT,0,0,0,0,0,0,0,0,49.6,1,15,6.61,MSS,Wide_Local_Excision,1.6,R0,9.8,0,Primary_Closure,0,14,0,1,Ipilimumab_mono,1L,35,SD,1.9,1,1,1,Endocrine,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,151.88,1,151.88,0,0.0,10.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000011,2015,56,Female,3,SSM,Trunk,0,0,6.9,0,0,0,0.38,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.04,IB,0,V600K,1,0,0,0,0,0,0,0,84.5,1,2,1.62,MSS,Wide_Local_Excision,0.7,R0,9.1,0,Skin_Graft,0,22,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,193.69,1,0.0,26.1,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000012,2017,61,Male,4,ALM,Acral,0,0,4.7,0,0,1,1.53,0,2.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.93,IIA,0,WT,0,0,0,0,1,0,0,0,17.0,1,6,8.48,MSS,Wide_Local_Excision,1.7,R0,6.9,0,Primary_Closure,0,46,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,68.1,0,18.66,1,0.0,4.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000013,2022,39,Female,1,SSM,Trunk,0,0,5.1,0,0,0,1.15,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.92,IIA,0,V600E,1,0,0,0,0,0,0,0,25.5,1,44,2.47,MSS,Wide_Local_Excision,1.8,R0,12.2,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,132.07,0,29.87,1,0.0,21.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000014,2021,51,Female,3,NM,Trunk,0,0,2.7,0,0,0,5.02,1,4.0,T4b,1,Negative,0,0,0,N0,M0,0.54,IIC,0,V600E,1,0,0,0,0,1,0,0,35.6,1,28,3.0,MSS,Wide_Local_Excision,2.0,R0,3.1,0,Primary_Closure,0,19,0,1,Pembrolizumab_mono,1L,6,CR,4.48,1,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,91.27,1,90.4,0,11.73,9.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000015,2016,39,Male,2,SSM,HeadNeck,1,0,4.3,0,0,2,0.91,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.83,IA,0,WT,0,0,1,1,1,1,0,0,5.2,0,7,1.38,MSS,Wide_Local_Excision,1.4,R0,15.9,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,69.93,1,40.61,0,0.0,20.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000016,2020,62,Female,5,SSM,UpperExtremity,1,1,8.5,0,0,1,0.68,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.41,IB,0,WT,0,1,0,1,0,0,0,0,31.5,1,35,6.16,MSS,Wide_Local_Excision,0.7,R0,1.0,1,Primary_Closure,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,75.08,1,75.08,1,0.0,8.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000017,2022,38,Female,3,SSM,HeadNeck,1,0,10.0,0,0,1,0.7,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.38,IA,0,V600E,1,0,0,0,0,1,0,0,10.7,1,8,3.25,MSS,Wide_Local_Excision,1.1,R0,1.8,0,Primary_Closure,0,17,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,51.78,1,0.0,8.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000018,2015,68,Female,2,SSM,Trunk,0,0,8.0,0,0,3,0.82,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.42,IB,0,V600E,1,0,0,0,0,1,0,0,93.7,1,41,6.34,MSS,Wide_Local_Excision,0.8,R0,1.0,0,None,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,238.16,1,39.56,1,0.0,23.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000019,2014,38,Female,3,NM,Trunk,0,0,6.3,1,0,0,3.55,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.64,IIB,0,V600E,1,0,0,0,1,0,0,0,12.9,1,18,2.31,MSS,Wide_Local_Excision,2.2,R0,5.6,0,Flap,0,14,0,1,Nivolumab_mono,1L,19,PD,19.21,0,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,50.09,1,50.09,1,0.0,16.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000020,2018,47,Male,6,SSM,UpperExtremity,0,0,5.6,0,0,1,1.33,0,0.0,T2a,1,Micrometastasis,1,1,0,N1a,M0,0.44,IIIA,0,V600E,1,0,0,0,0,0,0,0,31.0,1,14,1.93,MSS,Wide_Local_Excision,1.6,R0,9.6,0,Primary_Closure,0,37,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,72.7,0,None,1,Pembrolizumab,0,240.0,1,74.7,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000021,2021,47,Male,2,NM,UpperExtremity,0,0,4.6,0,0,0,3.06,0,7.0,T3a,1,Negative,0,0,0,N0,M0,0.55,IIB,0,V600E,1,0,0,0,0,0,0,0,13.0,1,18,3.22,MSS,Wide_Local_Excision,2.4,R0,3.8,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,43.6,1,43.6,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000022,2017,78,Male,3,SSM,Other,0,0,10.0,1,0,0,0.89,0,1.0,T1b,1,Micrometastasis,1,2,0,N2a,M0,0.74,IIIC,0,Non_V600,0,0,0,1,1,1,0,0,87.0,1,100,6.34,MSS,Wide_Local_Excision,1.1,R0,2.3,0,Skin_Graft,0,14,0,1,Pembrolizumab_mono,1L,14,CR,9.25,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,27.4,0,None,1,Ipilimumab,0,101.22,1,40.35,0,8.67,2.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000023,2023,68,Male,4,UM,Uveal,0,0,6.1,0,0,0,0.94,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.6,IA,0,WT,0,0,0,0,1,0,1,0,5.8,0,9,4.51,MSS,Wide_Local_Excision,0.9,R1,0.0,0,Primary_Closure,0,85,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,183.39,0,0.0,10.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000024,2023,53,Male,2,LMM,HeadNeck,0,0,10.0,0,0,0,6.94,1,5.0,T4b,1,Negative,0,0,0,N0,M0,1.17,IIC,0,V600E,1,0,0,1,0,0,0,0,38.1,1,25,2.23,MSS,Wide_Local_Excision,1.9,R0,7.5,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Ipilimumab,0,47.75,0,10.04,1,0.0,20.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000025,2019,64,Female,4,NM,HeadNeck,0,0,9.3,0,0,0,2.04,0,2.0,T3a,1,Negative,0,0,0,N0,M0,0.81,IIB,0,V600E,1,0,0,1,1,1,0,0,24.8,1,44,0.45,MSS,Wide_Local_Excision,1.9,R2,0.0,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,127.99,1,45.93,0,0.0,3.3,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000026,2018,23,Male,1,SSM,UpperExtremity,0,0,3.0,0,0,0,0.81,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.62,IA,0,WT,0,0,0,0,0,0,0,0,20.7,1,8,3.82,MSS,Wide_Local_Excision,0.9,R0,25.2,0,Primary_Closure,0,57,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,13.18,1,0.0,5.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000027,2014,56,Male,3,SSM,Trunk,0,1,5.2,0,0,1,12.04,1,3.0,T4b,1,Micrometastasis,1,2,0,N2a,M1a_1,1.21,IV,1,V600E,1,0,0,0,0,0,0,0,18.0,1,4,6.65,MSS,Wide_Local_Excision,2.3,R0,6.9,0,Primary_Closure,0,14,0,1,Atezolizumab_Cobimetinib_Vemu,1L,16,SD,8.68,1,1,0,GI,1,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,CR,42.46,1,0,None,0,0,1,0,0,0,1,0,0,3,1,0,0.0,1,0.1,0,None,0,None,0,63.33,0,8.22,1,0.0,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000028,2023,88,Female,3,SSM,UpperExtremity,0,0,5.2,0,0,0,1.61,1,3.0,T2b,1,Micrometastasis,1,1,1,N2c,M0,1.21,IIIC,0,V600E,1,0,0,0,1,0,0,0,8.8,0,11,2.06,MSS,Wide_Local_Excision,1.8,R0,8.6,0,Primary_Closure,0,29,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,9.4,0,None,0,None,1,51.9,1,33.35,0,0.0,16.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000029,2023,59,Male,3,SSM,Trunk,1,0,6.3,0,0,0,0.46,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.07,IA,0,WT,0,0,0,0,0,0,0,0,1.9,0,43,1.82,MSS,Wide_Local_Excision,0.7,R0,1.0,0,Primary_Closure,1,24,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,196.58,0,104.63,1,0.0,4.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000030,2018,58,Male,2,SSM,LowerExtremity,0,0,6.4,0,0,3,2.16,1,3.0,T3b,1,Negative,0,0,0,N0,M0,0.47,IIB,0,WT,0,0,0,0,0,0,0,0,35.4,1,14,0.64,MSS,Wide_Local_Excision,2.0,R0,28.6,1,Primary_Closure,0,69,0,1,Ipilimumab_mono,1L,35,PD,4.22,1,1,0,Endocrine,0,0,0,1,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,1,94.33,0,0.0,14.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000031,2019,65,Female,3,NM,UpperExtremity,0,0,10.0,0,0,1,1.85,0,0.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.56,IIA,0,V600E,1,0,0,0,1,0,0,0,10.1,1,16,2.69,MSS,Wide_Local_Excision,1.5,R0,3.2,0,Primary_Closure,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,44.39,0,0.0,17.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000032,2022,52,Male,4,UM,Uveal,0,0,4.3,0,0,2,2.27,0,6.0,T3a,1,Negative,0,0,1,N2c,M0,0.9,IIIC,0,WT,0,1,0,0,0,0,0,0,19.0,1,50,11.21,MSS,Wide_Local_Excision,1.8,R0,30.0,0,None,0,14,0,1,Ipilimumab_mono,1L,17,PR,0.27,1,1,1,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,6.7,0,None,0,None,0,163.33,0,78.86,1,16.13,7.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000033,2021,25,Male,2,SSM,LowerExtremity,0,0,7.0,0,0,0,1.04,1,2.0,T2b,1,Negative,0,0,0,N0,M0,0.85,IIB,0,V600E,1,0,0,1,0,0,0,0,19.9,1,9,1.56,MSS,Wide_Local_Excision,1.6,R0,3.2,0,Skin_Graft,0,14,0,1,Nivolumab_mono,1L,25,PD,9.02,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,159.31,1,40.54,1,0.0,31.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000034,2015,30,Male,2,SSM,UpperExtremity,0,0,7.7,1,0,0,0.88,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.49,IA,0,Non_V600,0,1,0,0,0,0,0,0,39.2,1,18,3.69,MSS,Wide_Local_Excision,1.3,R0,13.1,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,137.52,1,26.56,0,0.0,7.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000035,2021,60,Female,3,SSM,LowerExtremity,0,0,6.5,0,0,1,3.7,0,5.0,T3a,1,Negative,0,0,0,N0,M0,1.0,IIB,0,V600E,1,0,0,0,0,0,0,0,28.5,1,4,13.17,MSS,Wide_Local_Excision,2.2,R0,1.0,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,21,PR,27.63,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,1.06,1,29.31,2.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000036,2024,45,Male,2,SSM,UpperExtremity,0,0,6.7,1,0,1,1.78,0,4.0,T2a,1,Negative,0,0,0,N0,M1c,0.75,IV,1,WT,0,0,0,0,0,1,0,0,2.1,0,28,4.35,MSS,Wide_Local_Excision,1.8,R0,3.9,0,Primary_Closure,0,45,0,1,Pembrolizumab_mono,1L,10,CR,28.12,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,1,0,0,0,1,3,1,0,0.0,0,0.2,0,None,0,None,0,54.68,1,53.93,1,5.23,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000037,2022,77,Male,2,SSM,HeadNeck,0,0,4.4,0,0,0,2.37,1,6.0,T3b,1,Micrometastasis,1,2,0,N2a,M0,1.25,IIIC,0,WT,0,0,1,0,0,0,0,0,24.5,1,25,1.19,MSS,Wide_Local_Excision,1.9,R0,2.5,1,Primary_Closure,0,66,0,1,Pembrolizumab_mono,1L,20,PD,4.05,0,1,0,Pulmonary,0,1,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,17.7,0,None,0,None,0,146.68,1,40.56,1,0.0,24.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000038,2019,51,Male,4,SSM,Trunk,0,0,6.7,0,0,2,1.63,0,0.0,T2a,1,Macrometastasis,1,0,0,N0,M0,0.92,IIA,0,WT,0,0,0,0,0,0,0,0,11.4,1,44,2.42,MSS,Wide_Local_Excision,1.5,R0,2.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,88.6,1,0.0,2.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000039,2019,26,Male,2,SSM,Acral,1,0,7.5,0,0,1,0.88,0,3.0,T1b,0,Not_Performed,0,0,0,N0,M0,0.47,IB,0,WT,0,0,0,1,0,1,0,0,38.1,1,6,2.94,MSS,Wide_Local_Excision,0.8,R0,2.9,0,Primary_Closure,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,22.85,1,22.85,1,0.0,6.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000040,2016,36,Female,2,SSM,LowerExtremity,0,1,7.2,0,0,1,1.84,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.6,IIA,0,V600E,1,0,0,0,0,0,0,0,24.1,1,17,6.3,MSS,Wide_Local_Excision,1.5,R0,2.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,236.48,0,0.0,20.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000041,2021,18,Male,2,SSM,HeadNeck,0,0,7.6,0,0,0,2.8,0,5.0,T3a,1,Negative,0,0,1,N2c,M1b_1,1.21,IV,1,WT,0,0,0,0,0,0,0,0,24.3,1,6,15.84,MSS,Wide_Local_Excision,2.1,R0,6.5,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,1,0,0,4,0,0,0.0,0,0.4,0,None,0,None,0,2.31,1,2.31,1,0.0,6.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000042,2016,53,Female,1,NM,UpperExtremity,0,0,9.3,0,0,1,3.85,1,4.0,T3b,0,Not_Performed,0,0,0,N0,M0,0.79,IIB,0,V600E,1,0,0,0,0,0,0,0,12.1,1,16,0.22,MSS,Wide_Local_Excision,2.2,R0,1.8,0,Primary_Closure,1,20,0,1,Nivolumab_mono,1L,15,PD,21.11,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,118.73,1,86.98,1,0.0,4.0,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000043,2017,53,Male,3,NM,HeadNeck,0,0,8.4,0,0,0,12.35,1,0.0,T4b,1,Macrometastasis,1,2,0,N2a,M0,0.68,IIIC,0,V600E,1,0,0,1,1,0,0,0,7.2,0,88,1.01,MSS,Wide_Local_Excision,2.3,R0,3.7,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,CR,21.58,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,6.1,0,None,1,Nivolumab,0,26.53,1,26.53,1,0.0,19.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000044,2016,50,Male,2,SSM,Trunk,0,0,6.6,0,0,3,2.18,0,7.0,T3a,1,Negative,0,0,0,N0,M1d_1,1.82,IV,1,V600K,1,0,0,0,0,0,0,0,10.6,1,15,9.95,MSS,Wide_Local_Excision,2.1,R0,1.6,0,None,0,37,0,1,Ipilimumab_Nivolumab,2L,14,SD,19.21,1,1,1,Hepatic,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,0,0,0,0,0,2,1,0,0.0,1,0.4,0,None,0,None,0,13.23,1,3.88,0,0.0,48.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000045,2017,74,Female,1,NM,LowerExtremity,0,0,4.2,0,0,0,4.06,1,4.0,T4b,1,Micrometastasis,1,2,0,N2a,M0,0.42,IIIC,0,WT,0,0,0,0,0,0,0,0,3.6,0,5,0.89,MSS,Wide_Local_Excision,1.8,R0,2.3,0,Skin_Graft,0,14,0,1,Pembrolizumab_mono,1L,18,PD,6.38,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,5.8,0,None,1,Pembrolizumab,0,48.82,1,48.82,1,0.0,6.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000046,2018,76,Male,5,NM,Trunk,0,0,5.3,1,0,0,4.17,1,0.0,T4b,1,Negative,0,0,0,N0,M0,0.92,IIC,0,WT,0,0,0,0,0,0,0,0,9.4,0,10,0.1,MSS,Wide_Local_Excision,1.7,R0,11.6,0,None,0,16,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,133.84,1,15.64,1,0.0,11.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000047,2014,54,Male,4,SSM,Trunk,0,0,6.1,0,0,0,1.32,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.83,IIA,0,WT,0,0,0,0,0,0,0,0,4.6,0,4,1.12,MSS,Wide_Local_Excision,1.6,R0,1.0,1,Primary_Closure,0,21,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,49.43,1,44.33,0,0.0,17.2,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000048,2021,22,Female,3,SSM,UpperExtremity,1,0,7.0,0,0,1,0.5,0,2.0,T1b,1,Negative,0,0,0,N0,M0,0.77,IB,0,V600K,1,0,0,0,1,0,0,0,4.7,0,5,1.99,MSS,Wide_Local_Excision,1.3,R0,19.3,0,Primary_Closure,0,20,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,215.28,1,198.36,1,0.0,11.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000049,2018,66,Male,4,SSM,Trunk,0,0,5.5,0,0,4,1.13,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.83,IIA,0,WT,0,1,0,0,1,0,0,0,16.5,1,39,1.31,MSS,Wide_Local_Excision,1.5,R0,3.2,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,83.63,1,16.14,1,0.0,11.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000050,2024,65,Male,4,SSM,Trunk,0,0,4.6,0,0,2,1.4,0,1.0,T2a,1,Negative,0,0,0,N0,M1d_1,1.32,IV,1,WT,0,0,0,0,0,1,0,0,23.0,1,5,6.26,MSS,Wide_Local_Excision,1.2,R0,3.7,0,Primary_Closure,0,47,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,1,1,0,0,0,0,0,2,1,2,1.4,1,0.7,0,None,0,None,0,12.64,1,10.89,1,0.0,2.6,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000051,2015,61,Female,2,SSM,HeadNeck,1,0,4.1,0,0,1,0.9,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.8,IA,0,WT,0,0,0,0,1,0,0,0,14.6,1,27,2.07,MSS,Wide_Local_Excision,1.4,R0,20.6,0,Primary_Closure,0,97,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,102.24,1,102.24,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000052,2021,72,Male,3,SSM,Trunk,0,0,3.2,0,0,4,1.52,0,5.0,T2a,1,Negative,0,0,1,N2c,M0,2.05,IIIC,0,V600E,1,0,0,0,0,0,0,0,10.1,1,21,2.63,MSS,Wide_Local_Excision,1.6,R0,5.2,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,CR,10.03,0,1,PDGFRA,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,29.6,0,None,0,None,0,119.41,1,58.22,0,0.0,9.9,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000053,2015,38,Male,3,NM,LowerExtremity,0,0,6.0,0,0,1,3.55,0,6.0,T3a,1,Negative,0,0,0,N0,M0,1.19,IIB,0,V600K,1,0,0,0,0,1,0,0,7.0,0,12,1.37,MSS,Wide_Local_Excision,2.0,R0,21.4,0,Skin_Graft,0,14,0,1,Nivolumab_mono,1L,9,SD,0.26,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,215.04,1,130.77,1,0.0,17.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000054,2020,89,Male,2,SSM,Trunk,0,0,3.6,0,0,0,2.06,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.66,IIB,0,WT,0,0,0,0,1,0,0,0,11.6,1,25,5.99,MSS,Wide_Local_Excision,1.8,R0,4.4,0,Flap,0,14,0,1,Pembrolizumab_mono,1L,5,PR,12.28,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,135.29,1,135.29,0,12.92,3.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000055,2019,41,Male,2,NM,LowerExtremity,0,0,4.5,0,0,1,5.57,1,3.0,T4b,1,Negative,0,0,0,N0,M0,0.6,IIC,0,WT,0,0,0,0,0,0,0,0,7.8,0,8,2.09,MSS,Wide_Local_Excision,2.0,R0,1.0,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,2L,30,CR,7.52,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,240.0,0,240.0,0,16.32,4.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000056,2018,68,Male,1,NM,LowerExtremity,0,0,5.7,0,0,0,3.93,0,2.0,T3a,1,Micrometastasis,1,2,0,N2a,M0,0.3,IIIC,0,V600E,1,0,0,0,0,0,0,0,14.3,1,46,1.0,MSS,Wide_Local_Excision,2.1,R0,3.5,0,Skin_Graft,0,27,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,PR,11.33,0,1,BRAF_amplification,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,6.1,0,None,1,Pembrolizumab,0,139.3,0,139.3,1,0.0,9.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000057,2021,30,Female,3,SSM,Trunk,1,0,3.8,0,0,0,0.46,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.14,IA,0,V600E,1,0,0,0,0,0,0,0,4.4,0,10,0.81,MSS,Wide_Local_Excision,1.1,R0,4.9,0,Primary_Closure,0,25,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,156.91,0,144.82,1,0.0,4.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000058,2023,42,Male,3,SSM,LowerExtremity,0,0,7.3,0,0,0,4.2,1,5.0,T4b,1,Micrometastasis,1,0,0,N0,M0,1.01,IIC,0,V600E,1,0,0,0,1,1,0,0,26.3,1,14,1.69,MSS,Wide_Local_Excision,1.9,R0,18.2,0,Primary_Closure,0,14,0,1,Nivolumab_mono,2L,23,PR,1.57,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,234.84,1,126.33,0,49.87,13.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000059,2017,81,Female,3,SSM,HeadNeck,0,0,8.0,1,0,0,1.09,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.6,IIA,0,V600E,1,0,0,0,0,0,0,0,9.5,0,12,4.87,MSS,Wide_Local_Excision,1.5,R0,13.1,1,Flap,1,32,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,55.68,1,55.68,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000060,2023,52,Male,2,SSM,LowerExtremity,1,0,5.4,0,0,3,1.13,0,3.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.42,IIA,0,WT,0,1,0,1,0,0,0,0,20.3,1,40,1.03,MSS,Wide_Local_Excision,1.4,R0,1.0,0,Primary_Closure,0,73,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,140.48,1,82.44,1,0.0,4.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000061,2016,70,Male,2,SSM,Trunk,1,0,5.6,0,0,4,0.94,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.47,IA,0,V600E,1,0,0,0,0,0,0,0,30.5,1,34,3.22,MSS,Wide_Local_Excision,1.3,R0,5.2,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,8.94,0,0.0,10.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000062,2017,60,Male,2,SSM,UpperExtremity,1,1,7.6,0,0,0,0.85,1,0.0,T1b,1,Negative,0,0,0,N0,M0,0.88,IB,0,V600E,1,0,0,0,0,0,0,0,19.5,1,1,2.16,MSS,Wide_Local_Excision,1.2,R0,15.6,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,102.93,1,102.93,1,0.0,16.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000063,2017,55,Female,2,SSM,LowerExtremity,0,0,5.1,1,0,1,3.54,1,2.0,T3b,1,Macrometastasis,1,1,0,N1b,M0,0.71,IIIB,0,WT,0,0,0,0,0,1,0,0,28.4,1,26,9.85,MSS,Wide_Local_Excision,1.9,R0,12.1,0,Flap,0,14,0,1,Pembrolizumab_mono,3L+,7,PR,2.67,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,20.2,0,None,0,None,1,240.0,0,42.67,0,22.88,25.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000064,2024,78,Male,4,NM,Trunk,0,0,4.9,0,0,0,9.23,1,0.0,T4b,1,Negative,0,0,0,N0,M0,0.98,IIC,0,V600E,1,0,0,0,0,0,0,0,2.9,0,3,2.73,MSS,Wide_Local_Excision,1.8,R0,1.0,0,Primary_Closure,1,65,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,113.55,1,35.07,1,0.0,6.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000065,2015,53,Male,4,SSM,LowerExtremity,0,0,8.9,1,0,0,1.64,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.77,IIA,0,V600E,1,0,0,0,0,0,0,0,10.1,1,14,1.14,MSS,Wide_Local_Excision,1.6,R0,9.2,0,Primary_Closure,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,55.43,1,0.0,23.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000066,2018,28,Female,4,SSM,Trunk,0,0,8.3,0,0,0,1.11,0,2.0,T2a,1,Negative,0,0,0,N0,M0,1.09,IIA,0,V600R,1,0,0,0,0,0,0,0,36.3,1,18,3.6,MSS,Wide_Local_Excision,1.4,R0,20.3,0,Flap,0,21,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,110.42,1,106.27,1,0.0,7.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000067,2018,44,Female,4,SSM,LowerExtremity,0,0,7.7,0,0,0,1.85,1,1.0,T2b,1,Negative,0,0,0,N0,M0,0.86,IIB,0,V600K,1,0,0,0,0,0,0,0,22.5,1,14,3.7,MSS,Wide_Local_Excision,1.4,R0,9.7,0,Primary_Closure,0,26,0,1,Nivolumab_mono,1L,13,CR,4.71,1,1,1,Renal,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,240.0,1,240.0,1,17.45,48.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000068,2022,65,Male,5,SSM,Trunk,0,0,8.4,0,0,0,1.26,1,3.0,T2b,1,Negative,0,0,0,N0,M0,1.03,IIB,0,WT,0,1,0,1,0,0,0,0,65.8,1,33,1.46,MSS,Wide_Local_Excision,1.3,R0,16.9,0,Primary_Closure,0,14,0,1,Nivolumab_mono,1L,15,SD,6.39,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,238.27,1,7.38,1,0.0,14.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000069,2019,63,Female,2,SSM,Trunk,0,0,2.5,0,0,0,1.05,0,2.0,T2a,1,Negative,0,0,0,N0,M1c_1,1.14,IV,1,WT,0,0,0,0,0,0,0,0,58.6,1,41,2.25,MSS,Wide_Local_Excision,1.3,R0,12.9,0,Primary_Closure,0,32,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,1,0,1,0,1,4,0,0,0.0,1,0.3,0,None,0,None,0,46.02,1,3.73,1,0.0,15.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000070,2024,31,Male,1,SSM,Other,0,0,9.2,0,0,0,1.52,0,2.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.45,IIA,0,WT,0,0,0,0,1,0,0,0,19.1,1,9,3.07,MSS,Wide_Local_Excision,1.5,R0,5.7,1,Primary_Closure,0,17,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,89.05,1,0.0,3.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000071,2022,45,Male,1,SSM,HeadNeck,0,0,7.3,0,0,0,0.88,1,0.0,T1b,1,Negative,0,0,0,N0,M0,0.64,IB,0,V600E,1,0,0,0,0,0,0,0,12.3,1,9,2.1,MSS,Wide_Local_Excision,0.9,R0,3.7,0,None,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,150.84,0,13.09,1,0.0,22.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000072,2021,47,Male,2,SSM,HeadNeck,0,0,8.5,1,0,2,1.43,1,0.0,T2b,1,Micrometastasis,1,2,0,N2a,M0,1.14,IIIC,0,WT,0,0,0,0,0,0,0,0,7.0,0,19,0.59,MSS,Wide_Local_Excision,2.0,R0,2.2,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,18.8,0,None,1,Pembrolizumab,0,61.7,1,61.7,0,0.0,50.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000073,2022,51,Male,2,LMM,Acral,0,0,7.3,0,0,0,1.38,0,2.0,T2a,1,Negative,0,0,0,N0,M0,1.57,IIA,0,V600K,1,0,0,0,0,0,0,0,10.3,1,4,2.45,MSS,Wide_Local_Excision,1.6,R0,1.3,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,239.8,0,5.32,1,0.0,10.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000074,2015,34,Male,1,SSM,UpperExtremity,0,0,6.6,0,0,0,1.83,1,1.0,T2b,1,Negative,0,0,0,N0,M1d_1,1.83,IV,1,WT,0,1,0,0,1,0,0,0,10.8,1,12,33.66,MSS,Wide_Local_Excision,1.3,R0,1.8,0,Primary_Closure,0,115,0,1,Ipilimumab_Nivolumab,1L,12,PD,11.26,1,1,0,Pulmonary,0,1,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,1,0,0,0,0,1,3,1,3,0.8,1,0.2,1,Brain_SRS,0,None,0,16.93,1,9.57,1,0.0,7.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000075,2018,46,Female,5,SSM,Trunk,0,0,5.9,0,0,1,0.78,0,2.0,T1b,1,Negative,0,0,0,N0,M1b_1,1.16,IV,1,V600E,1,0,0,0,1,1,0,0,9.3,0,77,17.07,MSS,Wide_Local_Excision,0.7,R0,13.3,0,Primary_Closure,0,31,0,1,Ipilimumab_Nivolumab,1L,19,PR,3.6,1,1,1,Skin,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,PR,21.44,1,0,None,0,0,0,0,0,0,0,0,0,5,0,0,0.0,0,1.0,0,None,0,None,0,49.59,1,49.59,0,4.08,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000076,2020,45,Male,1,SSM,Trunk,1,0,7.2,0,0,0,1.97,1,1.0,T2b,1,Negative,0,0,0,N0,M0,0.34,IIB,0,V600E,1,0,0,1,1,0,0,0,7.2,0,4,1.51,MSS,Wide_Local_Excision,1.6,R0,3.2,0,Primary_Closure,0,21,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Ipilimumab,0,45.99,0,35.29,0,0.0,9.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000077,2016,69,Female,5,SSM,UpperExtremity,0,0,5.9,0,0,0,0.64,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.05,IB,0,V600E,1,0,0,0,1,1,0,0,20.7,1,14,5.58,MSS,Wide_Local_Excision,0.9,R0,11.6,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,102.76,1,49.23,0,0.0,6.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000078,2015,69,Female,3,SSM,Trunk,1,0,8.2,0,0,0,0.8,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.59,IA,0,WT,0,0,0,0,1,0,0,0,58.3,1,11,5.26,MSS,Wide_Local_Excision,1.3,R0,11.6,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,237.59,1,158.41,0,0.0,27.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000079,2015,54,Female,3,SSM,HeadNeck,0,0,3.3,1,0,1,0.83,0,2.0,T1b,1,Negative,0,0,0,N0,M0,2.42,IB,0,WT,0,0,0,0,1,1,0,0,31.6,1,100,4.27,MSS,Wide_Local_Excision,1.1,R0,5.8,0,Primary_Closure,0,66,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,56.12,1,0.0,13.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000080,2022,50,Female,3,NM,Trunk,0,0,5.4,0,0,1,1.65,0,0.0,T2a,1,Negative,0,0,1,N2c,M1c_1,3.33,IV,1,V600E,1,0,0,0,0,0,0,0,11.6,1,12,18.36,MSS,Wide_Local_Excision,1.1,R0,15.1,0,Primary_Closure,0,47,0,1,Atezolizumab_Cobimetinib_Vemu,3L+,28,PR,0.1,0,1,1,Pulmonary,0,0,0,0,0,1,0,1,Vemurafenib_Cobimetinib,1,PR,18.28,1,0,None,1,0,1,0,1,0,0,0,0,4,0,0,0.0,1,1.4,0,None,0,None,0,58.58,1,14.13,0,13.53,10.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000081,2021,59,Female,2,SSM,Trunk,0,0,10.0,0,0,1,2.44,1,2.0,T3b,1,Negative,0,0,0,N0,M0,1.72,IIB,0,Non_V600,0,0,0,0,0,0,0,0,33.8,1,12,3.22,MSS,Wide_Local_Excision,1.8,R0,4.4,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,141.56,1,139.66,0,0.0,17.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000082,2017,43,Female,3,SSM,Trunk,0,0,5.2,0,0,1,0.61,1,0.0,T1b,1,Negative,0,0,0,N0,M0,1.0,IB,0,WT,0,1,0,0,0,0,0,0,19.8,1,7,2.16,MSS,Wide_Local_Excision,0.9,R0,10.7,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,20.6,1,20.6,1,0.0,12.0,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000083,2022,38,Male,1,NM,Trunk,0,1,6.0,1,0,0,2.15,0,0.0,T3a,1,Negative,0,0,0,N0,M0,0.49,IIB,0,V600K,1,0,0,0,0,1,0,0,14.5,1,20,0.83,MSS,Wide_Local_Excision,2.1,R0,20.3,0,Primary_Closure,0,32,0,1,Pembrolizumab_mono,1L,20,PR,10.55,1,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,54.0,1,54.0,1,46.7,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000084,2021,41,Male,5,SSM,Trunk,0,0,4.7,1,0,0,2.89,0,5.0,T3a,1,Macrometastasis,1,1,0,N1b,M0,0.81,IIIB,0,V600E,1,0,0,0,1,0,0,0,13.8,1,26,0.97,MSS,Wide_Local_Excision,1.8,R0,6.6,0,Primary_Closure,0,30,0,1,Nivolumab_mono,2L,5,CR,4.21,1,1,0,Neurologic,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,CR,12.64,0,1,COT1_amplification,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,28.5,0,None,1,Pembrolizumab,0,240.0,1,240.0,1,23.87,4.2,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000085,2022,46,Male,2,SSM,LowerExtremity,0,0,7.2,1,0,0,0.8,1,1.0,T1b,1,Negative,0,0,0,N0,M0,1.01,IB,0,WT,0,0,0,0,0,1,0,0,12.8,1,8,1.23,MSS,Wide_Local_Excision,1.0,R0,5.0,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,35.8,1,1.88,0,0.0,3.9,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000086,2024,38,Male,2,SSM,Trunk,0,0,5.0,0,0,0,1.05,0,4.0,T2a,1,Negative,0,0,0,N0,M0,0.68,IIA,0,Non_V600,0,0,0,0,0,0,0,0,25.3,1,54,6.14,MSS,Wide_Local_Excision,1.2,R0,25.7,0,Primary_Closure,0,22,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,22.1,1,22.1,1,0.0,25.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000087,2023,59,Male,3,NM,UpperExtremity,0,0,6.1,0,0,0,1.72,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.04,IIA,0,WT,0,0,0,0,0,1,0,0,16.8,1,26,4.73,MSS,Wide_Local_Excision,1.5,R0,21.0,0,Skin_Graft,0,33,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,47.84,0,47.84,0,0.0,16.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000088,2015,68,Female,3,SSM,HeadNeck,0,0,8.2,1,0,0,2.15,1,5.0,T3b,1,Micrometastasis,1,3,0,N2a,M0,1.03,IIIC,0,WT,0,1,0,0,0,0,0,0,8.4,0,47,0.84,MSS,Wide_Local_Excision,2.1,R0,30.0,0,Flap,0,53,0,1,Ipilimumab_mono,1L,23,SD,1.26,0,1,1,Pulmonary,0,1,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,17.9,1,Nodal_Basin,1,Nivolumab,0,9.17,0,9.17,1,0.0,30.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000089,2022,31,Male,2,SSM,UpperExtremity,0,0,5.1,0,0,1,2.17,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.94,IIB,0,WT,0,0,1,0,0,1,0,0,8.1,0,14,2.09,MSS,Wide_Local_Excision,2.3,R0,5.0,0,Flap,0,14,0,1,Pembrolizumab_mono,1L,11,SD,20.1,1,1,0,Pulmonary,0,1,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,88.94,1,88.94,1,0.0,9.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000090,2018,57,Female,3,SSM,LowerExtremity,0,0,8.1,0,0,0,2.01,0,8.0,T3a,1,Negative,0,0,0,N0,M0,0.74,IIB,0,V600E,1,0,0,0,0,0,0,0,19.2,1,26,1.45,MSS,Wide_Local_Excision,2.0,R0,7.6,0,Skin_Graft,0,14,0,1,Nivolumab_mono,1L,20,SD,10.66,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,225.59,1,30.11,0,0.0,13.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000091,2018,53,Male,1,SSM,Trunk,0,0,8.1,0,0,0,1.75,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.46,IIA,0,WT,0,1,0,0,0,0,0,0,21.1,1,16,1.77,MSS,Wide_Local_Excision,1.3,R1,0.0,0,Primary_Closure,0,32,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,62.07,1,62.07,1,0.0,1.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000092,2021,62,Male,3,SSM,Trunk,0,0,8.6,0,0,1,1.26,0,1.0,T2a,1,Negative,0,0,0,N0,M1b_1,1.56,IV,1,V600E,1,0,0,1,0,0,0,0,11.7,1,86,1.55,MSS,Wide_Local_Excision,1.8,R0,1.0,0,Primary_Closure,0,14,0,1,Ipilimumab_Nivolumab,1L,1,PR,13.91,0,1,1,Endocrine,0,0,0,0,1,1,0,1,Vemurafenib_Cobimetinib,1,SD,19.02,1,0,None,0,0,1,0,0,0,1,0,0,3,1,0,0.0,1,0.9,0,None,0,None,0,50.11,1,22.58,1,2.95,22.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000093,2020,56,Male,2,SSM,Trunk,0,0,6.8,0,0,0,0.83,1,0.0,T1b,1,Negative,0,0,0,N0,M0,0.79,IB,0,WT,0,0,0,0,0,0,0,0,6.1,0,22,6.16,MSS,Wide_Local_Excision,1.0,R0,6.5,1,Primary_Closure,0,120,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,159.48,1,159.48,1,0.0,14.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000094,2018,33,Male,2,SSM,Acral,0,0,10.0,0,0,1,0.68,1,0.0,T1b,1,Negative,0,0,0,N0,M0,0.35,IB,0,WT,0,0,0,0,0,1,0,0,40.8,1,20,1.97,MSS,Wide_Local_Excision,1.2,R0,9.2,0,Primary_Closure,0,91,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,23.3,1,23.3,1,0.0,40.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000095,2024,36,Male,1,SSM,LowerExtremity,0,0,8.6,0,0,2,2.96,0,2.0,T3a,1,Macrometastasis,1,3,0,N2a,M0,0.79,IIIC,0,WT,0,0,0,1,0,1,0,0,34.4,1,13,2.38,MSS,Wide_Local_Excision,1.9,R0,7.1,1,Skin_Graft,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,12.6,1,Nodal_Basin,0,None,0,2.31,0,2.31,1,0.0,3.1,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000096,2015,57,Male,2,SSM,Trunk,0,0,7.1,1,0,3,2.05,0,3.0,T3a,1,Negative,0,0,0,N0,M0,0.71,IIB,0,V600K,1,0,0,0,0,0,0,0,3.1,0,12,2.39,MSS,Wide_Local_Excision,2.0,R0,5.6,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,3L+,19,CR,13.22,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,1,240.0,1,15.58,15.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000097,2015,73,Male,2,SSM,UpperExtremity,0,0,4.7,0,0,0,0.74,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M1c_1,1.07,IV,1,V600E,1,0,0,1,0,1,0,0,43.8,1,25,9.74,MSS,Wide_Local_Excision,0.8,R0,14.7,0,Primary_Closure,0,30,0,1,Atezolizumab_Cobimetinib_Vemu,1L,1,PR,12.36,1,1,1,GI,0,0,0,0,1,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,1,0,0,0,0,4,0,0,0.0,1,1.9,0,None,0,None,0,29.39,1,25.95,0,6.39,11.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000098,2014,21,Male,2,SSM,HeadNeck,0,0,6.3,1,0,0,1.23,1,2.0,T2b,1,Negative,0,0,1,N2c,M0,0.65,IIIC,0,V600E,1,0,0,0,0,0,0,0,12.7,1,45,2.18,MSS,Wide_Local_Excision,1.6,R0,1.5,0,Primary_Closure,0,120,0,1,Ipilimumab_mono,1L,19,SD,2.8,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,24.9,1,Nodal_Basin,1,Pembrolizumab,0,1.19,1,1.19,1,0.0,16.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000099,2022,62,Male,1,SSM,LowerExtremity,0,0,9.4,0,0,1,0.97,0,1.0,T1b,0,Not_Performed,0,0,0,N0,M0,0.65,IB,0,V600R,1,0,0,0,0,0,0,0,17.5,1,10,4.68,MSS,Wide_Local_Excision,1.2,R0,2.6,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,118.04,1,118.04,1,0.0,6.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000100,2018,63,Male,5,UM,Uveal,0,0,9.9,1,0,1,0.54,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.6,IA,0,WT,0,0,0,0,1,0,1,0,7.3,0,23,6.5,MSS,Wide_Local_Excision,0.9,R0,14.0,0,Primary_Closure,0,23,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,109.46,0,109.46,0,0.0,1.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000101,2018,51,Male,5,ALM,Acral,0,0,9.5,0,0,1,1.36,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.81,IIA,0,V600E,1,0,0,0,0,0,0,0,8.5,0,24,0.8,MSS,Wide_Local_Excision,1.4,R0,3.1,0,Primary_Closure,0,23,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,238.27,0,83.19,1,0.0,3.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000102,2021,65,Male,1,SSM,LowerExtremity,0,0,8.1,0,0,0,0.9,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.12,IA,0,WT,0,0,0,0,0,0,0,0,33.5,1,29,0.59,MSS,Wide_Local_Excision,1.1,R0,14.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,172.37,1,11.12,0,0.0,27.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000103,2018,45,Male,3,SSM,LowerExtremity,0,0,4.0,0,0,0,0.62,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.71,IA,0,V600E,1,0,0,0,0,0,0,0,18.2,1,4,2.1,MSS,Wide_Local_Excision,0.8,R0,1.0,0,Flap,1,32,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,199.02,1,129.04,1,0.0,32.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000104,2020,61,Male,4,UM,Uveal,1,0,7.5,0,0,0,0.43,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.35,IA,0,WT,0,0,0,0,0,0,1,0,14.8,1,8,4.86,MSS,Wide_Local_Excision,0.7,R1,0.0,1,Skin_Graft,0,14,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,72.73,0,0.0,2.6,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000105,2014,31,Male,2,NM,Trunk,0,0,4.0,1,0,0,1.17,0,2.0,T2a,1,Negative,0,0,0,N0,M1d,0.5,IV,1,V600E,1,0,0,0,0,0,0,0,3.0,0,5,12.7,MSS,Wide_Local_Excision,1.6,R0,2.1,1,Primary_Closure,0,28,0,1,Pembrolizumab_mono,2L,34,PR,12.12,0,1,0,Skin,0,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,SD,13.68,1,1,KRAS_mut,0,1,0,1,0,0,0,0,0,2,1,2,4.0,1,0.8,1,Brain_SRS,0,None,0,43.37,0,5.48,0,9.89,22.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000106,2015,19,Female,4,NM,Acral,0,0,3.5,0,0,0,2.7,1,3.0,T3b,1,Negative,0,0,0,N0,M0,0.57,IIB,0,Non_V600,0,1,0,0,1,0,0,0,30.3,1,21,3.45,MSS,Wide_Local_Excision,2.0,R0,2.6,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,49.28,1,9.62,1,0.0,6.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000107,2024,72,Female,1,SSM,UpperExtremity,0,0,7.0,1,0,2,1.13,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.65,IIA,0,V600E,1,0,0,0,0,0,0,0,43.9,1,8,0.67,MSS,Wide_Local_Excision,1.5,R0,20.8,0,Primary_Closure,0,78,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,127.23,0,14.35,1,0.0,3.1,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000108,2018,41,Female,1,SSM,Trunk,0,0,7.5,0,0,0,0.65,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.49,IA,0,WT,0,0,0,0,0,0,0,0,7.8,0,12,1.27,MSS,Wide_Local_Excision,1.1,R0,3.3,0,Primary_Closure,0,76,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,237.62,1,36.44,0,0.0,27.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000109,2015,49,Male,3,SSM,UpperExtremity,0,0,8.3,0,0,1,1.89,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.76,IIA,0,V600K,1,0,0,0,0,1,0,0,12.1,1,6,0.35,MSI_L,Wide_Local_Excision,1.6,R0,1.0,1,Primary_Closure,0,108,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,58.95,1,58.95,1,0.0,15.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000110,2018,50,Male,5,ALM,UpperExtremity,0,0,7.5,1,0,3,1.15,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.13,IIA,0,V600E,1,0,0,1,0,0,0,0,7.7,0,13,1.78,MSS,Wide_Local_Excision,1.5,R0,13.7,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,117.05,1,0.0,19.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000111,2017,34,Male,4,SSM,HeadNeck,0,0,7.6,0,0,0,1.8,0,3.0,T2a,1,Negative,0,0,0,N0,M0,1.08,IIA,0,V600E,1,0,0,1,1,0,0,0,9.4,0,6,0.35,MSS,Wide_Local_Excision,1.3,R0,16.8,0,Skin_Graft,0,79,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,119.44,1,81.44,1,0.0,6.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000112,2017,54,Female,1,SSM,Trunk,0,0,4.5,1,0,1,1.06,1,3.0,T2b,1,Negative,0,0,0,N0,M0,1.4,IIB,0,V600E,1,0,0,0,0,1,0,0,35.4,1,43,5.81,MSS,Wide_Local_Excision,1.4,R0,4.3,0,Primary_Closure,1,43,0,1,Pembrolizumab_mono,1L,14,PD,5.47,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Ipilimumab,0,38.24,0,38.24,0,0.0,14.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000113,2017,45,Female,3,SSM,LowerExtremity,0,0,6.3,1,1,1,0.69,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.48,IB,0,WT,0,0,0,0,0,1,0,0,17.9,1,32,6.94,MSS,Wide_Local_Excision,1.1,R0,2.5,1,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,67.52,0,67.52,1,0.0,6.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000114,2022,63,Female,2,SSM,UpperExtremity,0,0,3.5,0,0,0,1.3,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.33,IIA,0,V600E,1,0,0,0,0,0,0,0,12.5,1,23,2.24,MSS,Wide_Local_Excision,1.5,R1,0.0,0,Primary_Closure,0,14,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,117.49,1,3.74,1,0.0,37.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000115,2015,64,Female,2,SSM,Trunk,0,0,2.5,0,0,0,0.5,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.46,IA,0,V600E,1,0,0,0,0,1,0,0,125.7,1,15,0.6,MSS,Wide_Local_Excision,0.9,R0,13.1,0,Primary_Closure,1,34,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,124.15,0,105.62,0,0.0,10.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000116,2017,62,Male,1,LMM,Trunk,0,0,8.0,0,0,1,1.75,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.36,IIA,0,V600E,1,0,0,0,0,0,0,0,4.8,0,3,2.7,MSS,Wide_Local_Excision,1.3,R0,9.7,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,89.66,1,89.66,1,0.0,1.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000117,2019,60,Female,6,NM,HeadNeck,0,0,5.0,0,0,1,1.82,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.95,IIA,0,V600E,1,0,0,1,0,0,0,0,23.3,1,13,8.85,MSS,Wide_Local_Excision,1.6,R0,6.8,0,Skin_Graft,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,167.25,0,119.02,1,0.0,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000118,2019,82,Female,1,NM,Trunk,0,0,8.2,0,0,1,6.66,1,3.0,T4b,1,Negative,0,0,0,N0,M1c_1,1.3,IV,1,V600K,1,0,0,0,1,0,0,0,6.5,0,9,71.73,MSS,Amputation,2.0,R0,6.4,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,1,1,0,0,0,3,1,0,0.0,1,0.4,0,None,0,None,0,37.01,1,3.11,1,0.0,1.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000119,2023,39,Male,4,SSM,Trunk,0,0,8.7,0,0,4,0.95,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.61,IA,0,V600E,1,0,0,1,0,0,0,0,13.2,1,26,5.16,MSS,Wide_Local_Excision,1.2,R0,13.8,0,Primary_Closure,0,84,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,66.11,0,54.51,0,0.0,13.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000120,2024,56,Female,3,SSM,LowerExtremity,0,0,5.3,1,0,0,2.52,0,1.0,T3a,1,Micrometastasis,1,0,0,N0,M0,0.68,IIB,0,WT,0,1,0,0,0,0,0,0,16.9,1,37,1.36,MSS,Wide_Local_Excision,2.2,R0,1.5,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,96.95,1,96.36,1,0.0,4.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000121,2017,75,Male,3,SSM,Trunk,0,0,7.7,0,1,1,0.55,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.86,IA,0,V600E,1,0,0,0,0,0,0,0,29.5,1,28,1.0,MSS,Wide_Local_Excision,0.9,R0,5.1,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,135.31,1,0.0,6.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000122,2019,77,Female,3,SSM,Trunk,0,0,5.2,1,0,1,0.75,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.41,IB,0,V600K,1,0,0,0,0,0,0,0,12.2,1,71,1.89,MSS,Wide_Local_Excision,1.2,R0,10.6,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,101.26,1,101.26,1,0.0,11.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000123,2014,34,Female,4,SSM,Trunk,0,0,2.8,0,0,1,1.57,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.45,IIA,0,WT,0,1,1,0,0,0,0,0,11.2,1,11,0.43,MSS,Wide_Local_Excision,1.5,R0,3.7,1,Flap,0,66,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,98.8,1,98.8,1,0.0,7.9,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000124,2020,52,Male,1,SSM,HeadNeck,0,0,6.7,0,0,1,2.72,0,3.0,T3a,0,Not_Performed,0,0,0,N0,M0,0.74,IIB,0,V600E,1,0,0,0,0,0,0,0,12.0,1,11,12.24,MSS,Wide_Local_Excision,2.1,R0,14.4,0,Primary_Closure,0,33,0,1,Pembrolizumab_mono,1L,33,PR,10.74,1,1,0,Hepatic,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,0,144.11,1,10.2,19.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000125,2015,78,Female,1,SSM,Trunk,0,0,5.6,0,0,1,3.85,0,4.0,T3a,1,Negative,0,0,0,N0,M0,1.2,IIB,0,Non_V600,0,0,0,0,0,1,0,0,6.3,0,56,2.24,MSS,Wide_Local_Excision,1.6,R0,5.0,0,Primary_Closure,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,83.98,1,76.01,1,0.0,27.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000126,2014,65,Male,3,SSM,Trunk,0,0,5.6,0,0,2,1.24,1,1.0,T2b,1,Negative,0,0,0,N0,M0,0.73,IIB,0,WT,0,0,0,0,0,0,0,0,24.9,1,24,4.0,MSS,Wide_Local_Excision,1.3,R0,5.9,0,Skin_Graft,1,51,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,123.21,1,45.93,1,0.0,26.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000127,2021,60,Female,2,SSM,Trunk,1,0,10.0,0,0,0,4.34,1,3.0,T4b,1,Negative,0,0,0,N0,M0,0.54,IIC,0,WT,0,0,0,0,0,0,0,0,18.8,1,16,1.38,MSS,Wide_Local_Excision,1.8,R0,7.6,0,Flap,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,89.38,1,2.41,1,0.0,21.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000128,2015,53,Female,1,SSM,Trunk,0,0,3.4,0,0,1,0.98,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.31,IA,0,WT,0,0,0,0,0,0,0,0,21.2,1,100,0.58,MSS,Wide_Local_Excision,0.9,R0,15.4,0,Skin_Graft,1,42,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,70.86,1,70.86,1,0.0,15.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000129,2019,50,Female,1,SSM,Trunk,0,0,7.3,0,0,0,2.59,1,3.0,T3b,0,Not_Performed,0,0,0,N0,M0,1.08,IIB,0,WT,0,0,0,1,0,1,0,0,14.2,1,36,6.26,MSS,Wide_Local_Excision,2.0,R0,1.0,0,Primary_Closure,0,19,0,1,Nivolumab_mono,2L,18,PR,8.82,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,205.82,0,205.82,1,1.12,23.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000130,2015,61,Female,2,SSM,Trunk,0,0,4.5,0,0,1,0.62,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.55,IB,0,V600E,1,0,0,1,0,0,0,0,12.9,1,17,0.81,MSI_H,Wide_Local_Excision,1.0,R0,14.9,0,None,0,31,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,18.64,0,18.64,1,0.0,8.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000131,2022,52,Male,1,SSM,Trunk,0,0,8.3,0,0,1,1.61,0,3.0,T2a,0,Not_Performed,0,0,0,N0,M1b_1,1.61,IV,1,WT,0,0,0,1,0,0,0,0,38.4,1,10,4.0,MSS,Wide_Local_Excision,1.6,R0,1.0,0,Primary_Closure,0,37,0,1,Ipilimumab_Nivolumab,1L,22,SD,6.74,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,1,0,0,1,1,0,0.0,0,0.1,0,None,0,None,0,31.06,1,14.86,1,0.0,7.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000132,2022,47,Male,5,ALM,Acral,0,0,7.1,1,0,1,0.23,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.37,IA,0,V600K,1,0,0,0,0,0,0,0,3.3,0,75,2.85,MSS,Wide_Local_Excision,0.9,R0,11.1,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,240.0,1,0.0,15.6,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000133,2020,58,Male,4,SSM,HeadNeck,0,0,7.3,0,0,0,0.55,1,1.0,T1b,1,Negative,0,0,0,N0,M1c_1,1.9,IV,1,V600K,1,0,0,0,0,0,0,0,46.5,1,25,27.73,MSS,Wide_Local_Excision,1.1,R0,1.0,0,Primary_Closure,0,24,0,1,Atezolizumab_Cobimetinib_Vemu,1L,15,PR,3.66,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,5,0,0,0.0,0,0.7,0,None,0,None,0,32.44,1,32.44,1,3.51,40.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000134,2023,46,Male,2,SSM,Trunk,0,0,4.6,0,0,0,1.66,1,0.0,T2b,1,Negative,0,0,0,N0,M0,0.5,IIB,0,WT,0,0,0,0,0,1,0,0,20.2,1,20,1.07,MSS,Wide_Local_Excision,1.9,R0,18.4,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,34.73,1,34.73,1,0.0,20.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000135,2018,65,Male,6,SSM,Trunk,0,0,5.0,0,0,0,0.48,0,1.0,T1b,1,Micrometastasis,1,1,0,N1a,M0,0.67,IIIA,0,WT,0,1,0,0,0,1,0,0,44.3,1,39,1.77,MSS,Amputation,0.9,R0,12.6,0,Primary_Closure,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,18.9,0,None,1,Pembrolizumab,0,117.73,0,53.54,1,0.0,19.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000136,2016,95,Male,5,SSM,HeadNeck,1,0,8.4,1,1,0,1.62,0,3.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.46,IIA,0,WT,0,1,0,0,1,0,0,0,10.8,1,48,0.94,MSS,Wide_Local_Excision,1.4,R0,3.5,0,None,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,121.04,1,77.3,1,0.0,9.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000137,2015,54,Male,4,UM,Uveal,0,0,10.0,0,0,0,2.26,1,4.0,T3b,1,Macrometastasis,1,2,0,N2a,M0,0.8,IIIC,0,WT,0,0,0,1,0,0,1,0,6.1,0,35,3.82,MSS,Wide_Local_Excision,1.9,R0,13.7,0,Primary_Closure,0,18,0,1,Ipilimumab_mono,1L,23,PD,4.34,0,1,1,Skin,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,26.9,0,None,0,None,0,33.19,1,33.19,1,0.0,6.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000138,2016,62,Male,3,SSM,LowerExtremity,0,0,7.5,0,0,2,0.84,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.67,IB,0,WT,0,0,0,0,0,0,0,0,39.0,1,48,3.16,MSS,Wide_Local_Excision,1.0,R0,3.6,0,Primary_Closure,1,101,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,78.06,0,78.06,1,0.0,4.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000139,2016,44,Female,3,NM,Trunk,0,0,4.7,0,0,0,1.78,1,0.0,T2b,1,Negative,0,0,0,N0,M0,1.8,IIB,0,V600E,1,0,0,0,1,0,0,0,29.5,1,31,1.97,MSS,Wide_Local_Excision,1.4,R0,17.9,1,Primary_Closure,1,60,0,1,Pembrolizumab_mono,1L,18,PR,21.3,1,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,185.99,1,16.85,1.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000140,2017,66,Male,3,SSM,Trunk,0,0,7.2,1,0,3,0.86,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.37,IB,0,WT,0,0,0,0,0,1,0,0,11.9,1,35,1.27,MSS,Wide_Local_Excision,0.7,R0,20.3,1,Primary_Closure,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,91.45,1,60.16,0,0.0,4.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000141,2016,57,Female,1,SSM,Trunk,0,0,10.0,0,0,0,0.61,0,0.0,T1a,0,Not_Performed,0,0,1,N2c,M0,0.79,IIIC,0,WT,0,0,0,0,0,0,0,0,6.5,0,10,10.79,MSS,Wide_Local_Excision,0.7,R0,3.4,1,Skin_Graft,0,102,0,1,Pembrolizumab_mono,2L,5,CR,12.08,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,22.5,0,None,1,Nivolumab,0,55.35,0,42.82,1,1.0,1.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000142,2020,69,Male,1,SSM,Trunk,1,0,6.7,0,0,1,1.12,0,0.0,T2a,1,Negative,0,0,0,N0,M1b,0.59,IV,1,V600E,1,0,0,0,1,0,0,0,12.7,1,100,3.74,MSS,Wide_Local_Excision,1.7,R0,2.9,1,None,0,14,0,1,Nivolumab_mono,3L+,27,PD,11.31,1,1,0,GI,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,PR,8.37,1,0,None,0,0,1,0,0,0,0,0,0,2,1,0,0.0,1,0.4,0,None,0,None,0,24.03,1,7.44,1,0.0,1.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000143,2015,57,Male,5,ALM,Acral,1,0,9.4,0,0,1,1.29,0,0.0,T2a,1,Micrometastasis,1,1,0,N1a,M0,0.49,IIIA,0,WT,0,1,1,0,1,1,0,0,24.2,1,6,0.58,MSS,Wide_Local_Excision,1.8,R0,6.4,0,Skin_Graft,0,14,0,1,Pembrolizumab_mono,1L,35,PD,2.33,1,1,0,Endocrine,0,0,1,1,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,18.9,0,None,1,Pembrolizumab,0,240.0,1,190.94,1,0.0,2.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000144,2020,60,Male,3,SSM,UpperExtremity,0,0,5.0,0,0,1,0.97,0,1.0,T1b,1,Negative,0,0,0,N0,M1d_1,1.01,IV,1,V600E,1,0,0,0,0,0,0,0,59.6,1,27,4.98,MSS,Wide_Local_Excision,1.3,R0,1.0,0,None,0,14,0,1,Pembrolizumab_mono,1L,13,PR,11.81,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,1,0,0,0,0,0,2,1,2,2.3,1,0.5,1,Brain_SRS,0,None,0,43.7,1,10.41,0,7.6,14.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000145,2017,75,Male,6,SSM,Trunk,0,0,6.4,0,0,1,3.87,0,2.0,T3a,1,Negative,0,0,0,N0,M0,1.01,IIB,0,V600K,1,0,0,0,0,0,0,0,27.6,1,5,1.63,MSS,Wide_Local_Excision,2.0,R0,22.0,0,Primary_Closure,0,35,0,1,Pembrolizumab_mono,1L,28,PR,12.22,1,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,163.11,0,20.43,24.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000146,2021,19,Male,3,SSM,UpperExtremity,0,0,7.7,0,0,1,0.73,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.77,IA,0,WT,0,1,0,0,0,0,0,0,8.1,0,18,4.81,MSS,Wide_Local_Excision,0.8,R0,11.3,0,Primary_Closure,0,55,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,64.93,1,64.93,0,0.0,46.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000147,2019,82,Male,3,SSM,Trunk,0,0,7.3,0,0,2,3.18,0,3.0,T3a,1,Negative,0,0,0,N0,M0,1.29,IIB,0,WT,0,0,0,0,1,1,0,0,6.5,0,11,3.35,MSS,Wide_Local_Excision,1.9,R1,0.0,1,Primary_Closure,0,32,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,58.13,1,15.93,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000148,2023,63,Male,6,SSM,Trunk,0,0,5.0,0,0,1,0.58,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.31,IA,0,V600K,1,0,0,0,1,0,0,0,8.0,0,23,2.05,MSS,Wide_Local_Excision,0.7,R0,10.4,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,39.47,1,39.47,0,0.0,10.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000149,2018,74,Male,3,SSM,LowerExtremity,0,0,4.9,0,0,0,1.26,0,1.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.53,IIA,0,V600E,1,0,0,0,0,1,0,0,9.6,0,28,2.98,MSS,Wide_Local_Excision,1.2,R0,1.0,0,Primary_Closure,0,89,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,132.46,1,119.73,1,0.0,2.6,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000150,2017,37,Female,1,SSM,HeadNeck,0,0,8.5,0,0,0,2.75,0,1.0,T3a,1,Negative,0,0,0,N0,M0,1.34,IIB,0,V600E,1,0,0,0,0,1,0,0,13.1,1,8,2.94,MSS,Wide_Local_Excision,2.1,R0,12.2,0,Primary_Closure,0,14,0,1,Nivolumab_mono,1L,9,SD,12.27,1,1,1,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,130.71,1,14.15,0,0.0,13.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000151,2020,43,Male,4,NM,Trunk,0,0,8.9,0,0,1,7.73,1,3.0,T4b,1,Negative,0,0,0,N0,M0,1.07,IIC,0,V600E,1,0,0,0,0,0,0,0,36.6,1,19,10.76,MSS,Wide_Local_Excision,2.1,R0,8.2,0,Primary_Closure,0,62,0,1,Ipilimumab_mono,1L,12,PR,5.61,1,1,1,Neurologic,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,195.39,1,44.89,0,3.71,6.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000152,2021,59,Female,2,LMM,HeadNeck,0,0,9.5,0,0,0,0.89,0,1.0,T1b,1,Micrometastasis,1,1,0,N1a,M0,0.92,IIIA,0,V600E,1,0,0,0,0,0,0,0,6.9,0,81,2.45,MSS,Wide_Local_Excision,1.4,R0,21.7,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,18,PD,15.69,1,1,0,Skin,0,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,PD,1.66,1,1,MEK1_mut,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,12.6,0,None,1,Nivolumab,0,240.0,1,16.76,1,0.0,23.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000153,2018,56,Male,1,SSM,Trunk,0,0,10.0,1,0,1,1.77,0,0.0,T2a,1,Negative,0,0,0,N0,M1d,0.75,IV,1,V600E,1,0,0,0,0,1,0,0,93.7,1,5,1.71,MSS,Wide_Local_Excision,1.5,R0,8.2,0,Skin_Graft,0,84,0,1,Nivolumab_mono,2L,32,CR,26.34,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,1,0,0,0,0,0,4,0,6,2.2,1,0.4,1,Brain_SRS,0,None,0,19.81,0,14.24,0,5.59,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000154,2020,61,Female,2,SSM,Trunk,1,0,6.8,0,0,1,1.61,1,0.0,T2b,1,Negative,0,0,0,N0,M0,0.34,IIB,0,V600K,1,0,0,0,0,0,0,0,7.1,0,9,2.34,MSS,Wide_Local_Excision,1.2,R0,2.4,1,Flap,0,14,0,1,Nivolumab_mono,1L,24,PR,10.64,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,1,16.31,1,7.7,34.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000155,2019,74,Female,5,SSM,LowerExtremity,0,0,5.9,1,0,0,0.82,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.02,IA,0,WT,0,0,1,1,0,0,0,0,4.9,0,47,0.25,MSS,Wide_Local_Excision,1.0,R0,12.2,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,50.22,0,0.0,23.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000156,2017,28,Female,2,SSM,Trunk,0,0,9.2,0,0,1,1.85,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.13,IIA,0,V600E,1,0,0,0,1,0,0,0,57.9,1,22,1.95,MSS,Wide_Local_Excision,1.4,R0,6.4,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,158.4,0,21.76,1,0.0,12.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000157,2017,72,Female,2,SSM,UpperExtremity,0,0,7.9,1,0,1,4.42,1,8.0,T4b,1,Negative,0,0,0,N0,M0,0.57,IIC,0,V600R,1,0,0,0,0,0,0,0,43.2,1,23,4.79,MSS,Wide_Local_Excision,1.9,R0,6.2,1,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,3,PR,2.06,1,1,1,Endocrine,0,0,1,1,1,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,96.43,1,86.71,0,11.05,1.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000158,2023,57,Male,1,SSM,UpperExtremity,0,0,4.5,0,0,1,1.67,0,1.0,T2a,1,Negative,0,0,0,N0,M0,2.12,IIA,0,WT,0,0,0,0,0,0,0,0,13.0,1,56,3.24,MSS,Wide_Local_Excision,1.6,R0,2.3,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,60.32,1,26.55,1,0.0,23.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000159,2021,53,Male,1,NM,Trunk,0,0,4.4,0,0,1,5.2,1,4.0,T4b,1,Negative,0,0,0,N0,M0,0.8,IIC,0,V600E,1,0,0,1,0,0,0,0,20.4,1,9,2.54,MSS,Wide_Local_Excision,1.8,R0,20.2,1,Primary_Closure,0,16,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,54.43,1,54.43,1,0.0,6.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000160,2015,33,Male,1,NM,Trunk,0,0,7.5,0,0,2,5.6,0,4.0,T4a,1,Macrometastasis,1,0,0,N0,M0,0.31,IIC,0,WT,0,0,0,0,1,1,0,0,20.8,1,12,3.36,MSS,Wide_Local_Excision,2.0,R0,3.9,0,Primary_Closure,0,70,0,1,Nivolumab_mono,1L,26,PR,7.91,0,1,1,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,71.43,0,15.57,0,2.41,12.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000161,2024,65,Female,3,SSM,Trunk,0,0,6.1,0,0,1,0.43,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.86,IB,0,V600E,1,0,0,0,1,0,0,0,16.7,1,11,4.83,MSS,Wide_Local_Excision,1.1,R0,1.0,0,Primary_Closure,0,79,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,44.82,1,0.0,27.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000162,2021,89,Female,5,ALM,Other,0,0,6.4,0,0,3,1.66,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.56,IIA,0,WT,0,0,1,0,0,0,0,0,3.2,0,14,6.25,MSS,Wide_Local_Excision,1.8,R1,0.0,0,Skin_Graft,0,86,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,24.93,1,24.93,1,0.0,30.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000163,2014,67,Male,1,SSM,UpperExtremity,0,0,8.6,0,0,0,0.59,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.18,IB,0,WT,0,0,0,0,0,0,0,0,2.1,0,76,2.86,MSS,Wide_Local_Excision,1.1,R0,1.3,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,81.17,0,81.17,1,0.0,3.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000164,2022,33,Female,2,SSM,Trunk,0,0,8.0,1,0,1,0.79,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.92,IB,0,V600E,1,1,0,0,0,1,0,0,7.6,0,4,1.55,MSS,Wide_Local_Excision,1.2,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,153.99,1,45.44,1,0.0,34.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000165,2020,57,Male,1,SSM,Trunk,1,0,9.2,0,0,1,5.45,1,4.0,T4b,1,Negative,0,0,0,N0,M1a_1,1.02,IV,1,V600E,1,0,0,0,0,0,0,0,64.1,1,6,10.17,MSS,Wide_Local_Excision,1.9,R0,1.0,0,Skin_Graft,0,80,0,1,Pembrolizumab_mono,1L,6,PR,12.59,0,1,0,Neurologic,0,0,0,0,0,0,0,1,Vemurafenib_mono,0,CR,2.5,1,1,NRAS_mut,0,0,1,0,0,1,0,1,1,1,1,0,0.0,1,1.5,0,None,0,None,0,18.43,0,18.43,1,14.26,6.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000166,2024,55,Female,1,SSM,UpperExtremity,0,0,2.6,0,0,0,1.01,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.35,IIA,0,WT,0,1,0,0,0,0,0,0,66.2,1,5,4.37,MSS,Wide_Local_Excision,1.4,R0,2.8,0,Skin_Graft,0,59,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,207.46,1,76.58,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000167,2019,75,Female,3,NM,Trunk,0,0,7.0,0,0,0,2.08,0,2.0,T3a,1,Negative,0,0,0,N0,M0,1.08,IIB,0,V600E,1,0,1,0,0,0,0,0,12.2,1,81,3.02,MSS,Wide_Local_Excision,2.3,R0,1.4,1,Primary_Closure,0,42,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,0,57.1,1,0.0,4.1,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000168,2019,54,Male,3,NM,UpperExtremity,0,0,7.9,1,0,1,7.84,0,2.0,T4a,1,Negative,0,0,0,N0,M0,0.53,IIC,0,WT,0,0,0,0,0,1,0,0,7.0,0,11,2.26,MSS,Wide_Local_Excision,1.7,R0,4.2,0,Primary_Closure,0,98,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,92.09,1,50.48,1,0.0,37.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000169,2017,45,Female,3,SSM,LowerExtremity,0,0,3.4,0,0,0,0.62,1,1.0,T1b,1,Negative,0,0,0,N0,M0,0.7,IB,0,V600R,1,0,0,0,1,0,0,0,18.7,1,14,1.15,MSS,Amputation,0.9,R0,22.4,0,Primary_Closure,0,62,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,3.0,1,0.0,3.9,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000170,2017,62,Female,4,UM,Uveal,0,0,5.2,0,0,2,0.88,1,0.0,T1b,1,Negative,0,0,0,N0,M0,0.91,IB,0,WT,0,0,0,0,0,0,0,1,4.9,0,4,4.33,MSS,Wide_Local_Excision,1.2,R0,11.7,0,Primary_Closure,1,43,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,74.35,0,74.35,1,0.0,11.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000171,2020,77,Male,3,SSM,Trunk,0,0,4.8,1,0,0,2.88,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.64,IIB,0,WT,0,0,0,0,0,0,0,0,24.3,1,15,1.63,MSS,Wide_Local_Excision,2.0,R0,10.6,0,Primary_Closure,0,44,0,1,Nivolumab_mono,1L,33,SD,8.49,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,238.43,0,47.37,1,0.0,6.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000172,2023,65,Male,1,SSM,Trunk,0,0,6.5,1,0,0,1.24,1,4.0,T2b,1,Negative,0,0,0,N0,M0,0.65,IIB,0,V600K,1,0,0,0,0,0,0,0,2.0,0,48,1.95,MSS,Wide_Local_Excision,1.4,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,135.38,1,28.47,0,0.0,25.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000173,2023,50,Male,1,SSM,Trunk,0,0,9.8,0,0,1,0.4,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.75,IA,0,V600E,1,0,0,0,1,0,0,0,187.6,1,26,1.91,MSS,Wide_Local_Excision,0.9,R0,4.8,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,115.02,1,0.0,8.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000174,2022,72,Female,6,ALM,Acral,1,0,10.0,0,0,0,1.76,1,2.0,T2b,1,Micrometastasis,1,1,0,N1a,M0,0.48,IIIB,0,WT,0,1,0,0,0,0,0,0,8.0,0,18,2.87,MSS,Wide_Local_Excision,1.5,R0,8.0,1,Flap,0,61,0,1,Pembrolizumab_mono,1L,23,PD,19.56,0,1,1,Renal,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,41.8,0,None,0,None,0,30.81,1,30.81,1,0.0,7.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000175,2020,31,Male,3,SSM,HeadNeck,0,0,4.9,0,0,0,0.91,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.3,IA,0,V600E,1,0,0,0,0,0,0,0,12.8,1,4,0.8,MSS,Wide_Local_Excision,1.2,R0,6.1,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,240.0,0,0.0,29.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000176,2019,63,Female,5,SSM,Trunk,0,0,7.6,0,0,1,3.53,0,3.0,T3a,1,Negative,0,0,1,N2c,M0,0.82,IIIC,0,WT,0,0,0,1,1,1,0,0,8.4,0,14,3.14,MSS,Wide_Local_Excision,2.2,R1,0.0,1,Skin_Graft,0,22,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,6.8,0,None,1,Nivolumab,0,35.31,0,30.9,0,0.0,20.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000177,2017,28,Female,4,SSM,UpperExtremity,0,0,7.6,0,0,1,0.79,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.33,IA,0,V600E,1,0,0,0,0,0,0,0,33.0,1,23,1.12,MSS,Wide_Local_Excision,1.0,R0,6.4,0,None,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,101.73,0,73.85,0,0.0,1.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000178,2022,69,Male,3,DM,HeadNeck,0,0,7.3,0,0,0,2.5,0,6.0,T3a,1,Negative,0,0,0,N0,M0,0.5,IIB,0,V600E,1,0,0,0,0,0,0,0,4.9,0,7,1.16,MSS,Wide_Local_Excision,2.2,R0,9.3,1,Primary_Closure,0,26,0,1,Nivolumab_mono,1L,20,PR,2.53,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,240.0,1,155.71,1,1.0,15.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000179,2017,59,Male,5,LMM,Trunk,0,0,7.3,0,0,1,4.16,0,5.0,T4a,0,Not_Performed,0,0,0,N0,M0,0.36,IIC,0,WT,0,0,0,0,0,0,0,0,16.1,1,38,4.06,MSS,Wide_Local_Excision,2.1,R0,23.0,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,29,SD,7.68,0,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Ipilimumab,0,26.9,0,26.9,1,0.0,6.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000180,2016,95,Female,2,NM,Trunk,0,0,7.1,0,0,1,1.93,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.38,IIA,0,WT,0,1,0,0,0,0,0,0,21.6,1,48,0.9,MSS,Wide_Local_Excision,1.7,R0,2.7,0,Skin_Graft,0,105,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,167.92,0,66.8,1,0.0,1.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000181,2023,39,Female,1,LMM,HeadNeck,0,0,9.9,0,0,1,1.05,0,1.0,T2a,1,Micrometastasis,1,3,0,N2a,M0,0.88,IIIC,0,V600E,1,0,0,1,0,1,0,0,13.7,1,12,4.05,MSS,Wide_Local_Excision,1.3,R0,2.5,1,Flap,1,30,0,1,Nivolumab_mono,2L,18,PR,8.8,1,1,0,GI,1,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,CR,9.13,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,24.0,0,None,1,Pembrolizumab,0,191.49,1,101.45,1,22.1,7.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000182,2020,55,Male,1,LMM,HeadNeck,0,0,8.7,1,0,0,1.58,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.68,IIA,0,WT,0,0,0,0,0,0,0,0,20.7,1,41,2.17,MSS,Wide_Local_Excision,1.8,R0,1.8,0,Skin_Graft,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,172.05,1,160.44,0,0.0,9.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000183,2017,85,Male,1,SSM,UpperExtremity,1,0,4.4,0,0,0,0.66,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.67,IB,0,V600K,1,0,0,0,0,0,0,0,26.8,1,18,0.54,MSS,Wide_Local_Excision,1.0,R0,2.3,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,79.34,1,79.34,1,0.0,5.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000184,2023,76,Male,1,SSM,LowerExtremity,0,0,8.1,0,0,3,1.45,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.44,IIA,0,V600E,1,0,0,1,0,0,0,0,19.7,1,63,5.96,MSS,Wide_Local_Excision,1.0,R0,3.5,0,Skin_Graft,0,52,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,190.79,1,159.65,1,0.0,1.0,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000185,2024,45,Female,2,NM,HeadNeck,0,0,8.3,0,0,1,2.99,0,13.0,T3a,1,Negative,0,0,0,N0,M0,0.57,IIB,0,WT,0,0,0,0,0,1,0,0,18.9,1,100,2.56,MSS,Wide_Local_Excision,2.3,R0,8.6,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,222.36,1,38.73,1,0.0,9.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000186,2017,60,Male,3,SSM,LowerExtremity,0,0,7.1,0,0,0,1.01,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.86,IIA,0,V600R,1,0,0,0,0,1,0,0,45.7,1,7,2.74,MSS,Wide_Local_Excision,1.5,R0,5.1,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,108.27,1,46.62,1,0.0,7.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000187,2019,57,Female,3,SSM,Other,0,0,8.8,0,0,2,1.24,0,4.0,T2a,1,Negative,0,0,0,N0,M0,0.73,IIA,0,V600K,1,0,0,0,0,0,0,0,4.2,0,43,4.48,MSS,Wide_Local_Excision,1.4,R0,17.0,0,Primary_Closure,0,89,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,204.9,1,204.9,1,0.0,1.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000188,2019,61,Male,3,SSM,LowerExtremity,0,0,6.9,0,0,0,1.26,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.03,IIA,0,WT,0,1,0,0,0,1,0,0,7.9,0,74,6.64,MSS,Wide_Local_Excision,1.4,R0,2.6,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,90.25,1,90.25,1,0.0,11.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000189,2021,45,Female,1,NM,HeadNeck,0,0,6.9,1,0,1,3.93,0,2.0,T3a,1,Micrometastasis,1,0,0,N0,M0,1.09,IIB,0,V600K,1,0,0,1,0,0,0,0,15.3,1,8,2.35,MSS,Wide_Local_Excision,2.1,R0,10.6,1,Primary_Closure,0,77,0,1,Nivolumab_mono,1L,26,CR,11.51,0,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,1,240.0,1,4.91,27.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000190,2024,55,Male,3,SSM,HeadNeck,0,1,6.7,0,0,1,0.79,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.67,IA,0,WT,0,0,0,0,1,0,0,0,8.4,0,11,3.28,MSS,Wide_Local_Excision,0.8,R0,6.8,0,Primary_Closure,0,52,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,121.68,1,57.79,1,0.0,32.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000191,2020,68,Male,5,ALM,Acral,0,0,2.5,0,0,3,0.81,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.35,IA,0,WT,0,0,1,0,0,0,0,0,4.4,0,11,2.69,MSI_H,Wide_Local_Excision,0.9,R0,1.3,0,Skin_Graft,0,54,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,129.06,0,129.06,1,0.0,2.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000192,2022,59,Female,1,SSM,LowerExtremity,0,0,6.3,0,0,3,1.1,0,2.0,T2a,1,Micrometastasis,1,3,0,N2a,M0,0.55,IIIC,0,V600E,1,0,0,0,1,1,0,0,42.0,1,18,1.52,MSS,Wide_Local_Excision,1.4,R0,9.5,0,Primary_Closure,0,71,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,PR,34.07,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,7.9,1,Nodal_Basin,1,Pembrolizumab,0,88.42,1,79.32,0,0.0,9.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000193,2020,64,Female,2,SSM,HeadNeck,0,1,5.2,0,0,0,1.16,1,1.0,T2b,1,Negative,0,0,0,N0,M0,0.71,IIB,0,V600E,1,0,0,1,0,1,0,0,13.3,1,14,0.56,MSS,Wide_Local_Excision,1.4,R0,6.2,0,Flap,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,108.17,0,108.17,0,0.0,2.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000194,2023,53,Male,2,NM,UpperExtremity,0,0,4.1,0,0,1,2.57,0,1.0,T3a,1,Negative,0,0,0,N0,M0,0.54,IIB,0,WT,0,0,0,0,0,0,0,0,3.5,0,16,2.38,MSS,Wide_Local_Excision,1.9,R0,10.9,0,Primary_Closure,0,40,0,1,Ipilimumab_mono,2L,26,SD,1.41,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,0,21.5,1,0.0,20.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000195,2018,31,Male,2,SSM,LowerExtremity,0,0,9.4,0,0,0,1.51,1,4.0,T2b,1,Negative,0,0,0,N0,M0,0.49,IIB,0,WT,0,1,0,0,0,0,0,0,10.7,1,46,6.03,MSS,Wide_Local_Excision,1.7,R0,13.8,1,Primary_Closure,0,93,0,1,Pembrolizumab_mono,1L,6,PR,12.25,1,1,1,Endocrine,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,227.01,1,134.02,0,12.53,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000196,2018,72,Male,4,SSM,UpperExtremity,0,0,7.5,0,0,1,0.34,0,2.0,T1b,1,Negative,0,0,0,N0,M1c_1,3.01,IV,1,V600E,1,0,0,0,1,0,0,0,15.7,1,3,17.18,MSS,Wide_Local_Excision,1.1,R0,2.2,0,Primary_Closure,0,14,0,1,Ipilimumab_Nivolumab,2L,1,PR,2.81,1,1,1,GI,0,0,0,0,1,0,0,1,Vemurafenib_mono,0,CR,9.51,0,0,None,0,0,0,0,1,1,1,0,0,1,1,0,0.0,1,0.9,0,None,0,None,0,7.55,0,7.55,0,15.63,7.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000197,2018,62,Male,3,SSM,HeadNeck,0,0,6.4,1,0,1,0.72,1,0.0,T1b,1,Negative,0,0,0,N0,M0,1.96,IB,0,V600E,1,0,0,0,0,0,0,0,15.5,1,8,0.85,MSS,Wide_Local_Excision,1.1,R0,9.9,0,None,0,89,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,128.2,1,77.49,1,0.0,3.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000198,2024,45,Male,3,LMM,HeadNeck,1,0,5.4,0,0,0,0.99,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.61,IA,0,V600E,1,0,0,0,0,0,0,0,23.4,1,39,4.81,MSS,Wide_Local_Excision,1.1,R0,4.6,0,Flap,0,19,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,58.59,1,40.5,1,0.0,6.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000199,2020,52,Female,1,SSM,LowerExtremity,0,0,7.1,0,1,0,0.66,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.74,IA,0,WT,0,0,0,1,0,1,0,0,21.9,1,35,1.56,MSS,Wide_Local_Excision,1.0,R0,1.0,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,80.78,1,0.0,15.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000200,2015,32,Male,4,SSM,LowerExtremity,0,0,8.5,0,0,0,3.75,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.44,IIB,0,WT,0,1,0,0,0,0,0,0,13.4,1,7,0.38,MSS,Wide_Local_Excision,1.8,R0,1.0,0,Skin_Graft,0,17,0,1,Pembrolizumab_mono,1L,6,PR,34.64,0,1,0,Pulmonary,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,22.97,1,22.97,1,14.67,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000201,2014,40,Female,3,NM,Acral,0,0,4.8,1,0,0,3.55,0,2.0,T3a,1,Negative,0,0,0,N0,M0,1.22,IIB,0,WT,0,1,0,0,0,0,0,0,5.8,0,35,4.52,MSS,Wide_Local_Excision,2.4,R0,12.1,0,Skin_Graft,0,14,0,1,Pembrolizumab_mono,1L,26,PD,29.8,1,1,0,Pulmonary,0,1,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,1,48.72,1,0.0,4.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000202,2019,48,Male,4,UM,Uveal,0,0,6.5,0,0,0,1.36,0,2.0,T2a,1,Negative,0,0,0,N0,M0,1.05,IIA,0,WT,0,0,0,0,0,0,1,0,14.0,1,75,0.94,MSS,Wide_Local_Excision,1.7,R0,11.7,0,Primary_Closure,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,30.32,1,0.0,11.2,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000203,2022,76,Male,3,SSM,LowerExtremity,0,0,8.2,0,0,2,0.86,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M1c_1,1.05,IV,1,WT,0,1,0,1,0,0,0,0,9.1,0,19,9.91,MSS,Wide_Local_Excision,1.3,R1,0.0,0,Primary_Closure,0,14,1,1,Ipilimumab_Nivolumab,1L,34,SD,18.25,1,1,1,Skin,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,1,0,0,0,0,1,1,0,0.0,0,0.5,0,None,0,None,0,31.55,0,12.48,1,0.0,1.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000204,2019,46,Female,2,SSM,LowerExtremity,0,0,2.6,0,0,0,1.19,1,0.0,T2b,1,Negative,0,0,0,N0,M0,1.28,IIB,0,V600E,1,0,0,0,0,0,0,0,11.9,1,7,5.01,MSS,Wide_Local_Excision,1.7,R0,5.9,0,Flap,0,14,0,1,Pembrolizumab_mono,1L,22,PR,17.79,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,87.35,1,45.98,1,14.88,21.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000205,2020,67,Male,2,SSM,HeadNeck,0,0,6.4,0,0,1,0.51,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.62,IA,0,V600E,1,0,0,0,0,0,0,0,26.1,1,48,1.67,MSS,Wide_Local_Excision,0.9,R0,5.5,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,10.45,1,0.0,11.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000206,2022,48,Female,1,SSM,HeadNeck,0,0,5.6,0,1,2,1.07,0,2.0,T2a,1,Micrometastasis,1,0,0,N0,M0,0.66,IIA,0,V600E,1,0,0,1,0,0,0,0,20.7,1,100,2.89,MSS,Wide_Local_Excision,1.0,R0,19.5,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,188.54,1,79.21,1,0.0,3.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000207,2019,60,Male,2,SSM,UpperExtremity,0,0,6.2,0,0,1,0.62,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.47,IB,0,V600K,1,0,0,0,0,0,0,0,29.0,1,8,13.91,MSS,Wide_Local_Excision,0.8,R0,9.1,0,Primary_Closure,0,79,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,86.71,1,0.0,1.7,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000208,2023,54,Female,1,SSM,UpperExtremity,0,0,5.5,0,0,0,0.99,0,1.0,T1b,1,Negative,0,0,1,N2c,M1b_1,2.16,IV,1,V600K,1,0,0,0,0,1,0,0,11.0,1,21,3.68,MSS,Wide_Local_Excision,1.1,R0,17.6,0,Flap,0,33,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,PR,5.04,1,1,BRAF_amplification,0,0,0,0,0,0,1,0,0,1,1,0,0.0,0,0.2,0,None,0,None,0,10.74,0,10.74,1,0.0,5.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000209,2021,70,Female,1,SSM,Trunk,0,0,6.8,0,0,2,0.2,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.3,IA,0,V600E,1,0,0,1,1,0,0,0,50.1,1,59,2.42,MSS,Wide_Local_Excision,1.0,R0,12.9,0,None,0,74,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,200.8,1,187.95,1,0.0,8.8,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000210,2022,48,Female,1,SSM,Acral,0,0,10.0,0,0,1,0.54,0,2.0,T1b,1,Negative,0,0,0,N0,M1c_1,1.02,IV,1,V600E,1,0,0,0,0,0,0,0,25.7,1,22,22.86,MSS,Wide_Local_Excision,0.9,R0,3.4,1,Primary_Closure,0,16,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,CR,8.19,1,0,None,0,0,0,0,1,0,0,0,0,2,1,0,0.0,0,0.7,0,None,0,None,0,40.05,0,7.7,0,0.0,3.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000211,2022,31,Male,5,SSM,Trunk,0,0,5.9,0,0,1,3.34,0,4.0,T3a,1,Macrometastasis,1,0,0,N0,M0,0.59,IIB,0,WT,0,1,0,0,0,0,0,0,16.4,1,3,2.2,MSS,Wide_Local_Excision,1.5,R0,2.4,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,11.35,1,11.35,1,0.0,5.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000212,2020,34,Male,2,SSM,LowerExtremity,0,0,7.1,1,0,2,2.15,0,2.0,T3a,1,Negative,0,0,0,N0,M0,1.06,IIB,0,V600E,1,0,1,0,1,1,0,0,24.3,1,31,3.19,MSS,Wide_Local_Excision,2.0,R0,1.0,0,Skin_Graft,0,118,0,1,Ipilimumab_mono,1L,17,PD,1.04,1,1,1,GI,1,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,187.61,1,112.08,1,0.0,37.3,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000213,2014,48,Male,2,SSM,LowerExtremity,0,0,10.0,0,0,1,3.02,0,2.0,T3a,1,Negative,0,0,0,N0,M0,0.87,IIB,0,V600E,1,0,0,0,0,0,0,0,8.7,0,8,0.95,MSS,Wide_Local_Excision,1.8,R0,6.2,1,Flap,1,20,0,1,Pembrolizumab_mono,2L,27,SD,0.57,1,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,107.56,1,46.41,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000214,2018,37,Male,2,NM,Trunk,0,0,5.4,1,0,1,9.25,1,5.0,T4b,1,Micrometastasis,1,5,0,N2b,M0,0.37,IIIC,0,V600E,1,0,0,0,0,0,0,0,2.8,0,6,0.52,MSS,Wide_Local_Excision,1.9,R1,0.0,0,Primary_Closure,0,19,1,1,Pembrolizumab_mono,2L,27,CR,9.41,1,0,0,None,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,SD,22.65,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,21.7,0,None,1,Ipilimumab,1,13.64,1,13.64,1,11.77,2.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000215,2015,63,Male,4,NM,Trunk,0,1,10.0,1,0,2,5.61,1,2.0,T4b,1,Micrometastasis,1,3,0,N2a,M0,0.82,IIIC,0,V600E,1,0,0,0,1,0,0,0,9.2,0,4,1.59,MSS,Wide_Local_Excision,2.2,R0,23.0,0,Primary_Closure,0,14,0,1,Nivolumab_mono,3L+,4,CR,4.99,1,1,1,GI,0,0,0,0,0,1,0,1,Encorafenib_Binimetinib,1,SD,4.9,1,1,COT1_amplification,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,20.2,0,None,1,Nivolumab,0,240.0,1,64.47,1,20.12,4.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000216,2019,49,Male,3,NM,Trunk,0,0,6.5,0,0,0,2.55,1,2.0,T3b,1,Negative,0,0,0,N0,M0,0.81,IIB,0,V600E,1,0,0,0,0,1,0,0,27.3,1,66,2.06,MSS,Wide_Local_Excision,1.8,R0,11.4,1,Skin_Graft,0,51,0,1,Pembrolizumab_mono,1L,20,SD,3.08,0,1,1,Skin,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,117.77,0,94.24,0,0.0,4.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000217,2015,94,Male,4,SSM,HeadNeck,0,0,10.0,0,0,1,0.58,0,1.0,T1b,1,Negative,0,0,1,N2c,M0,0.86,IIIC,0,WT,0,0,1,0,0,0,0,0,16.0,1,9,2.6,MSS,Wide_Local_Excision,0.8,R0,6.6,0,Primary_Closure,0,14,0,1,Nivolumab_mono,1L,31,PD,2.01,1,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,14.6,0,None,1,Pembrolizumab,0,58.41,1,36.34,1,0.0,3.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000218,2019,29,Male,2,SSM,UpperExtremity,0,0,8.0,0,0,0,2.68,0,5.0,T3a,1,Negative,0,0,0,N0,M0,0.93,IIB,0,V600E,1,0,0,1,0,0,0,0,13.4,1,28,0.64,MSS,Wide_Local_Excision,2.0,R0,2.1,0,Skin_Graft,0,14,0,1,Nivolumab_mono,2L,25,PR,13.89,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,67.3,1,67.3,1,6.3,3.6,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000219,2017,62,Male,4,ALM,UpperExtremity,0,0,7.1,0,0,0,1.26,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.35,IIA,0,Non_V600,0,0,1,0,1,0,0,0,5.2,0,36,3.39,MSS,Wide_Local_Excision,1.7,R0,16.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,57.25,1,57.25,1,0.0,24.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000220,2014,38,Male,3,SSM,LowerExtremity,0,0,6.4,0,0,1,6.88,1,3.0,T4b,1,Negative,0,0,0,N0,M0,0.87,IIC,0,WT,0,0,0,0,0,1,0,0,3.1,0,24,1.03,MSS,Amputation,1.9,R0,13.9,1,None,0,14,0,1,Nivolumab_mono,2L,35,CR,17.84,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,234.05,1,162.3,1,5.93,19.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000221,2015,49,Male,2,SSM,Trunk,0,0,5.3,0,0,0,0.93,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.75,IA,0,V600E,1,0,0,1,0,0,0,0,46.9,1,27,3.25,MSS,Wide_Local_Excision,1.3,R0,1.0,0,Primary_Closure,0,63,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,23.41,0,23.41,1,0.0,4.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000222,2019,59,Female,4,SSM,HeadNeck,0,0,6.7,0,0,3,4.77,1,5.0,T4b,0,Not_Performed,0,0,0,N0,M0,1.17,IIC,0,WT,0,1,0,0,0,0,0,0,12.7,1,29,4.23,MSS,Wide_Local_Excision,1.7,R0,10.8,0,Flap,0,24,0,1,Nivolumab_mono,2L,26,SD,6.78,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Ipilimumab,0,106.6,1,68.55,0,0.0,6.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000223,2014,19,Male,4,SSM,Trunk,0,0,8.3,1,0,0,1.08,0,1.0,T2a,1,Negative,0,0,0,N0,M1b,1.0,IV,1,V600E,1,0,0,0,0,0,0,0,10.6,1,23,25.51,MSS,Wide_Local_Excision,1.2,R0,2.9,0,Primary_Closure,0,52,0,1,Atezolizumab_Cobimetinib_Vemu,2L,4,PR,0.88,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,0,0,0,0,0,4,0,0,0.0,1,0.9,0,None,0,None,0,26.89,1,22.2,1,13.92,15.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000224,2023,50,Male,4,UM,Uveal,0,0,6.5,0,0,1,3.06,0,5.0,T3a,1,Negative,0,0,0,N0,M0,1.07,IIB,0,WT,0,0,0,0,0,0,1,0,16.9,1,9,0.93,MSS,Wide_Local_Excision,1.7,R0,18.0,0,Flap,0,65,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,145.08,1,7.09,1,0.0,3.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000225,2022,87,Male,6,SSM,Trunk,1,0,5.9,1,0,0,3.94,1,4.0,T3b,1,Negative,0,0,0,N0,M0,0.8,IIB,0,V600E,1,0,0,1,1,1,0,0,40.9,1,9,6.88,MSS,Wide_Local_Excision,1.7,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,213.75,0,116.95,0,0.0,4.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000226,2021,54,Female,5,ALM,Acral,0,0,6.0,1,0,3,0.59,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.88,IA,0,WT,0,0,1,0,0,1,0,0,3.9,0,18,4.02,MSS,Wide_Local_Excision,1.1,R0,2.2,1,Skin_Graft,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,195.08,1,57.88,1,0.0,9.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000227,2015,61,Male,2,SSM,UpperExtremity,0,0,8.5,1,0,0,0.85,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M1b,0.61,IV,1,Non_V600,0,1,0,0,0,0,0,0,6.9,0,18,4.57,MSS,Wide_Local_Excision,0.8,R0,27.3,0,Flap,0,34,0,1,TIL_therapy,2L,29,SD,4.83,1,1,0,Cardiac,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,3,1,0,0.0,0,0.6,0,None,0,None,0,14.44,0,14.14,1,0.0,1.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000228,2022,73,Female,2,SSM,LowerExtremity,0,0,9.0,0,0,0,0.58,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.75,IA,0,V600K,1,0,0,0,1,0,0,0,38.1,1,31,6.47,MSS,Wide_Local_Excision,0.7,R0,3.6,0,Skin_Graft,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,28.28,1,28.28,1,0.0,3.2,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000229,2020,54,Female,1,SSM,UpperExtremity,0,1,5.2,0,0,0,0.51,0,1.0,T1b,0,Not_Performed,0,0,1,N2c,M0,1.76,IIIC,0,WT,0,0,0,0,1,1,0,0,13.4,1,60,2.14,MSS,Wide_Local_Excision,1.1,R0,2.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,3.5,0,None,0,None,0,204.64,1,36.19,1,0.0,12.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000230,2018,47,Male,4,SSM,Trunk,0,0,5.2,0,0,1,1.91,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.55,IIA,0,V600E,1,0,0,0,0,0,0,0,9.2,0,28,1.22,MSS,Wide_Local_Excision,1.7,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,223.25,1,26.06,1,0.0,7.8,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000231,2014,20,Female,1,SSM,Trunk,0,0,7.3,0,0,4,1.05,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.18,IIA,0,V600E,1,0,1,0,0,1,0,0,11.9,1,9,0.9,MSS,Wide_Local_Excision,1.7,R0,8.1,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,70.39,1,43.64,1,0.0,6.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000232,2019,67,Female,2,SSM,Trunk,0,0,9.6,0,0,3,1.24,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.7,IIA,0,WT,0,0,0,0,0,0,0,0,8.0,0,2,1.83,MSS,Wide_Local_Excision,1.7,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,74.41,0,0.0,19.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000233,2022,50,Male,5,UM,Uveal,0,0,8.8,1,0,0,1.77,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.41,IIA,0,WT,0,1,0,0,1,0,1,0,2.0,0,9,3.71,MSS,Wide_Local_Excision,1.3,R0,7.8,1,Skin_Graft,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,70.26,1,70.26,1,0.0,5.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000234,2014,40,Male,1,SSM,Trunk,0,0,4.0,0,0,0,0.33,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.69,IA,0,V600E,1,0,0,1,0,0,0,0,27.9,1,5,6.08,MSS,Wide_Local_Excision,1.1,R0,3.6,0,None,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,103.24,1,0.0,9.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000235,2014,50,Female,5,ALM,Other,0,0,6.0,0,0,0,2.95,1,4.0,T3b,0,Not_Performed,0,0,0,N0,M0,0.6,IIB,0,WT,0,0,0,0,0,0,0,0,10.0,1,10,2.04,MSS,Wide_Local_Excision,2.1,R0,4.5,0,Skin_Graft,0,28,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,12.61,1,12.61,1,0.0,36.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000236,2018,47,Female,3,NM,Trunk,0,0,4.6,0,0,1,2.74,0,2.0,T3a,1,Micrometastasis,1,2,0,N2a,M0,0.93,IIIC,0,WT,0,0,0,0,0,0,0,0,24.6,1,25,5.28,MSS,Wide_Local_Excision,1.9,R0,3.8,0,Primary_Closure,0,23,0,1,Pembrolizumab_mono,1L,28,SD,6.77,1,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.3,1,Nodal_Basin,0,None,0,67.92,1,58.55,1,0.0,10.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000237,2019,48,Male,1,SSM,Trunk,0,0,6.0,1,0,1,1.74,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.77,IIA,0,WT,0,1,0,0,0,1,0,0,18.9,1,22,1.68,MSS,Wide_Local_Excision,1.5,R0,4.5,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,61.24,1,61.24,0,0.0,5.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000238,2019,66,Male,2,NM,Trunk,0,0,9.7,1,1,0,5.4,1,4.0,T4b,1,Macrometastasis,1,1,0,N1b,M0,0.49,IIIB,0,WT,0,0,0,0,0,0,0,0,23.3,1,100,1.07,MSS,Wide_Local_Excision,1.7,R0,10.4,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,23.4,0,None,1,Nivolumab,0,119.45,1,119.45,1,0.0,1.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000239,2018,35,Female,2,SSM,Trunk,0,0,3.7,0,0,1,3.13,1,5.0,T3b,1,Negative,0,0,0,N0,M0,1.33,IIB,0,WT,0,0,0,0,0,1,0,0,2.9,0,32,0.7,MSS,Wide_Local_Excision,1.9,R0,5.7,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,126.29,1,126.29,0,0.0,6.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000240,2016,73,Male,2,SSM,LowerExtremity,0,0,3.3,1,0,2,1.12,0,1.0,T2a,1,Micrometastasis,1,3,0,N2a,M0,1.15,IIIC,0,V600E,1,0,0,0,0,1,0,0,7.5,0,100,1.33,MSI_L,Wide_Local_Excision,1.6,R1,0.0,0,Flap,0,14,1,1,Pembrolizumab_mono,1L,27,PR,6.64,0,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,19.8,1,Nodal_Basin,1,Pembrolizumab,0,75.7,1,18.05,1,27.55,3.6,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000241,2014,34,Female,1,NM,UpperExtremity,0,0,4.8,0,0,0,0.79,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.4,IA,0,Non_V600,0,1,0,0,0,0,0,0,23.7,1,41,0.72,MSS,Wide_Local_Excision,1.3,R1,0.0,0,Primary_Closure,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,80.24,1,80.24,1,0.0,7.2,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000242,2014,46,Male,3,NM,Trunk,0,0,7.1,0,0,0,3.64,0,1.0,T3a,1,Negative,0,0,0,N0,M0,0.81,IIB,0,V600E,1,0,0,0,0,0,0,0,5.4,0,59,9.98,MSS,Wide_Local_Excision,2.2,R0,18.7,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,32.68,1,32.68,1,0.0,3.3,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000243,2015,87,Female,5,SSM,LowerExtremity,0,0,7.7,1,0,0,1.38,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.73,IIA,0,V600E,1,0,0,0,0,0,0,0,20.2,1,14,2.84,MSS,Wide_Local_Excision,1.6,R0,26.9,0,Skin_Graft,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,12.64,1,12.64,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000244,2021,75,Female,1,SSM,LowerExtremity,0,0,7.4,1,0,0,0.58,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.98,IA,0,WT,0,1,1,0,0,0,0,0,4.9,0,7,1.85,MSS,Wide_Local_Excision,1.0,R0,1.0,0,Primary_Closure,0,22,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,135.11,1,58.2,1,0.0,2.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000245,2022,58,Female,5,SSM,HeadNeck,1,0,8.9,0,0,0,1.33,0,4.0,T2a,1,Negative,0,0,0,N0,M0,0.59,IIA,0,V600R,1,0,0,0,0,1,0,0,15.2,1,13,7.93,MSS,Wide_Local_Excision,1.5,R0,14.5,0,Primary_Closure,0,22,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,116.51,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000246,2018,41,Female,3,LMM,Acral,0,0,3.0,0,0,1,0.93,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.78,IB,0,V600E,1,0,0,0,0,0,0,0,54.4,1,20,0.71,MSS,Wide_Local_Excision,0.7,R0,1.1,0,Primary_Closure,0,53,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,227.65,1,206.81,1,0.0,1.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000247,2014,48,Female,3,SSM,LowerExtremity,0,0,8.9,0,0,0,0.47,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.69,IA,0,WT,0,0,0,0,0,0,0,0,27.9,1,11,1.79,MSS,Wide_Local_Excision,0.8,R0,2.7,1,Primary_Closure,0,56,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,99.36,1,61.48,1,0.0,6.5,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000248,2018,58,Female,3,SSM,LowerExtremity,0,0,5.9,0,0,1,1.92,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.41,IIA,0,V600E,1,0,0,0,0,0,0,0,3.4,0,7,9.9,MSS,Wide_Local_Excision,1.3,R0,1.3,1,Primary_Closure,0,31,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,233.68,1,48.87,1,0.0,33.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000249,2024,57,Female,3,SSM,LowerExtremity,0,0,8.0,0,0,2,0.81,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.78,IA,0,V600E,1,0,0,0,0,0,0,0,29.6,1,30,1.78,MSS,Wide_Local_Excision,1.1,R0,2.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,59.62,1,59.62,1,0.0,12.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000250,2016,55,Male,4,SSM,UpperExtremity,0,0,3.9,0,0,2,0.9,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.62,IA,0,V600R,1,0,0,0,1,0,0,0,64.4,1,7,14.16,MSI_L,Wide_Local_Excision,1.2,R1,0.0,0,Skin_Graft,0,16,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,137.89,1,0.0,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000251,2019,56,Female,2,SSM,LowerExtremity,0,0,6.5,0,0,1,0.87,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.67,IA,0,WT,0,0,0,0,0,0,0,0,140.6,1,4,3.75,MSS,Wide_Local_Excision,1.1,R0,11.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,112.93,0,0.0,4.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000252,2019,53,Male,2,LMM,Trunk,0,0,7.0,1,0,0,2.85,0,7.0,T3a,1,Negative,0,0,0,N0,M0,0.86,IIB,0,V600K,1,0,0,0,0,0,0,0,21.9,1,7,5.69,MSS,Wide_Local_Excision,2.2,R0,15.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,154.9,1,131.6,1,0.0,26.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000253,2017,33,Female,2,SSM,LowerExtremity,0,0,8.8,0,0,0,1.17,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.23,IIA,0,V600E,1,0,0,0,1,0,0,0,5.0,0,16,5.82,MSS,Wide_Local_Excision,1.5,R0,17.2,0,Skin_Graft,0,59,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,202.9,1,81.56,1,0.0,3.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000254,2018,48,Female,1,SSM,Acral,0,1,3.3,0,0,0,1.27,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.53,IIA,0,V600K,1,0,0,0,0,0,0,0,21.2,1,7,2.0,MSS,Wide_Local_Excision,1.3,R0,6.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,116.22,1,116.22,0,0.0,7.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000255,2019,71,Male,3,SSM,Trunk,0,1,6.6,0,0,3,0.88,0,1.0,T1b,1,Macrometastasis,1,0,0,N0,M0,0.65,IB,0,V600E,1,0,0,0,0,0,0,0,53.8,1,16,1.35,MSS,Wide_Local_Excision,1.0,R0,9.3,0,Primary_Closure,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,240.0,1,0.0,21.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000256,2019,35,Male,1,NM,HeadNeck,0,0,4.3,0,0,3,4.84,0,2.0,T4a,1,Negative,0,0,0,N0,M0,0.55,IIC,0,WT,0,0,0,0,0,0,0,0,12.9,1,36,1.82,MSS,Wide_Local_Excision,1.9,R0,9.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,34.69,1,34.69,0,0.0,6.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000257,2021,53,Male,2,NM,HeadNeck,0,1,7.5,0,1,0,9.0,1,7.0,T4b,1,Micrometastasis,1,1,0,N1a,M0,0.53,IIIB,0,V600E,1,0,0,0,0,1,0,0,34.6,1,36,0.91,MSS,Wide_Local_Excision,2.1,R0,8.0,0,Primary_Closure,0,19,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,SD,18.34,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,14.1,0,None,1,Nivolumab,0,14.84,1,14.84,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000258,2020,43,Female,1,SSM,Trunk,0,0,8.1,1,0,0,1.89,0,2.0,T2a,1,Micrometastasis,1,2,0,N2a,M0,0.58,IIIC,0,WT,0,0,0,0,0,1,0,0,7.7,0,10,1.9,MSS,Wide_Local_Excision,1.4,R2,0.0,0,Primary_Closure,0,120,1,1,Nivolumab_mono,2L,20,SD,3.87,1,1,0,Neurologic,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,6.8,0,None,1,Pembrolizumab,0,59.28,1,59.28,1,0.0,4.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000259,2014,58,Male,1,SSM,UpperExtremity,0,0,9.1,0,0,0,1.94,0,4.0,T2a,1,Negative,0,0,0,N0,M0,0.68,IIA,0,V600E,1,0,0,0,0,0,0,0,20.2,1,5,1.99,MSS,Wide_Local_Excision,1.5,R0,10.1,0,None,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,45.77,1,45.77,1,0.0,30.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000260,2014,50,Male,3,SSM,HeadNeck,1,0,5.4,0,0,0,1.83,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.94,IIA,0,V600E,1,0,0,1,0,0,0,0,2.0,0,11,7.73,MSS,Wide_Local_Excision,1.6,R0,1.0,0,Primary_Closure,0,50,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,53.16,1,53.16,0,0.0,76.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000261,2018,80,Female,3,SSM,Acral,0,0,8.4,0,0,3,0.46,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.84,IA,0,V600E,1,0,0,0,0,0,0,0,7.0,0,39,3.21,MSS,Wide_Local_Excision,0.9,R1,0.0,0,Primary_Closure,0,47,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,17.69,1,17.69,1,0.0,62.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000262,2023,65,Female,2,NM,Trunk,0,0,9.2,0,0,0,1.9,1,2.0,T2b,1,Negative,0,0,0,N0,M0,0.49,IIB,0,WT,0,0,0,0,0,0,0,0,14.9,1,49,13.24,MSS,Wide_Local_Excision,1.7,R0,1.0,0,Primary_Closure,1,14,0,1,Pembrolizumab_mono,1L,5,PD,38.61,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,60.59,1,60.59,1,0.0,7.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000263,2014,36,Male,1,SSM,Trunk,0,0,3.2,0,0,0,1.04,0,2.0,T2a,1,Negative,0,0,0,N0,M0,1.24,IIA,0,WT,0,1,0,0,1,1,0,0,11.2,1,28,0.36,MSS,Wide_Local_Excision,1.2,R0,15.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,25.54,0,25.54,1,0.0,6.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000264,2014,67,Male,2,SSM,LowerExtremity,0,0,7.7,0,0,0,0.72,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.08,IB,0,V600K,1,0,0,0,0,0,0,0,5.3,0,66,0.76,MSS,Wide_Local_Excision,1.1,R0,15.8,0,Skin_Graft,0,64,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,101.98,1,0.0,12.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000265,2021,76,Female,6,ALM,LowerExtremity,1,0,8.4,1,0,0,0.57,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.52,IA,0,WT,0,1,0,0,0,0,0,0,3.0,0,100,1.51,MSS,Wide_Local_Excision,1.0,R0,17.1,1,Skin_Graft,0,28,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,227.78,1,2.31,1,0.0,8.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000266,2018,47,Female,3,SSM,Trunk,1,0,6.0,1,0,0,0.32,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.21,IA,0,V600E,1,0,0,0,0,1,0,0,19.5,1,12,6.6,MSS,Wide_Local_Excision,1.2,R0,16.4,1,None,0,120,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,38.83,1,38.83,0,0.0,22.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000267,2016,62,Female,3,SSM,Trunk,0,0,4.1,1,0,2,0.47,1,0.0,T1b,1,Negative,0,0,0,N0,M0,0.84,IB,0,V600K,1,0,0,0,0,0,0,0,14.0,1,88,1.83,MSS,Wide_Local_Excision,0.7,R0,6.2,0,Primary_Closure,0,43,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,51.15,1,51.15,1,0.0,1.2,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000268,2016,49,Male,2,SSM,Trunk,0,0,8.4,0,0,0,1.0,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.7,IA,0,V600E,1,0,0,0,0,0,0,0,15.7,1,15,0.62,MSS,Wide_Local_Excision,0.7,R0,1.0,0,Primary_Closure,1,91,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,112.49,1,112.49,1,0.0,6.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000269,2021,71,Male,2,SSM,UpperExtremity,0,0,4.1,0,0,1,1.14,1,1.0,T2b,1,Negative,0,0,0,N0,M0,0.85,IIB,0,WT,0,1,0,0,0,1,0,0,26.9,1,55,1.64,MSS,Wide_Local_Excision,1.7,R0,25.8,0,Skin_Graft,0,31,0,1,Pembrolizumab_mono,2L,11,PR,5.41,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,162.99,1,10.55,6.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000270,2019,44,Male,5,SSM,LowerExtremity,0,0,6.1,0,0,0,0.69,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.73,IA,0,V600E,1,0,0,0,1,0,0,0,11.4,1,41,0.77,MSS,Wide_Local_Excision,0.9,R0,1.0,0,Primary_Closure,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,216.62,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000271,2021,47,Female,3,SSM,LowerExtremity,0,0,6.4,0,0,0,1.27,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.92,IIA,0,WT,0,0,0,0,0,0,0,0,44.5,1,3,0.66,MSS,Wide_Local_Excision,1.5,R0,6.8,0,Primary_Closure,0,39,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,104.13,1,0.0,1.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000272,2017,46,Male,2,SSM,LowerExtremity,0,0,7.9,0,0,0,0.89,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.8,IA,0,WT,0,0,0,0,0,0,0,0,6.8,0,8,9.9,MSS,Wide_Local_Excision,0.9,R0,12.4,0,Primary_Closure,0,17,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,226.37,1,48.6,1,0.0,24.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000273,2019,47,Male,2,SSM,Trunk,0,0,5.2,1,0,0,2.57,1,3.0,T3b,0,Not_Performed,0,0,0,N0,M1b_1,2.17,IV,1,V600E,1,0,0,0,1,0,0,0,70.1,1,6,80.0,MSS,Wide_Local_Excision,2.2,R0,4.8,0,Primary_Closure,0,34,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,1,0,0,0,0,0,0,1,1,0,0.0,1,0.8,0,None,0,None,0,12.47,1,12.47,0,0.0,6.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000274,2023,74,Female,1,SSM,Trunk,0,0,5.1,0,0,0,1.07,0,5.0,T2a,1,Negative,0,0,0,N0,M0,0.33,IIA,0,V600E,1,0,0,0,0,1,0,0,36.5,1,3,2.3,MSS,Wide_Local_Excision,1.6,R0,3.1,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,240.0,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000275,2017,67,Female,5,SSM,Trunk,1,0,6.7,0,0,0,1.95,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.91,IIA,0,WT,0,0,0,1,0,1,0,0,11.3,1,48,1.86,MSS,Wide_Local_Excision,1.5,R0,2.1,0,Flap,1,39,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,24.62,1,24.62,1,0.0,20.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000276,2018,84,Female,2,SSM,Trunk,0,0,8.5,0,0,1,1.38,0,5.0,T2a,1,Negative,0,0,0,N0,M0,0.64,IIA,0,V600E,1,0,0,0,0,0,0,0,11.9,1,100,1.64,MSS,Wide_Local_Excision,1.3,R0,4.6,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,159.41,1,159.41,1,0.0,16.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000277,2015,93,Male,2,SSM,Trunk,1,0,10.0,0,0,1,0.45,1,0.0,T1b,1,Negative,0,0,0,N0,M0,1.01,IB,0,V600K,1,0,0,0,0,0,0,0,17.7,1,15,1.02,MSS,Wide_Local_Excision,1.1,R0,1.6,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,92.57,1,72.49,1,0.0,19.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000278,2021,40,Male,6,SSM,Trunk,0,0,3.5,0,0,3,1.13,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.9,IIA,0,WT,0,1,0,0,1,1,0,0,24.2,1,47,1.56,MSS,Wide_Local_Excision,1.3,R0,25.6,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,163.1,1,61.98,0,0.0,5.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000279,2014,58,Male,3,LMM,Trunk,0,0,7.1,0,0,0,0.51,0,1.0,T1b,1,Negative,0,0,0,N0,M1a_1,2.4,IV,1,V600E,1,0,0,0,0,0,0,0,36.0,1,88,5.99,MSS,Wide_Local_Excision,0.9,R0,1.0,0,Skin_Graft,0,24,0,1,Atezolizumab_Cobimetinib_Vemu,1L,24,SD,45.33,0,0,0,None,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,PR,22.14,1,0,None,0,0,1,0,0,0,0,1,0,2,1,0,0.0,1,0.1,0,None,0,None,0,14.96,1,1.13,1,0.0,4.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000280,2016,38,Male,1,LMM,UpperExtremity,0,0,4.3,1,0,1,1.11,0,0.0,T2a,1,Negative,0,0,0,N0,M1a_1,1.61,IV,1,WT,0,0,0,0,0,1,0,0,5.1,0,25,10.85,MSS,Wide_Local_Excision,1.2,R0,1.4,0,Skin_Graft,0,92,0,1,Pembrolizumab_mono,1L,29,SD,15.82,1,1,1,Pulmonary,0,1,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,0,0,0,1,0,2,1,0,0.0,1,1.4,0,None,0,None,0,37.62,0,14.11,1,0.0,10.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000281,2021,44,Male,1,SSM,LowerExtremity,0,0,8.5,0,0,1,0.71,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M1a_1,2.52,IV,1,V600E,1,0,0,0,0,0,0,0,21.3,1,20,6.3,MSS,Wide_Local_Excision,1.0,R0,6.3,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,19,PD,5.14,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,1,0,0,1,2,1,0,0.0,1,0.8,0,None,0,None,0,5.42,0,5.42,0,0.0,1.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000282,2014,46,Male,1,SSM,LowerExtremity,0,0,4.6,1,0,0,1.57,0,3.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.79,IIA,0,V600K,1,0,0,1,0,0,0,0,2.8,0,16,0.75,MSS,Wide_Local_Excision,1.7,R0,6.6,0,None,0,20,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,133.6,1,0.0,1.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000283,2024,40,Female,3,SSM,HeadNeck,1,0,5.2,1,0,0,0.47,1,1.0,T1b,1,Negative,0,0,0,N0,M0,0.7,IB,0,V600E,1,0,0,0,0,0,0,0,13.0,1,34,4.41,MSS,Wide_Local_Excision,1.0,R0,13.3,0,Primary_Closure,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,46.48,1,46.28,1,0.0,7.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000284,2018,40,Female,1,SSM,LowerExtremity,0,0,5.3,0,0,1,1.21,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.45,IIA,0,V600K,1,0,0,0,0,0,0,0,48.0,1,48,2.93,MSS,Wide_Local_Excision,1.4,R0,17.2,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,98.09,0,98.09,1,0.0,16.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000285,2018,54,Female,5,SSM,UpperExtremity,0,0,6.3,0,0,1,1.79,1,1.0,T2b,1,Micrometastasis,1,3,0,N2a,M0,0.56,IIIC,0,V600E,1,0,0,1,0,1,0,0,4.8,0,32,1.21,MSS,Wide_Local_Excision,1.5,R0,2.8,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Encorafenib_Binimetinib,1,PR,36.76,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,1.2,0,None,1,Pembrolizumab,0,27.68,1,17.82,0,0.0,5.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000286,2019,37,Male,5,SSM,Trunk,0,0,7.1,0,0,0,2.27,0,2.0,T3a,1,Negative,0,0,0,N0,M0,0.65,IIB,0,V600E,1,0,0,0,0,0,0,0,4.2,0,31,2.31,MSS,Wide_Local_Excision,2.0,R0,10.1,1,Flap,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,11.47,1,11.47,1,0.0,43.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000287,2021,70,Male,2,SSM,UpperExtremity,0,0,7.5,0,0,0,0.7,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.45,IA,0,V600E,1,0,0,0,0,0,0,0,17.9,1,19,3.16,MSS,Wide_Local_Excision,1.0,R0,6.1,0,Flap,1,23,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,240.0,1,0.0,12.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000288,2019,42,Male,3,SSM,Trunk,0,0,6.5,0,0,4,1.22,1,0.0,T2b,1,Negative,0,0,0,N0,M0,0.99,IIB,0,V600E,1,0,0,0,0,1,0,0,45.5,1,4,2.08,MSI_H,Wide_Local_Excision,1.5,R0,6.7,0,Primary_Closure,0,15,0,1,Pembrolizumab_mono,1L,28,SD,9.87,0,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,0,94.49,0,0.0,47.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000289,2023,95,Male,2,SSM,UpperExtremity,0,0,3.8,1,0,0,1.37,0,1.0,T2a,1,Negative,0,0,0,N0,M1b_1,1.68,IV,1,V600R,1,0,0,1,0,0,0,0,19.5,1,49,36.86,MSS,Wide_Local_Excision,1.3,R0,3.0,0,Skin_Graft,0,14,0,1,Nivolumab_mono,2L,32,PR,3.96,1,1,0,Hepatic,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,CR,3.39,1,1,NRAS_mut,0,1,0,0,0,0,0,0,0,2,1,0,0.0,1,0.4,0,None,0,None,0,37.34,1,37.33,1,3.92,10.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000290,2024,49,Male,1,SSM,Trunk,0,0,8.0,0,0,3,3.54,1,4.0,T3b,1,Negative,0,0,0,N0,M0,0.61,IIB,0,V600E,1,0,0,0,0,1,0,0,3.3,0,6,1.0,MSI_L,Wide_Local_Excision,2.0,R0,8.0,0,Primary_Closure,0,25,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,72.52,1,72.52,0,0.0,12.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000291,2016,58,Male,3,NM,Trunk,0,0,6.4,0,0,1,1.24,0,0.0,T2a,1,Micrometastasis,1,1,0,N1a,M0,0.6,IIIA,0,V600E,1,0,0,1,1,0,0,0,3.9,0,37,9.85,MSS,Wide_Local_Excision,1.1,R0,2.7,0,Skin_Graft,0,71,0,1,Nivolumab_mono,1L,6,PR,4.43,1,1,0,Endocrine,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,PD,34.25,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,5.4,0,None,1,Pembrolizumab,0,59.16,1,59.16,1,16.24,14.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000292,2021,36,Female,1,SSM,Trunk,1,0,8.8,1,0,2,0.63,1,0.0,T1b,0,Not_Performed,0,0,0,N0,M0,0.76,IB,0,V600E,1,0,0,0,0,0,0,0,16.2,1,43,0.43,MSS,Wide_Local_Excision,1.1,R0,1.4,0,Primary_Closure,1,47,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,25.08,1,25.08,1,0.0,80.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000293,2017,81,Male,5,ALM,Acral,0,0,5.1,0,0,1,8.55,1,5.0,T4b,1,Negative,0,0,0,N0,M0,0.45,IIC,0,WT,0,0,0,0,1,0,0,0,14.8,1,6,3.18,MSS,Wide_Local_Excision,1.8,R0,2.7,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,35.19,0,35.19,1,0.0,3.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000294,2024,74,Female,2,SSM,HeadNeck,0,0,3.3,1,0,0,0.99,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.3,IA,0,V600E,1,0,0,0,1,1,0,0,16.7,1,11,2.68,MSS,Wide_Local_Excision,1.2,R0,2.4,0,Flap,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,51.94,1,51.94,0,0.0,5.3,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000295,2016,61,Male,1,NM,LowerExtremity,0,0,6.4,1,0,1,0.93,1,0.0,T1b,0,Not_Performed,0,0,0,N0,M0,0.89,IB,0,V600E,1,0,0,0,0,1,0,0,17.5,1,100,3.35,MSS,Wide_Local_Excision,0.5,R0,19.3,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,175.39,1,83.25,1,0.0,3.3,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000296,2017,51,Male,5,ALM,Acral,0,0,9.1,0,0,1,0.8,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.32,IB,0,WT,0,1,0,1,0,0,0,0,6.3,0,18,1.13,MSS,Wide_Local_Excision,1.3,R0,1.9,0,Primary_Closure,0,92,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,142.76,1,34.79,1,0.0,6.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000297,2021,82,Male,4,UM,Uveal,0,0,6.8,0,1,1,0.17,1,1.0,T1b,1,Negative,0,0,0,N0,M0,1.04,IB,0,WT,0,0,0,0,0,0,1,0,5.2,0,6,5.1,MSS,Wide_Local_Excision,0.7,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,181.15,0,76.91,0,0.0,30.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000298,2022,39,Male,4,NM,Trunk,0,0,6.1,0,0,0,4.14,0,5.0,T4a,1,Negative,0,0,0,N0,M0,1.38,IIC,0,WT,0,0,0,0,1,0,0,0,24.1,1,45,1.83,MSS,Wide_Local_Excision,1.8,R0,1.5,0,Primary_Closure,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,67.04,0,67.04,1,0.0,7.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000299,2015,80,Male,3,NM,LowerExtremity,0,0,4.8,0,0,0,6.17,1,3.0,T4b,1,Negative,0,0,0,N0,M0,0.69,IIC,0,V600E,1,0,0,0,0,1,0,0,39.5,1,9,0.77,MSS,Wide_Local_Excision,2.1,R0,3.5,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,99.86,1,84.63,1,0.0,3.5,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000300,2020,69,Female,4,SSM,UpperExtremity,0,0,10.0,0,0,0,0.63,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.25,IA,0,WT,0,1,0,0,0,0,0,0,31.3,1,3,0.83,MSS,Wide_Local_Excision,1.1,R0,12.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,152.11,1,152.11,1,0.0,3.2,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000301,2017,58,Male,2,NM,Trunk,0,0,4.4,1,0,0,2.52,1,8.0,T3b,1,Negative,0,0,0,N0,M0,0.73,IIB,0,V600R,1,0,0,0,0,0,0,0,13.3,1,34,2.21,MSS,Wide_Local_Excision,1.9,R0,2.7,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,110.02,1,44.94,0,0.0,44.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000302,2020,18,Male,4,SSM,Trunk,1,0,5.0,1,0,1,2.29,1,3.0,T3b,1,Negative,0,0,0,N0,M0,1.4,IIB,0,V600R,1,1,0,0,0,0,0,0,12.8,1,8,0.56,MSS,Amputation,2.2,R0,2.7,0,Primary_Closure,0,40,0,1,Nivolumab_mono,1L,29,CR,9.7,1,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,1,150.61,0,31.83,2.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000303,2020,41,Female,2,SSM,HeadNeck,0,0,7.6,0,0,2,0.35,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.62,IB,0,V600E,1,0,0,0,0,0,0,0,11.8,1,28,8.44,MSS,Wide_Local_Excision,0.8,R0,1.0,0,Primary_Closure,0,30,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,78.8,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000304,2024,68,Male,2,SSM,LowerExtremity,1,0,2.8,0,0,1,0.48,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.3,IA,0,V600E,1,0,0,0,1,0,0,0,25.9,1,9,4.63,MSS,Wide_Local_Excision,0.9,R0,5.1,0,Skin_Graft,0,26,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,199.77,0,106.92,1,0.0,10.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000305,2024,76,Female,5,LMM,HeadNeck,0,0,9.0,0,0,1,1.02,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.72,IIA,0,V600E,1,0,0,0,0,0,0,0,8.9,0,41,8.62,MSS,Wide_Local_Excision,1.4,R0,5.2,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,205.25,1,68.35,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000306,2021,74,Male,2,SSM,LowerExtremity,0,0,7.7,0,0,0,0.71,1,1.0,T1b,1,Negative,0,0,0,N0,M0,1.47,IB,0,V600E,1,0,0,0,0,0,0,0,59.6,1,24,7.93,MSS,Wide_Local_Excision,0.9,R0,2.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,115.01,0,0.0,5.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000307,2021,31,Female,1,SSM,Trunk,0,0,8.3,1,0,0,0.98,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.92,IB,0,WT,0,0,0,0,0,1,0,0,8.3,0,2,1.51,MSS,Wide_Local_Excision,0.6,R0,2.5,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,240.0,1,0.0,15.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000308,2023,61,Male,2,SSM,UpperExtremity,0,0,7.6,0,0,0,0.5,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.6,IA,0,V600E,1,0,0,0,1,1,0,0,17.8,1,29,1.0,MSS,Wide_Local_Excision,1.0,R0,14.2,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,76.84,0,20.31,1,0.0,6.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000309,2016,73,Male,2,SSM,Trunk,0,0,6.2,0,0,0,1.39,0,2.0,T2a,1,Negative,0,0,0,N0,M1c_1,2.49,IV,1,V600E,1,0,0,0,1,1,0,0,12.5,1,15,28.13,MSS,Wide_Local_Excision,1.5,R0,5.7,0,Primary_Closure,1,15,0,1,Ipilimumab_Nivolumab,1L,32,CR,11.78,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,1,0,1,0,0,0,0,4,0,0,0.0,1,0.8,0,None,0,None,0,13.56,1,13.56,1,1.0,2.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000310,2021,30,Female,2,SSM,UpperExtremity,0,0,4.4,1,0,0,1.08,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.09,IIA,0,V600E,1,0,0,0,0,0,0,0,10.5,1,82,1.45,MSS,Wide_Local_Excision,1.7,R0,3.3,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,188.92,0,38.26,1,0.0,3.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000311,2022,56,Female,2,SSM,LowerExtremity,0,0,6.2,0,1,0,1.76,0,1.0,T2a,1,Micrometastasis,1,2,1,N2c,M0,0.72,IIIC,0,V600E,1,0,0,1,0,1,0,0,85.3,1,30,8.21,MSS,Wide_Local_Excision,1.2,R0,1.0,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,24.4,0,None,1,Pembrolizumab,0,149.87,1,21.29,1,0.0,6.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000312,2015,61,Male,4,SSM,Trunk,0,0,4.5,0,0,0,1.38,0,1.0,T2a,1,Negative,0,0,0,N0,M1d_1,2.62,IV,1,V600E,1,0,0,0,0,0,0,0,10.6,1,43,6.86,MSS,Wide_Local_Excision,1.4,R0,1.1,0,Flap,1,62,0,1,Atezolizumab_Cobimetinib_Vemu,1L,15,CR,2.59,1,1,0,Pulmonary,0,1,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,PR,5.12,1,0,None,0,1,0,1,0,0,0,0,0,2,1,3,1.9,1,0.7,1,Brain_SRS,0,None,0,24.36,1,23.9,1,43.11,1.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000313,2023,52,Female,2,SSM,LowerExtremity,0,0,7.5,0,0,1,1.39,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.6,IIA,0,V600E,1,0,0,0,0,1,0,0,11.8,1,10,1.69,MSS,Wide_Local_Excision,1.7,R0,11.0,0,Flap,0,76,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,167.86,1,51.93,0,0.0,3.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000314,2021,27,Male,2,SSM,Trunk,0,0,8.1,0,0,0,0.44,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.11,IA,0,V600K,1,0,0,0,1,0,0,0,8.8,0,9,1.28,MSS,Wide_Local_Excision,1.1,R0,6.2,1,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,43.01,1,43.01,0,0.0,11.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000315,2017,51,Male,2,SSM,LowerExtremity,0,0,9.5,0,0,0,1.69,1,1.0,T2b,1,Negative,0,0,0,N0,M1d,0.53,IV,1,V600E,1,0,0,0,0,0,0,0,15.5,1,19,25.03,MSS,Wide_Local_Excision,1.6,R0,11.4,0,None,0,92,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,PR,2.96,0,1,NRAS_mut,0,1,0,1,0,0,0,0,0,1,1,1,2.0,1,0.2,0,None,0,None,0,83.9,1,25.81,1,0.0,1.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000316,2019,51,Male,4,SSM,LowerExtremity,0,0,7.2,0,0,0,0.95,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.56,IB,0,V600K,1,0,0,0,0,0,0,0,13.8,1,14,5.6,MSS,Wide_Local_Excision,1.1,R0,7.6,1,Flap,0,120,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,107.15,1,0.0,28.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000317,2019,54,Female,1,SSM,LowerExtremity,0,0,8.3,0,0,1,1.07,0,2.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.63,IIA,0,WT,0,1,0,0,0,0,0,0,6.1,0,76,0.58,MSS,Wide_Local_Excision,1.6,R0,1.7,1,Flap,0,38,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,66.56,1,66.56,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000318,2024,47,Male,1,SSM,UpperExtremity,0,0,5.9,1,0,1,2.5,0,3.0,T3a,1,Micrometastasis,1,4,0,N2b,M0,1.11,IIIC,0,WT,0,0,0,0,0,0,0,0,10.7,1,17,0.68,MSS,Amputation,2.4,R0,30.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,7.9,0,None,0,None,0,55.37,1,46.0,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000319,2024,49,Female,2,SSM,Acral,0,0,5.5,0,0,0,0.73,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.78,IB,0,V600K,1,0,0,0,0,0,0,0,24.4,1,6,6.57,MSS,Wide_Local_Excision,1.0,R0,1.9,0,Primary_Closure,0,75,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,22.6,1,0.0,7.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000320,2022,54,Male,5,ALM,Acral,0,0,7.4,0,1,0,3.09,0,3.0,T3a,1,Negative,0,0,0,N0,M0,0.85,IIB,0,WT,0,0,0,0,0,0,0,0,3.9,0,9,3.6,MSS,Wide_Local_Excision,1.8,R0,10.5,0,Skin_Graft,0,14,0,1,Pembrolizumab_mono,1L,13,SD,1.56,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,18.95,0,18.95,1,0.0,28.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000321,2021,51,Female,4,ALM,Acral,0,0,5.7,1,0,3,3.3,0,2.0,T3a,1,Negative,0,0,0,N0,M0,0.39,IIB,0,WT,0,0,0,0,1,0,0,0,2.1,0,52,1.63,MSS,Wide_Local_Excision,2.1,R0,2.4,0,Flap,0,24,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,112.33,1,47.72,1,0.0,2.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000322,2015,52,Female,3,SSM,LowerExtremity,0,0,7.0,0,0,1,2.03,0,1.0,T3a,1,Macrometastasis,1,3,0,N2a,M0,0.96,IIIC,0,WT,0,0,0,0,0,0,0,0,15.7,1,17,7.84,MSS,Wide_Local_Excision,1.9,R0,10.4,0,Flap,0,66,0,1,Ipilimumab_mono,1L,26,PD,4.15,1,1,0,Skin,0,0,0,0,0,0,1,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,15.1,0,None,1,Pembrolizumab,0,124.77,0,47.82,0,0.0,1.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000323,2024,50,Male,3,SSM,Trunk,0,0,4.4,0,0,1,0.6,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.83,IA,0,V600E,1,0,0,0,1,0,0,0,11.2,1,16,0.67,MSS,Wide_Local_Excision,1.0,R0,10.2,0,Skin_Graft,0,40,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,160.6,1,0.0,2.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000324,2015,58,Male,2,SSM,Trunk,0,0,4.7,0,0,1,0.26,0,2.0,T1b,0,Not_Performed,0,0,0,N0,M1d,0.93,IV,1,V600E,1,0,0,1,0,0,0,0,10.0,1,58,2.28,MSS,Wide_Local_Excision,1.1,R0,8.9,0,Flap,0,14,0,1,Atezolizumab_Cobimetinib_Vemu,1L,33,PR,2.62,1,1,0,Endocrine,0,0,0,1,0,0,0,1,Dabrafenib_Trametinib,1,SD,27.96,1,0,None,0,0,0,1,0,0,0,0,1,3,1,1,3.7,1,0.4,1,Brain_SRS,0,None,0,50.26,0,25.06,0,18.19,35.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000325,2015,26,Male,1,NM,Trunk,0,0,7.8,0,0,1,7.45,0,2.0,T4a,1,Micrometastasis,1,2,0,N2a,M0,0.86,IIIC,0,WT,0,0,0,0,0,0,0,0,7.2,0,8,1.89,MSS,Wide_Local_Excision,1.8,R0,30.0,0,Skin_Graft,1,93,0,1,Pembrolizumab_mono,2L,22,PR,2.55,1,1,1,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,22.2,0,None,1,Ipilimumab,0,15.1,1,15.1,0,1.86,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000326,2014,64,Female,1,SSM,Trunk,0,0,8.3,0,0,2,1.3,0,1.0,T2a,1,Macrometastasis,1,3,0,N2a,M0,0.63,IIIC,0,V600E,1,0,0,0,0,0,0,0,4.3,0,2,3.25,MSS,Wide_Local_Excision,1.4,R0,2.9,0,Skin_Graft,0,54,0,1,Nivolumab_mono,1L,32,PD,11.25,1,1,0,Endocrine,0,0,1,1,0,0,0,1,Dabrafenib_Trametinib,1,CR,27.88,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,21.0,0,None,1,Nivolumab,0,17.38,1,17.38,1,0.0,19.4,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000327,2024,56,Male,1,NM,Trunk,0,1,4.5,0,0,0,2.08,0,9.0,T3a,1,Negative,0,0,0,N0,M1c_1,1.4,IV,1,WT,0,0,0,0,1,0,0,0,8.6,0,9,25.29,MSS,Wide_Local_Excision,2.1,R0,1.0,0,Primary_Closure,0,14,0,1,Relatlimab_Nivolumab,2L,25,SD,1.65,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,1,0,1,0,0,0,0,4,0,0,0.0,1,0.4,0,None,0,None,0,10.29,1,2.37,1,0.0,31.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000328,2019,57,Male,2,SSM,Trunk,0,0,7.8,1,0,1,2.73,0,3.0,T3a,1,Negative,0,0,0,N0,M0,0.67,IIB,0,V600E,1,0,0,0,0,0,0,0,30.9,1,25,1.62,MSS,Wide_Local_Excision,1.9,R0,2.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,103.44,1,103.44,0,0.0,7.7,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000329,2016,72,Male,2,SSM,UpperExtremity,0,0,5.4,0,0,0,0.66,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.62,IA,0,V600E,1,0,0,1,0,0,0,0,10.7,1,16,3.61,MSS,Wide_Local_Excision,1.2,R0,4.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,15.01,1,15.01,1,0.0,3.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000330,2014,25,Female,2,SSM,Trunk,0,0,6.5,1,0,1,0.89,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.77,IA,0,WT,0,1,0,0,0,1,0,0,11.4,1,4,1.9,MSS,Wide_Local_Excision,0.8,R0,3.4,0,Primary_Closure,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,109.07,1,27.98,0,0.0,12.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000331,2018,25,Male,3,NM,LowerExtremity,0,0,9.3,1,0,0,5.05,0,2.0,T4a,1,Negative,0,0,0,N0,M0,1.07,IIC,0,WT,0,0,0,0,0,1,0,0,11.2,1,55,5.46,MSS,Amputation,1.8,R0,18.4,0,Primary_Closure,0,17,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,132.1,1,13.62,1,0.0,1.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000332,2021,61,Male,2,SSM,UpperExtremity,0,0,8.1,0,0,0,0.55,0,1.0,T1b,1,Micrometastasis,1,1,0,N1a,M0,0.5,IIIA,0,V600K,1,0,0,0,0,0,0,0,40.6,1,24,5.32,MSS,Wide_Local_Excision,1.4,R0,21.7,0,Primary_Closure,1,14,0,1,Nivolumab_mono,3L+,29,PD,3.39,1,1,0,Skin,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,PR,14.12,1,1,Other,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,1.4,0,None,1,Pembrolizumab,0,49.32,1,49.32,0,0.0,7.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000333,2024,56,Female,3,SSM,LowerExtremity,0,0,8.1,0,1,3,1.11,0,1.0,T2a,0,Not_Performed,0,0,0,N0,M0,1.67,IIA,0,WT,0,0,0,0,0,0,0,0,7.1,0,30,0.93,MSS,Wide_Local_Excision,1.2,R0,6.5,0,Flap,0,25,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,91.1,1,0.0,3.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000334,2020,59,Male,3,LMM,Trunk,0,0,10.0,0,0,2,2.57,0,6.0,T3a,1,Negative,0,0,0,N0,M0,0.62,IIB,0,WT,0,0,0,0,1,0,0,0,18.7,1,30,3.87,MSS,Wide_Local_Excision,2.0,R0,16.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,42.0,1,42.0,0,0.0,2.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000335,2020,49,Female,2,SSM,UpperExtremity,0,0,5.1,1,1,0,1.39,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.75,IIA,0,V600E,1,0,0,0,0,0,0,0,14.2,1,5,0.9,MSS,Wide_Local_Excision,1.9,R0,6.5,0,Skin_Graft,0,22,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,20.51,0,20.51,1,0.0,18.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000336,2023,67,Male,2,SSM,Trunk,0,0,4.5,0,0,4,2.87,0,1.0,T3a,0,Not_Performed,0,0,1,N2c,M0,1.06,IIIC,0,WT,0,0,0,0,1,0,0,0,15.8,1,27,2.09,MSS,Wide_Local_Excision,2.0,R0,13.9,0,Primary_Closure,0,14,0,1,Nivolumab_mono,1L,24,PD,29.33,0,1,0,Pulmonary,0,1,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,24.8,0,None,1,Ipilimumab,0,89.46,1,29.93,1,0.0,18.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000337,2023,71,Male,3,SSM,LowerExtremity,0,0,5.1,0,0,0,2.65,0,6.0,T3a,1,Negative,0,0,0,N0,M0,0.34,IIB,0,V600E,1,0,0,0,0,0,0,0,18.2,1,50,3.38,MSS,Wide_Local_Excision,2.3,R0,1.0,0,Flap,0,14,0,1,Pembrolizumab_mono,2L,7,CR,10.28,0,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,203.78,1,4.71,4.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000338,2017,64,Female,3,NM,Trunk,0,0,6.0,1,0,0,3.52,1,2.0,T3b,1,Micrometastasis,1,0,0,N0,M0,0.67,IIB,0,V600E,1,0,0,0,0,0,0,0,15.7,1,63,1.03,MSS,Wide_Local_Excision,2.1,R0,14.2,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,228.9,1,87.83,0,0.0,9.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000339,2024,52,Female,2,SSM,HeadNeck,0,0,1.8,0,0,2,0.23,0,3.0,T1b,1,Negative,0,0,0,N0,M0,0.59,IB,0,WT,0,0,0,0,0,1,0,0,28.3,1,41,3.75,MSS,Wide_Local_Excision,1.0,R0,5.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,164.23,1,98.04,0,0.0,10.0,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000340,2019,59,Female,4,ALM,HeadNeck,0,0,6.1,1,0,0,0.55,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.8,IA,0,WT,0,0,0,1,1,0,0,0,4.6,0,33,1.33,MSS,Wide_Local_Excision,1.0,R0,30.0,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,204.97,1,0.0,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000341,2024,69,Male,3,SSM,UpperExtremity,0,0,5.4,0,0,0,2.05,0,3.0,T3a,1,Micrometastasis,1,2,0,N2a,M0,0.86,IIIC,0,WT,0,0,0,0,0,0,0,0,60.6,1,4,1.26,MSS,Wide_Local_Excision,1.6,R0,1.7,1,Primary_Closure,0,14,0,1,Nivolumab_mono,3L+,34,CR,7.05,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,23.1,0,None,1,Pembrolizumab,0,44.61,1,44.61,1,3.48,8.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000342,2015,59,Male,5,UM,Uveal,0,0,8.1,0,0,1,0.41,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.72,IA,0,WT,0,0,0,0,0,1,1,0,5.4,0,20,3.52,MSS,Wide_Local_Excision,0.9,R0,13.3,0,Primary_Closure,0,56,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,240.0,1,0.0,30.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000343,2015,67,Male,1,NM,UpperExtremity,0,0,7.2,0,0,0,2.78,1,5.0,T3b,1,Negative,0,0,0,N0,M1a,0.93,IV,1,V600E,1,0,0,0,0,0,0,0,3.8,0,8,0.48,MSS,Wide_Local_Excision,2.0,R0,9.2,1,Skin_Graft,0,14,0,1,Atezolizumab_Cobimetinib_Vemu,2L,26,PR,13.67,1,1,0,Endocrine,0,0,0,1,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,2,1,0,0.0,0,1.0,0,None,0,None,0,18.2,1,18.2,0,13.68,8.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000344,2023,42,Male,2,SSM,UpperExtremity,0,0,5.3,0,0,0,1.52,0,1.0,T2a,0,Not_Performed,0,0,0,N0,M0,1.13,IIA,0,V600E,1,0,0,0,0,0,0,0,25.0,1,72,0.98,MSS,Wide_Local_Excision,1.5,R0,6.6,1,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,206.53,0,47.67,1,0.0,15.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000345,2021,67,Male,4,NM,Trunk,0,0,7.7,0,0,0,9.79,1,3.0,T4b,0,Not_Performed,0,0,0,N0,M0,0.84,IIC,0,V600R,1,0,0,0,0,1,0,0,20.5,1,62,4.6,MSS,Wide_Local_Excision,2.5,R0,2.2,0,Primary_Closure,0,33,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,112.09,1,86.31,1,0.0,18.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000346,2015,70,Male,1,NM,Trunk,0,0,7.9,0,0,1,2.34,0,4.0,T3a,0,Not_Performed,0,0,0,N0,M0,0.75,IIB,0,WT,0,0,0,0,1,0,0,0,15.4,1,8,2.18,MSS,Wide_Local_Excision,2.1,R0,12.2,0,Flap,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,32.2,1,32.2,0,0.0,2.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000347,2023,63,Male,4,ALM,UpperExtremity,0,0,5.0,0,0,0,0.76,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.79,IB,0,WT,0,0,0,0,1,0,0,0,6.6,0,19,0.62,MSS,Wide_Local_Excision,1.1,R0,1.5,0,Primary_Closure,0,55,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,28.57,1,28.57,1,0.0,2.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000348,2015,42,Male,1,SSM,Trunk,0,0,5.5,0,0,0,1.16,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.54,IIA,0,V600E,1,0,0,0,0,0,0,0,2.8,0,26,3.97,MSS,Wide_Local_Excision,1.7,R0,1.0,0,Primary_Closure,0,36,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,128.86,1,45.82,0,0.0,2.0,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000349,2021,53,Male,2,SSM,Other,0,0,2.0,0,0,1,1.53,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.79,IIA,0,V600E,1,0,0,0,0,1,0,0,3.2,0,49,1.44,MSS,Wide_Local_Excision,1.6,R0,2.5,0,Primary_Closure,0,17,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,140.77,1,30.42,1,0.0,25.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000350,2016,68,Male,2,SSM,Trunk,0,1,4.3,0,0,0,1.08,1,2.0,T2b,1,Negative,0,0,0,N0,M0,0.6,IIB,0,V600E,1,0,0,0,0,0,0,0,56.0,1,4,0.65,MSS,Wide_Local_Excision,1.5,R0,1.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,124.17,1,58.24,0,0.0,1.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000351,2014,57,Female,1,SSM,Trunk,0,0,5.0,0,1,0,2.5,0,5.0,T3a,1,Negative,0,0,0,N0,M0,0.35,IIB,0,Non_V600,0,0,1,0,1,0,0,0,9.4,0,2,0.27,MSS,Wide_Local_Excision,2.0,R0,2.2,0,Primary_Closure,0,14,0,1,Nivolumab_mono,1L,24,SD,24.8,1,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,82.07,1,82.07,1,0.0,6.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000352,2022,39,Female,4,SSM,Acral,0,0,6.6,1,0,1,0.69,0,2.0,T1b,1,Negative,0,0,0,N0,M0,0.42,IB,0,WT,0,0,0,0,0,1,0,0,32.5,1,21,4.12,MSS,Wide_Local_Excision,0.9,R0,10.1,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,192.48,1,192.48,1,0.0,25.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000353,2023,63,Male,2,SSM,Trunk,0,0,4.6,1,0,1,1.31,0,4.0,T2a,1,Negative,0,0,0,N0,M0,0.61,IIA,0,V600E,1,0,0,0,0,0,0,0,4.2,0,2,1.01,MSS,Wide_Local_Excision,1.6,R0,1.7,0,Primary_Closure,0,106,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,37.85,0,9.96,0,0.0,5.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000354,2015,66,Female,5,SSM,Trunk,0,0,5.5,0,0,0,1.64,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.71,IIA,0,V600E,1,0,0,0,0,0,0,0,6.5,0,23,0.74,MSS,Wide_Local_Excision,1.5,R0,20.1,0,None,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,131.22,0,121.07,1,0.0,3.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000355,2015,58,Female,2,SSM,LowerExtremity,0,0,4.0,0,0,2,0.91,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.59,IA,0,Non_V600,0,1,0,0,0,0,0,0,25.8,1,36,3.34,MSS,Wide_Local_Excision,1.1,R0,11.5,0,Primary_Closure,1,75,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,48.9,0,14.54,1,0.0,8.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000356,2020,60,Male,4,SSM,HeadNeck,0,0,6.8,0,0,1,2.16,0,6.0,T3a,1,Negative,0,0,0,N0,M0,0.85,IIB,0,V600E,1,0,0,0,0,0,0,0,13.8,1,69,3.81,MSS,Amputation,1.8,R0,2.4,0,Skin_Graft,0,46,0,1,Pembrolizumab_mono,1L,4,CR,27.13,0,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,240.0,1,38.27,1,15.16,9.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000357,2014,52,Male,5,NM,LowerExtremity,0,0,7.4,0,0,0,3.88,0,3.0,T3a,1,Negative,0,0,0,N0,M1a_1,3.46,IV,1,V600E,1,0,0,0,0,0,0,0,23.1,1,11,23.05,MSS,Wide_Local_Excision,2.0,R0,3.9,0,Primary_Closure,0,72,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,PD,12.2,1,1,KRAS_mut,0,0,0,0,0,0,0,1,0,2,1,0,0.0,0,0.4,0,None,0,None,0,13.22,1,8.0,0,0.0,16.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000358,2022,80,Male,3,NM,UpperExtremity,0,0,7.3,0,1,1,6.08,1,3.0,T4b,0,Not_Performed,0,0,0,N0,M0,0.51,IIC,0,V600R,1,0,0,0,0,1,0,0,14.8,1,23,4.15,MSS,Wide_Local_Excision,2.3,R0,8.6,0,Primary_Closure,0,17,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,123.75,1,20.82,0,0.0,7.0,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000359,2024,42,Male,2,SSM,Acral,0,0,6.5,0,0,1,1.37,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.95,IIA,0,V600E,1,0,0,0,0,1,0,0,12.7,1,38,10.35,MSS,Wide_Local_Excision,1.5,R0,1.6,0,Primary_Closure,1,24,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,144.23,1,144.23,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000360,2022,47,Female,3,SSM,Trunk,1,0,3.4,0,0,1,1.56,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.28,IIA,0,V600E,1,0,0,0,0,0,0,0,8.7,0,6,5.87,MSS,Wide_Local_Excision,1.9,R0,30.0,0,Skin_Graft,0,18,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,96.1,1,0.0,16.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000361,2016,65,Female,4,ALM,Other,0,0,5.3,0,0,1,0.77,0,2.0,T1b,1,Negative,0,0,0,N0,M1c_1,1.74,IV,1,V600K,1,0,1,0,0,0,0,0,4.1,0,50,10.96,MSS,Wide_Local_Excision,1.0,R0,2.3,1,Skin_Graft,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,1,0,0,0,1,1,1,0,0.0,0,0.6,0,None,0,None,0,39.86,1,14.1,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000362,2016,71,Male,5,SSM,HeadNeck,0,1,5.7,0,0,1,0.77,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.82,IB,0,WT,0,0,0,0,0,1,0,0,46.1,1,26,2.57,MSS,Wide_Local_Excision,1.0,R0,1.0,0,Primary_Closure,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,152.33,1,61.36,1,0.0,24.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000363,2021,33,Female,2,SSM,HeadNeck,0,0,5.7,0,0,4,2.83,1,2.0,T3b,1,Micrometastasis,1,2,0,N2a,M0,0.35,IIIC,0,V600E,1,0,0,0,1,0,0,0,52.6,1,11,1.4,MSS,Wide_Local_Excision,2.0,R0,27.4,0,Primary_Closure,0,60,0,1,Ipilimumab_mono,1L,11,PD,13.25,1,1,0,Skin,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,PR,30.34,1,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,19.6,0,None,1,Nivolumab,0,78.69,1,39.96,1,0.0,12.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000364,2014,36,Male,2,SSM,Trunk,0,0,6.6,0,0,1,1.87,1,3.0,T2b,1,Negative,0,0,0,N0,M0,0.41,IIB,0,WT,0,0,0,0,1,1,0,0,6.5,0,23,1.91,MSS,Wide_Local_Excision,1.4,R0,7.4,0,Primary_Closure,0,97,0,1,Pembrolizumab_mono,3L+,8,PR,0.84,1,1,0,Renal,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,50.31,1,50.31,0,1.0,1.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000365,2019,24,Female,1,SSM,Trunk,0,0,9.4,0,0,1,0.59,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.59,IB,0,V600E,1,1,0,1,1,0,0,0,6.2,0,17,2.85,MSS,Wide_Local_Excision,0.6,R0,1.0,0,Primary_Closure,0,25,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,50.6,0,0.0,8.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000366,2018,57,Female,3,SSM,LowerExtremity,1,0,8.1,1,0,1,1.36,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.17,IIA,0,V600E,1,0,1,0,1,0,0,0,11.4,1,44,0.73,MSS,Wide_Local_Excision,1.7,R0,11.5,0,Skin_Graft,0,32,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,215.48,1,46.65,1,0.0,15.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000367,2022,39,Male,6,NM,UpperExtremity,0,0,4.5,0,0,2,0.66,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.54,IA,0,WT,0,0,0,0,0,0,0,0,19.7,1,14,1.08,MSS,Wide_Local_Excision,1.4,R0,1.0,0,Primary_Closure,0,34,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,87.12,1,87.12,1,0.0,1.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000368,2016,50,Male,1,SSM,UpperExtremity,1,0,7.9,1,0,3,0.8,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.53,IA,0,V600E,1,0,0,0,0,0,0,0,13.0,1,25,0.64,MSS,Wide_Local_Excision,1.1,R0,1.3,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,89.46,1,0.0,4.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000369,2022,67,Female,3,SSM,HeadNeck,0,0,7.8,1,0,0,2.35,1,4.0,T3b,0,Not_Performed,0,0,0,N0,M0,0.75,IIB,0,V600E,1,0,0,0,0,1,0,0,22.4,1,11,2.41,MSS,Wide_Local_Excision,2.1,R0,1.8,0,None,0,27,0,1,Pembrolizumab_mono,2L,7,SD,4.21,1,1,0,Hepatic,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,61.24,1,61.24,1,0.0,8.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000370,2021,46,Female,5,LMM,HeadNeck,0,0,4.9,0,0,0,1.1,0,1.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.75,IIA,0,V600E,1,0,0,0,0,0,0,0,14.4,1,8,2.14,MSS,Wide_Local_Excision,1.5,R0,4.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,24.61,1,0.0,7.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000371,2016,60,Male,1,NM,Trunk,0,0,8.2,0,0,1,3.8,0,3.0,T3a,1,Negative,0,0,0,N0,M0,0.54,IIB,0,WT,0,0,0,1,0,0,0,0,13.7,1,24,1.19,MSS,Wide_Local_Excision,2.2,R0,1.0,0,Flap,0,14,0,1,Pembrolizumab_mono,1L,5,CR,1.76,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,233.29,1,233.29,0,1.34,11.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000372,2017,52,Male,1,SSM,Trunk,0,0,6.2,0,0,0,0.15,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.64,IA,0,V600E,1,0,0,0,0,0,0,0,103.4,1,8,3.86,MSS,Wide_Local_Excision,1.0,R0,5.1,1,Skin_Graft,0,91,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,159.46,1,0.0,1.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000373,2014,67,Male,3,SSM,Trunk,0,0,3.7,0,0,1,0.91,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.67,IA,0,WT,0,0,0,1,0,1,0,0,9.9,0,45,0.87,MSS,Wide_Local_Excision,1.1,R0,8.0,0,Primary_Closure,0,52,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,129.88,1,127.37,1,0.0,30.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000374,2018,64,Female,3,SSM,Trunk,0,0,7.4,0,0,1,1.52,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.78,IIA,0,V600E,1,0,0,1,1,0,0,0,55.7,1,36,1.15,MSS,Wide_Local_Excision,1.2,R0,3.7,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,224.93,1,145.46,1,0.0,13.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000375,2016,45,Female,1,SSM,Trunk,0,0,6.9,0,0,2,1.66,1,2.0,T2b,0,Not_Performed,0,0,0,N0,M0,0.63,IIB,0,V600E,1,0,0,1,1,0,0,0,47.7,1,9,3.73,MSS,Wide_Local_Excision,1.4,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,42.38,1,15.81,1,0.0,4.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000376,2015,54,Female,4,SSM,LowerExtremity,0,0,6.0,0,0,0,2.35,0,5.0,T3a,1,Macrometastasis,1,1,0,N1b,M1b,0.75,IV,1,V600E,1,0,0,0,0,1,0,0,22.5,1,25,10.22,MSS,Wide_Local_Excision,2.1,R0,12.2,0,Skin_Graft,0,14,0,1,Ipilimumab_Nivolumab,1L,23,SD,6.67,0,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,1,0,0,0,0,0,0,1,1,0,0.0,1,1.2,0,None,0,None,0,35.38,1,13.51,1,0.0,6.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000377,2020,70,Female,4,ALM,Acral,0,0,6.4,0,0,1,1.04,0,1.0,T2a,0,Not_Performed,0,0,0,N0,M0,1.21,IIA,0,V600E,1,0,0,0,1,1,0,0,6.0,0,9,1.06,MSS,Wide_Local_Excision,1.7,R0,3.8,0,Skin_Graft,0,29,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,55.76,1,40.09,0,0.0,1.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000378,2020,63,Female,4,SSM,UpperExtremity,0,0,5.1,0,0,0,1.07,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.44,IIA,0,WT,0,0,0,0,0,1,0,0,15.4,1,4,2.41,MSS,Wide_Local_Excision,1.7,R0,18.1,0,Flap,0,24,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,47.75,1,47.75,1,0.0,8.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000379,2014,34,Female,4,SSM,Trunk,0,0,7.7,0,0,1,0.47,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.55,IA,0,V600E,1,0,0,0,0,0,0,0,9.9,0,11,1.07,MSI_L,Wide_Local_Excision,0.7,R0,3.7,0,Skin_Graft,0,72,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,140.2,0,22.51,0,0.0,8.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000380,2016,67,Male,4,NM,LowerExtremity,0,1,6.4,0,0,0,3.03,0,4.0,T3a,1,Negative,0,0,0,N0,M0,1.15,IIB,0,WT,0,0,0,0,0,0,0,0,15.2,1,19,1.71,MSS,Wide_Local_Excision,1.7,R0,1.0,0,Flap,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,116.28,0,56.73,1,0.0,26.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000381,2014,39,Female,2,SSM,LowerExtremity,0,0,6.8,0,0,0,0.5,0,1.0,T1b,0,Not_Performed,0,0,0,N0,M0,0.92,IB,0,V600E,1,0,1,0,0,0,0,0,6.4,0,34,2.24,MSS,Wide_Local_Excision,1.1,R0,4.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,165.95,1,14.2,1,0.0,10.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000382,2021,64,Male,4,ALM,Acral,0,0,7.2,0,0,1,0.33,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.09,IA,0,WT,0,0,0,0,0,0,0,0,9.2,0,23,3.13,MSS,Wide_Local_Excision,0.9,R0,19.1,0,None,0,61,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,62.38,1,62.38,0,0.0,12.4,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000383,2017,73,Male,2,NM,UpperExtremity,0,0,4.2,0,0,1,1.64,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.71,IIA,0,V600E,1,0,0,0,0,0,0,0,33.0,1,50,2.58,MSS,Wide_Local_Excision,1.7,R0,16.5,0,Skin_Graft,0,25,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,42.1,0,22.02,0,0.0,15.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000384,2014,61,Female,1,SSM,LowerExtremity,0,0,4.7,0,0,1,3.45,1,6.0,T3b,1,Negative,0,0,0,N0,M0,0.69,IIB,0,WT,0,0,0,0,0,1,0,0,38.2,1,7,2.49,MSS,Wide_Local_Excision,1.7,R0,12.9,0,Skin_Graft,0,14,0,1,Pembrolizumab_mono,1L,17,PR,19.59,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,67.5,0,39.56,1,9.45,19.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000385,2016,59,Female,3,SSM,UpperExtremity,0,0,2.1,0,0,0,0.99,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.08,IA,0,V600E,1,0,0,0,1,0,0,0,11.0,1,14,0.84,MSS,Wide_Local_Excision,1.0,R1,0.0,0,Flap,0,14,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,81.09,1,81.09,1,0.0,17.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000386,2024,53,Female,1,DM,LowerExtremity,0,0,7.6,0,0,0,1.4,0,2.0,T2a,1,Negative,0,0,0,N0,M1b,0.86,IV,1,V600K,1,0,0,0,0,1,0,0,2.6,0,100,19.52,MSS,Amputation,1.5,R0,1.7,0,Primary_Closure,0,16,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Vemurafenib_mono,0,SD,10.79,0,1,BRAF_amplification,0,0,0,0,0,1,1,0,0,5,0,0,0.0,1,0.5,0,None,0,None,0,9.9,1,6.87,0,0.0,3.4,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000387,2016,67,Male,2,NM,HeadNeck,0,0,4.1,0,0,0,2.44,0,7.0,T3a,1,Negative,0,0,0,N0,M0,1.39,IIB,0,WT,0,0,0,0,0,1,0,0,19.9,1,3,3.11,MSS,Wide_Local_Excision,2.1,R0,2.1,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,4,PD,5.44,1,1,1,Skin,0,0,0,0,1,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,134.65,1,73.12,1,0.0,5.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000388,2021,77,Male,5,UM,Uveal,1,0,6.8,0,0,3,0.34,0,2.0,T1b,1,Negative,0,0,0,N0,M1a_1,2.25,IV,1,WT,0,0,0,0,0,0,0,1,2.9,0,13,3.03,MSS,Wide_Local_Excision,0.8,R0,1.0,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,1,0,1,1,0,0.0,0,0.6,0,None,0,None,0,18.1,1,7.3,0,0.0,1.2,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000389,2019,60,Male,2,SSM,Trunk,0,0,7.2,0,1,2,2.31,0,3.0,T3a,1,Micrometastasis,1,0,0,N0,M0,0.71,IIB,0,V600E,1,0,0,0,0,0,0,0,15.9,1,7,1.12,MSS,Wide_Local_Excision,1.6,R0,3.3,0,Flap,0,79,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,87.1,1,87.1,1,0.0,2.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000390,2015,70,Male,2,LMM,HeadNeck,0,0,7.7,0,0,0,0.26,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.3,IA,0,WT,0,0,0,0,0,0,0,0,21.5,1,16,4.16,MSS,Wide_Local_Excision,1.0,R0,1.0,0,Skin_Graft,0,16,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,118.48,1,67.72,1,0.0,12.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000391,2017,48,Male,3,SSM,UpperExtremity,0,0,4.1,1,0,0,0.81,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.39,IA,0,V600E,1,0,0,0,0,0,0,0,12.4,1,13,0.7,MSS,Wide_Local_Excision,1.1,R0,8.9,0,Primary_Closure,0,29,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,23.76,1,23.76,1,0.0,11.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000392,2014,47,Male,3,SSM,UpperExtremity,0,0,6.4,0,0,0,1.15,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.63,IIA,0,V600E,1,0,1,0,0,0,0,0,10.0,1,37,1.42,MSS,Wide_Local_Excision,1.7,R0,6.1,0,Primary_Closure,0,29,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,221.85,1,106.77,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000393,2022,37,Male,1,SSM,LowerExtremity,0,0,9.8,0,0,1,1.41,1,3.0,T2b,0,Not_Performed,0,0,0,N0,M0,0.48,IIB,0,V600E,1,0,0,1,0,0,0,0,25.4,1,26,1.6,MSI_L,Wide_Local_Excision,1.4,R0,2.5,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,48.21,1,48.21,1,0.0,8.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000394,2017,39,Female,4,SSM,UpperExtremity,0,0,9.9,0,0,0,0.72,0,1.0,T1b,1,Negative,0,0,0,N0,M1c_1,3.24,IV,1,WT,0,0,0,1,0,0,0,0,13.8,1,5,10.62,MSS,Wide_Local_Excision,1.2,R0,12.8,0,Primary_Closure,0,39,0,1,Pembrolizumab_mono,1L,16,PD,18.38,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,0,0,0,0,0,3,1,0,0.0,1,0.4,0,None,0,None,0,8.06,0,5.78,1,0.0,4.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000395,2019,27,Male,4,SSM,Trunk,0,0,8.5,0,0,0,0.33,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.44,IA,0,V600E,1,0,0,0,1,0,0,0,20.7,1,11,1.58,MSS,Wide_Local_Excision,1.1,R0,1.0,0,Flap,0,40,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,222.78,0,114.88,0,0.0,3.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000396,2015,68,Male,2,SSM,HeadNeck,0,0,7.2,0,0,0,0.68,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.61,IB,0,WT,0,0,0,0,0,0,0,0,22.5,1,20,2.39,MSI_L,Wide_Local_Excision,1.3,R0,10.1,0,Primary_Closure,0,16,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,40.28,0,0.0,9.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000397,2023,85,Female,3,NM,Trunk,1,0,4.5,0,0,0,2.07,0,5.0,T3a,1,Negative,0,0,0,N0,M1d,0.89,IV,1,WT,0,0,0,0,0,1,0,0,19.8,1,42,5.44,MSS,Wide_Local_Excision,2.0,R0,10.0,0,Primary_Closure,1,45,0,1,Pembrolizumab_mono,1L,6,PR,3.24,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,1,1,0,0.0,0,0.2,0,None,0,None,0,50.45,1,12.03,1,1.62,1.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000398,2016,79,Male,2,SSM,HeadNeck,0,1,7.9,0,0,0,0.7,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.2,IB,0,V600E,1,0,0,0,0,0,0,0,23.4,1,100,1.46,MSS,Wide_Local_Excision,0.7,R0,4.5,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,124.38,1,124.38,0,0.0,21.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000399,2020,30,Female,1,SSM,Trunk,0,0,6.2,0,0,0,2.37,0,6.0,T3a,1,Negative,0,0,0,N0,M0,0.58,IIB,0,V600E,1,0,0,0,0,1,0,0,7.6,0,40,0.49,MSS,Wide_Local_Excision,2.0,R0,17.4,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,149.73,1,32.64,1,0.0,2.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000400,2023,68,Female,2,SSM,UpperExtremity,0,1,7.6,0,0,1,0.51,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.89,IA,0,WT,0,0,0,1,0,0,0,0,7.2,0,7,10.24,MSS,Wide_Local_Excision,1.0,R0,9.3,0,Skin_Graft,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,153.14,1,153.14,1,0.0,11.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000401,2021,79,Male,1,SSM,UpperExtremity,0,0,5.2,0,0,1,1.48,1,2.0,T2b,1,Negative,0,0,0,N0,M0,0.8,IIB,0,V600E,1,0,0,0,1,0,0,0,14.5,1,18,2.37,MSS,Wide_Local_Excision,1.6,R0,10.0,0,Primary_Closure,0,27,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,67.59,1,67.59,1,0.0,1.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000402,2020,51,Female,5,ALM,Acral,0,1,6.2,1,0,0,1.34,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.06,IIA,0,V600E,1,0,0,0,1,0,0,0,5.4,0,24,2.21,MSS,Wide_Local_Excision,1.2,R0,26.7,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,64.17,1,64.17,1,0.0,1.7,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000403,2023,58,Female,5,NM,Trunk,1,0,6.8,0,0,1,6.86,1,7.0,T4b,1,Macrometastasis,1,2,0,N2a,M0,1.04,IIIC,0,V600E,1,0,0,0,0,0,0,0,9.9,0,12,2.41,MSS,Wide_Local_Excision,1.9,R0,16.2,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,15,PD,5.97,0,1,0,Cardiac,0,0,0,0,0,0,0,1,Vemurafenib_Cobimetinib,1,CR,10.17,1,1,MEK1_mut,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,1.7,0,None,1,Nivolumab,0,53.12,1,3.13,1,0.0,19.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000404,2015,24,Female,4,SSM,HeadNeck,0,0,7.0,0,0,0,1.09,0,0.0,T2a,1,Negative,0,0,1,N2c,M0,0.73,IIIC,0,WT,0,0,0,0,0,0,0,0,18.2,1,32,3.24,MSS,Wide_Local_Excision,1.7,R0,6.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,19.0,0,None,1,Nivolumab,0,40.29,1,40.29,1,0.0,4.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000405,2024,61,Female,3,DM,LowerExtremity,0,0,7.5,1,0,1,2.09,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.38,IIB,0,V600E,1,0,0,0,1,1,0,0,3.3,0,2,4.37,MSS,Wide_Local_Excision,2.0,R0,1.0,0,Skin_Graft,1,30,0,1,Pembrolizumab_mono,2L,8,PD,2.02,0,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,60.44,1,47.78,1,0.0,1.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000406,2020,39,Female,3,LMM,HeadNeck,1,0,5.3,0,0,3,1.06,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.68,IIA,0,V600E,1,0,0,0,0,0,0,0,38.8,1,35,0.57,MSS,Wide_Local_Excision,1.4,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,113.32,0,0.0,1.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000407,2018,60,Female,6,SSM,UpperExtremity,0,1,3.8,0,0,0,1.63,0,0.0,T2a,0,Not_Performed,0,0,0,N0,M1c,0.79,IV,1,V600E,1,0,0,0,0,0,0,0,46.4,1,12,4.13,MSS,Wide_Local_Excision,1.9,R0,15.7,0,Primary_Closure,0,14,0,1,Ipilimumab_Nivolumab,1L,5,PR,34.26,1,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,1,0,0,0,0,2,1,0,0.0,0,0.3,0,None,0,None,0,27.53,0,3.49,1,30.66,11.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000408,2016,32,Male,2,NM,Trunk,0,0,9.7,1,0,2,1.22,0,2.0,T2a,1,Macrometastasis,1,0,0,N0,M0,0.83,IIA,0,V600E,1,0,0,0,0,0,0,0,5.2,0,18,5.42,MSS,Wide_Local_Excision,1.3,R0,8.6,0,Primary_Closure,0,21,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,156.81,0,80.42,0,0.0,21.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000409,2022,65,Female,1,SSM,UpperExtremity,0,0,10.0,0,0,1,0.19,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.55,IA,0,WT,0,1,0,1,0,1,0,0,5.9,0,87,1.9,MSS,Wide_Local_Excision,1.2,R0,27.4,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,69.73,1,42.29,0,0.0,20.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000410,2024,73,Female,3,DM,Trunk,0,0,7.4,0,0,1,1.56,0,1.0,T2a,0,Not_Performed,0,0,0,N0,M0,1.17,IIA,0,V600K,1,0,0,0,0,0,0,0,6.3,0,6,1.82,MSS,Wide_Local_Excision,1.7,R1,0.0,0,Primary_Closure,0,23,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,55.59,1,29.41,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000411,2021,44,Female,2,SSM,Trunk,0,1,3.9,0,0,0,1.62,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.74,IIA,0,WT,0,1,0,0,0,0,0,0,16.0,1,26,0.17,MSS,Wide_Local_Excision,1.5,R0,10.7,1,Skin_Graft,0,52,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,34.04,1,0.0,1.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000412,2014,38,Female,2,SSM,LowerExtremity,0,0,5.0,0,0,0,1.67,0,3.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.51,IIA,0,WT,0,0,0,0,0,1,0,0,12.4,1,44,0.74,MSS,Wide_Local_Excision,1.5,R0,28.2,0,Primary_Closure,0,21,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,135.11,1,18.68,0,0.0,4.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000413,2019,22,Male,1,SSM,UpperExtremity,0,0,7.5,0,0,0,0.83,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.62,IB,0,V600E,1,0,0,0,0,0,0,0,9.6,0,24,3.03,MSS,Wide_Local_Excision,1.0,R0,9.6,1,Primary_Closure,0,78,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,41.85,1,41.85,1,0.0,28.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000414,2022,52,Female,3,LMM,Trunk,0,0,9.2,0,0,4,3.4,0,3.0,T3a,1,Negative,0,0,0,N0,M0,1.6,IIB,0,WT,0,1,0,0,1,0,0,0,11.8,1,4,5.23,MSS,Wide_Local_Excision,2.0,R0,6.3,0,Skin_Graft,0,14,0,1,Nivolumab_mono,2L,22,PR,7.02,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,130.81,1,86.39,0,4.37,1.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000415,2018,47,Female,2,SSM,Trunk,0,0,4.1,1,0,1,0.87,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.97,IB,0,WT,0,1,0,0,0,1,0,0,22.1,1,77,3.58,MSS,Wide_Local_Excision,0.9,R0,4.9,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,177.58,1,177.58,0,0.0,3.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000416,2022,32,Male,1,SSM,Trunk,0,0,6.3,0,0,0,1.61,1,3.0,T2b,1,Negative,0,0,0,N0,M0,1.13,IIB,0,WT,0,0,0,0,0,0,0,0,5.2,0,16,1.88,MSS,Wide_Local_Excision,1.4,R1,0.0,0,Primary_Closure,0,14,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,72.22,0,64.25,1,0.0,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000417,2021,64,Male,1,SSM,Trunk,0,0,6.9,0,0,1,1.82,0,0.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.49,IIA,0,WT,0,0,0,0,0,0,0,0,97.8,1,12,9.34,MSS,Wide_Local_Excision,1.4,R0,3.8,0,Primary_Closure,0,32,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,57.23,1,0.0,12.6,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000418,2014,49,Male,2,NM,UpperExtremity,0,0,8.2,0,0,0,11.66,1,4.0,T4b,1,Negative,0,0,0,N0,M0,0.56,IIC,0,V600E,1,0,0,0,0,0,0,0,15.3,1,15,4.47,MSS,Wide_Local_Excision,1.9,R0,9.1,0,Flap,0,26,0,1,Pembrolizumab_mono,1L,26,PR,17.41,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,143.61,1,143.61,0,1.16,2.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000419,2020,39,Male,4,SSM,Trunk,0,0,5.8,1,0,0,0.96,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.56,IA,0,WT,0,0,0,0,1,0,0,0,34.8,1,14,1.46,MSS,Wide_Local_Excision,0.9,R0,5.0,1,Primary_Closure,1,24,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,32.2,1,32.2,1,0.0,6.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000420,2015,69,Female,5,ALM,Acral,0,0,3.4,0,0,1,0.76,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.8,IA,0,V600E,1,0,0,0,0,0,0,0,1.9,0,6,11.46,MSS,Wide_Local_Excision,0.6,R0,27.4,0,None,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,116.08,0,33.02,1,0.0,1.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000421,2019,74,Male,3,SSM,Trunk,0,0,7.7,1,0,0,0.42,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.69,IB,0,WT,0,0,0,0,1,0,0,0,23.7,1,24,0.83,MSS,Wide_Local_Excision,1.0,R0,4.1,0,Flap,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,128.12,0,53.53,1,0.0,14.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000422,2018,66,Male,3,SSM,Trunk,0,0,8.7,0,0,1,3.56,0,3.0,T3a,1,Negative,0,0,0,N0,M0,0.61,IIB,0,V600E,1,0,0,0,1,0,0,0,16.3,1,11,0.62,MSI_H,Wide_Local_Excision,1.9,R0,11.1,1,Primary_Closure,0,14,0,1,Nivolumab_mono,1L,4,PR,9.84,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,166.72,1,166.72,0,4.96,19.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000423,2022,54,Female,2,SSM,HeadNeck,0,0,6.3,0,0,1,1.61,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.64,IIA,0,V600K,1,0,0,0,0,0,0,0,29.8,1,39,1.43,MSS,Wide_Local_Excision,1.1,R0,20.9,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,126.85,1,0.0,21.7,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000424,2023,66,Female,4,SSM,Trunk,0,0,7.3,0,0,1,1.65,0,0.0,T2a,1,Negative,0,0,0,N0,M0,0.54,IIA,0,WT,0,1,0,0,0,0,0,0,12.8,1,34,1.09,MSS,Wide_Local_Excision,1.4,R0,9.5,0,None,1,19,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,163.27,1,27.75,1,0.0,2.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000425,2019,38,Female,3,SSM,UpperExtremity,0,0,5.6,0,0,1,10.63,1,1.0,T4b,1,Macrometastasis,1,3,0,N2a,M0,0.69,IIIC,0,V600R,1,0,0,0,0,0,0,0,51.9,1,100,1.49,MSS,Wide_Local_Excision,1.9,R0,1.7,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,34,PR,3.1,0,1,1,Pulmonary,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,17.1,0,None,0,None,0,46.2,0,46.2,1,17.57,10.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000426,2019,57,Female,3,NM,HeadNeck,0,0,4.8,1,0,0,4.39,1,8.0,T4b,0,Not_Performed,0,0,0,N0,M0,1.16,IIC,0,V600E,1,0,0,0,0,0,0,0,4.5,0,16,3.79,MSS,Wide_Local_Excision,2.3,R0,1.9,1,Primary_Closure,0,34,0,1,Pembrolizumab_mono,1L,9,PR,14.41,1,1,0,GI,1,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,76.53,0,76.53,1,27.69,1.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000427,2020,59,Female,1,SSM,HeadNeck,0,0,8.6,0,0,1,0.48,0,1.0,T1b,1,Negative,0,0,0,N0,M1c_1,1.03,IV,1,WT,0,0,0,0,0,1,0,0,32.1,1,9,21.09,MSS,Wide_Local_Excision,0.9,R0,1.2,0,Primary_Closure,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,1,0,0,0,0,2,1,0,0.0,0,0.1,0,None,0,None,0,21.17,0,13.2,1,0.0,23.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000428,2021,49,Female,1,NM,LowerExtremity,0,0,7.3,0,0,1,3.05,1,8.0,T3b,1,Negative,0,0,0,N0,M0,0.85,IIB,0,WT,0,0,0,0,1,1,0,0,16.5,1,5,1.99,MSS,Wide_Local_Excision,2.1,R0,8.2,0,Skin_Graft,1,14,0,1,Pembrolizumab_mono,1L,4,PD,3.3,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,18.35,1,18.35,0,0.0,9.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000429,2020,63,Female,6,SSM,Trunk,0,0,7.5,0,0,0,0.61,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.29,IA,0,Non_V600,0,1,0,0,1,0,0,0,6.6,0,100,2.1,MSS,Wide_Local_Excision,1.3,R0,6.3,0,Flap,0,27,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,222.72,1,130.42,1,0.0,26.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000430,2022,44,Male,3,NM,UpperExtremity,0,1,9.5,0,0,0,2.65,0,1.0,T3a,1,Negative,0,0,0,N0,M0,0.69,IIB,0,WT,0,1,0,0,0,0,0,0,71.5,1,39,0.31,MSS,Wide_Local_Excision,1.9,R0,6.5,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,101.86,1,48.01,0,0.0,18.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000431,2024,69,Female,4,ALM,Other,1,0,4.4,0,0,0,0.91,0,1.0,T1b,1,Negative,0,0,0,N0,M1c,0.96,IV,1,WT,0,0,1,0,0,1,0,0,2.2,0,10,7.97,MSS,Wide_Local_Excision,1.0,R1,0.0,0,Primary_Closure,0,25,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,2,1,0,0.0,0,0.6,0,None,0,None,0,7.47,1,4.69,1,0.0,12.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000432,2023,65,Male,4,NM,HeadNeck,0,0,5.4,0,0,0,2.32,1,5.0,T3b,1,Negative,0,0,0,N0,M0,1.07,IIB,0,WT,0,1,0,0,1,0,0,0,2.9,0,100,1.47,MSS,Wide_Local_Excision,2.3,R0,1.1,0,Primary_Closure,0,22,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,108.85,1,108.85,1,0.0,19.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000433,2015,18,Male,1,SSM,Trunk,0,0,6.8,0,0,1,0.45,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.5,IA,0,V600E,1,0,0,0,0,0,0,0,17.3,1,78,1.02,MSS,Wide_Local_Excision,1.0,R0,11.7,0,Skin_Graft,0,43,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,116.52,0,116.52,1,0.0,1.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000434,2019,76,Male,3,NM,Trunk,0,0,5.4,1,0,0,10.67,1,2.0,T4b,1,Negative,0,0,0,N0,M0,0.73,IIC,0,V600E,1,0,0,0,0,0,0,0,26.4,1,5,1.66,MSS,Wide_Local_Excision,2.1,R0,1.0,1,Primary_Closure,0,35,0,1,Pembrolizumab_mono,1L,7,PD,12.45,1,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,194.43,1,40.0,0,0.0,4.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000435,2019,18,Female,2,SSM,Trunk,0,0,8.1,0,0,1,1.48,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.49,IIA,0,WT,0,0,0,0,0,0,0,0,21.4,1,9,6.15,MSS,Wide_Local_Excision,1.4,R0,1.0,0,Skin_Graft,0,120,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,180.67,1,45.46,1,0.0,6.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000436,2019,47,Female,3,SSM,Trunk,0,0,6.1,1,0,0,1.02,1,1.0,T2b,1,Negative,0,0,0,N0,M0,0.35,IIB,0,WT,0,0,0,0,0,0,0,0,50.4,1,18,1.88,MSS,Wide_Local_Excision,1.6,R0,2.2,0,Skin_Graft,0,120,0,1,Nivolumab_mono,1L,32,SD,17.01,1,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,240.0,0,59.02,1,0.0,10.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000437,2019,73,Male,1,SSM,LowerExtremity,0,0,4.5,0,1,0,2.04,0,4.0,T3a,0,Not_Performed,0,0,0,N0,M0,0.7,IIB,0,V600E,1,0,0,1,0,0,0,0,42.7,1,7,0.69,MSS,Wide_Local_Excision,2.0,R0,1.0,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,53.28,1,53.28,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000438,2021,51,Female,2,SSM,Trunk,0,0,6.6,0,0,0,1.67,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.45,IIA,0,V600E,1,0,0,0,0,0,0,0,18.5,1,18,1.06,MSS,Wide_Local_Excision,1.1,R0,2.9,0,None,0,48,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,95.1,1,0.0,7.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000439,2018,33,Male,3,NM,Trunk,0,0,6.8,0,0,0,4.25,0,2.0,T4a,1,Negative,0,0,0,N0,M0,0.74,IIC,0,V600E,1,0,0,0,0,1,0,0,92.7,1,41,7.86,MSS,Wide_Local_Excision,1.9,R0,17.4,0,Primary_Closure,0,14,0,1,Nivolumab_mono,1L,31,PR,6.7,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,105.05,1,2.67,20.1,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000440,2016,39,Female,3,SSM,Trunk,0,0,8.4,0,0,4,1.94,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.16,IIA,0,WT,0,0,0,1,0,0,0,0,31.7,1,5,6.82,MSS,Wide_Local_Excision,1.3,R0,26.5,1,Primary_Closure,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,211.95,0,0.0,8.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000441,2019,73,Female,3,LMM,HeadNeck,0,0,7.3,0,0,0,1.32,1,1.0,T2b,1,Negative,0,0,0,N0,M0,1.56,IIB,0,WT,0,0,0,0,1,0,0,0,11.3,1,27,3.22,MSS,Wide_Local_Excision,1.5,R0,1.5,0,Primary_Closure,0,17,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,93.03,1,69.79,1,0.0,24.8,Non_Cancer,HC-ONC-009,1.0.0,42 |
| MEL-0000442,2023,26,Female,2,SSM,Trunk,0,1,7.4,0,0,0,1.92,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.77,IIA,0,V600K,1,0,0,0,0,0,0,0,9.6,0,64,0.57,MSI_H,Wide_Local_Excision,1.3,R0,6.3,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,130.12,0,120.19,0,0.0,2.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000443,2017,75,Female,2,NM,Trunk,0,0,7.1,0,0,0,5.93,0,5.0,T4a,1,Negative,0,0,0,N0,M0,1.11,IIC,0,V600E,1,0,0,0,0,0,0,0,40.6,1,30,2.56,MSS,Wide_Local_Excision,2.1,R0,10.6,0,Primary_Closure,0,42,0,1,Nivolumab_mono,1L,13,PD,9.37,0,1,0,GI,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,23.55,1,23.55,1,0.0,4.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000444,2014,56,Male,5,SSM,Trunk,0,0,6.1,0,0,0,1.34,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.87,IIA,0,V600E,1,0,0,0,0,1,0,0,8.0,0,19,2.72,MSS,Wide_Local_Excision,1.5,R0,1.2,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,150.24,1,14.44,1,0.0,19.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000445,2024,37,Male,2,SSM,Acral,0,0,5.1,0,0,1,1.03,0,1.0,T2a,1,Macrometastasis,1,2,0,N2a,M0,0.64,IIIC,0,WT,0,1,0,0,0,1,0,0,10.8,1,10,2.04,MSS,Wide_Local_Excision,1.3,R0,3.0,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,10.7,0,None,1,Nivolumab,0,3.8,1,3.8,0,0.0,3.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000446,2016,47,Female,2,NM,Trunk,0,0,7.1,1,0,1,10.22,1,5.0,T4b,1,Negative,0,0,0,N0,M0,0.34,IIC,0,V600E,1,0,0,0,0,0,0,0,12.4,1,46,1.27,MSS,Wide_Local_Excision,1.9,R0,6.6,0,Skin_Graft,0,35,0,1,Pembrolizumab_mono,1L,25,CR,7.07,1,1,1,Pulmonary,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,121.29,0,121.29,1,2.18,8.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000447,2020,40,Female,3,DM,LowerExtremity,0,0,5.8,0,1,0,0.86,1,1.0,T1b,1,Negative,0,0,0,N0,M0,1.42,IB,0,V600E,1,0,0,0,1,0,0,0,9.0,0,6,1.5,MSS,Wide_Local_Excision,1.1,R0,1.0,0,Primary_Closure,1,33,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,189.93,1,0.0,22.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000448,2022,70,Male,2,SSM,Trunk,0,0,9.9,0,0,1,1.58,1,0.0,T2b,1,Negative,0,0,0,N0,M0,0.49,IIB,0,V600E,1,0,0,1,1,1,0,0,12.8,1,25,1.2,MSS,Wide_Local_Excision,1.7,R0,5.2,0,Skin_Graft,0,20,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,69.25,1,57.65,1,0.0,16.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000449,2017,68,Male,3,SSM,Trunk,1,0,9.2,0,0,0,1.6,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.29,IIA,0,WT,0,0,0,0,0,0,0,0,5.2,0,21,0.8,MSS,Wide_Local_Excision,1.3,R0,1.3,1,Skin_Graft,0,55,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,71.7,1,71.7,0,0.0,8.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000450,2017,29,Male,2,SSM,Trunk,0,0,7.8,0,0,2,0.78,1,0.0,T1b,1,Negative,0,0,0,N0,M0,0.92,IB,0,V600E,1,0,0,0,0,0,0,0,38.0,1,62,5.97,MSS,Wide_Local_Excision,0.8,R0,4.3,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,56.97,1,56.97,1,0.0,1.0,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000451,2017,50,Male,4,SSM,Trunk,0,0,7.3,0,0,1,0.68,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.5,IB,0,V600E,1,0,0,0,1,0,0,0,10.9,1,11,4.05,MSS,Wide_Local_Excision,1.4,R1,0.0,0,None,0,14,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,55.08,0,0.0,63.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000452,2015,43,Male,4,LMM,UpperExtremity,0,1,6.3,1,0,0,0.94,1,1.0,T1b,1,Negative,0,0,0,N0,M0,0.84,IB,0,V600E,1,0,0,0,0,0,0,0,75.5,1,12,1.59,MSS,Wide_Local_Excision,1.0,R0,3.7,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,106.38,0,106.38,1,0.0,4.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000453,2015,77,Male,5,NM,UpperExtremity,0,0,4.0,1,0,1,2.48,0,1.0,T3a,1,Negative,0,0,1,N2c,M0,1.74,IIIC,0,WT,0,0,0,0,0,1,0,0,19.1,1,6,2.65,MSI_L,Wide_Local_Excision,2.0,R0,1.0,0,Primary_Closure,0,54,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,25.3,0,None,1,Pembrolizumab,0,50.3,0,12.42,1,0.0,8.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000454,2016,35,Female,3,SSM,LowerExtremity,0,0,6.1,0,1,2,0.43,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.37,IB,0,V600E,1,0,0,0,0,0,0,0,41.3,1,31,2.73,MSS,Wide_Local_Excision,0.9,R0,10.9,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,222.19,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000455,2019,82,Male,2,SSM,Trunk,0,0,6.7,1,0,0,0.76,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.6,IA,0,V600E,1,0,0,1,0,1,0,0,24.8,1,13,13.03,MSS,Wide_Local_Excision,1.0,R1,0.0,1,Primary_Closure,0,34,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,176.22,0,106.28,1,0.0,3.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000456,2019,56,Male,3,SSM,UpperExtremity,0,0,7.0,1,0,4,1.45,1,1.0,T2b,1,Negative,0,0,0,N0,M0,0.56,IIB,0,V600E,1,0,0,0,1,0,0,0,43.0,1,8,4.02,MSI_H,Wide_Local_Excision,1.8,R0,1.7,0,Primary_Closure,0,61,0,1,Pembrolizumab_mono,3L+,6,PR,20.97,1,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Ipilimumab,0,225.58,1,28.08,0,6.14,4.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000457,2014,38,Male,4,DM,LowerExtremity,0,0,7.4,0,0,2,2.91,0,2.0,T3a,1,Negative,0,0,1,N2c,M0,0.77,IIIC,0,V600E,1,0,0,0,1,1,0,0,19.9,1,9,3.9,MSS,Wide_Local_Excision,2.1,R1,0.0,0,Primary_Closure,1,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,17.4,0,None,0,None,1,68.48,1,68.48,1,0.0,24.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000458,2023,46,Male,3,SSM,Trunk,0,0,8.3,0,0,0,1.77,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.69,IIA,0,WT,0,0,0,0,0,0,0,0,18.1,1,34,2.06,MSS,Wide_Local_Excision,1.7,R0,12.6,0,Primary_Closure,0,15,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,124.74,1,117.61,0,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000459,2021,44,Female,3,NM,Trunk,0,0,5.1,0,0,1,0.57,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M1c,0.93,IV,1,WT,0,0,0,0,0,0,0,0,36.0,1,7,31.0,MSS,Wide_Local_Excision,1.0,R0,1.0,0,Flap,0,41,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,4,0,0,0.0,0,1.3,0,None,0,None,0,12.05,0,5.36,1,0.0,22.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000460,2014,36,Male,3,SSM,Trunk,0,0,5.1,0,0,1,1.88,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.0,IIA,0,V600E,1,0,0,1,0,0,0,0,109.6,1,7,6.05,MSS,Wide_Local_Excision,1.3,R0,3.3,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,144.65,1,144.65,1,0.0,22.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000461,2023,58,Female,3,SSM,Trunk,0,0,9.4,0,1,1,0.81,0,1.0,T1b,0,Not_Performed,0,0,0,N0,M0,0.38,IB,0,WT,0,0,0,0,1,0,0,0,12.1,1,49,3.37,MSS,Wide_Local_Excision,0.9,R0,7.0,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,57.56,1,0.0,8.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000462,2014,37,Female,3,SSM,UpperExtremity,1,0,8.0,0,0,0,1.65,1,0.0,T2b,1,Negative,0,0,0,N0,M0,0.89,IIB,0,V600E,1,0,1,0,0,0,0,0,28.3,1,17,1.03,MSS,Wide_Local_Excision,1.3,R0,3.1,0,Skin_Graft,0,48,0,1,Ipilimumab_mono,1L,16,PD,0.44,1,1,0,Renal,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,69.55,1,69.55,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000463,2020,79,Male,4,ALM,Other,0,0,5.7,0,0,2,1.19,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.69,IIA,0,WT,0,0,0,0,0,1,0,0,5.9,0,52,2.88,MSS,Wide_Local_Excision,1.5,R0,16.5,0,Skin_Graft,0,63,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,39.34,1,39.34,1,0.0,2.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000464,2019,50,Female,2,SSM,Other,0,0,6.3,0,0,1,1.05,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.75,IIA,0,V600E,1,0,0,0,0,0,0,0,22.5,1,14,3.91,MSS,Wide_Local_Excision,1.7,R0,8.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,185.59,0,145.31,1,0.0,15.3,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000465,2019,28,Female,3,SSM,Acral,0,0,6.3,0,0,1,1.12,0,3.0,T2a,1,Negative,0,0,1,N2c,M0,0.82,IIIC,0,V600E,1,0,0,0,0,0,0,0,15.5,1,20,0.37,MSS,Wide_Local_Excision,1.5,R0,30.0,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,2L,29,PR,10.67,0,1,0,Endocrine,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,8.1,0,None,1,Pembrolizumab,0,88.07,1,65.68,1,58.18,10.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000466,2024,44,Male,1,SSM,UpperExtremity,0,0,6.6,0,0,0,1.18,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.2,IIA,0,WT,0,1,0,0,0,0,0,0,2.7,0,23,0.96,MSS,Wide_Local_Excision,1.4,R0,4.1,0,Primary_Closure,0,98,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,75.62,0,0.0,8.0,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000467,2024,42,Male,4,SSM,Trunk,0,0,7.4,0,0,0,3.08,0,4.0,T3a,1,Negative,0,0,0,N0,M0,1.1,IIB,0,WT,0,0,0,0,1,0,0,0,12.8,1,80,2.67,MSS,Wide_Local_Excision,1.8,R0,19.1,0,Primary_Closure,0,31,0,1,Pembrolizumab_mono,1L,5,SD,6.34,1,1,1,Endocrine,0,0,0,1,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,82.56,0,79.13,0,0.0,30.1,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000468,2017,69,Female,5,ALM,HeadNeck,0,0,10.0,1,0,2,1.18,0,1.0,T2a,1,Negative,0,0,0,N0,M0,0.55,IIA,0,WT,0,0,0,0,1,0,0,0,10.9,1,74,0.43,MSS,Wide_Local_Excision,1.6,R0,2.2,0,Primary_Closure,0,35,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,227.4,0,49.44,0,0.0,25.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000469,2020,89,Female,1,SSM,Trunk,1,0,6.9,0,0,1,2.57,0,4.0,T3a,1,Negative,0,0,0,N0,M0,0.72,IIB,0,WT,0,1,0,1,0,0,0,0,8.1,0,63,0.49,MSS,Wide_Local_Excision,1.8,R0,13.8,0,Primary_Closure,0,99,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,79.39,0,79.39,1,0.0,10.1,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000470,2024,57,Male,4,SSM,Trunk,1,0,7.8,0,0,0,2.32,0,4.0,T3a,1,Micrometastasis,1,1,0,N1a,M0,0.62,IIIB,0,WT,0,0,0,0,1,0,0,0,31.3,1,11,1.61,MSS,Wide_Local_Excision,1.8,R0,1.8,0,Primary_Closure,0,29,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,4.9,0,None,1,Pembrolizumab,0,230.56,0,24.71,1,0.0,12.8,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000471,2022,60,Female,3,SSM,Trunk,0,0,3.1,0,0,2,1.91,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.38,IIA,0,WT,0,0,0,0,1,0,0,0,17.4,1,7,2.96,MSS,Wide_Local_Excision,1.7,R0,17.2,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,122.97,0,12.7,1,0.0,9.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000472,2023,28,Male,3,SSM,UpperExtremity,0,0,5.5,1,0,2,0.34,0,2.0,T1b,1,Negative,0,0,0,N0,M0,0.71,IB,0,V600E,1,0,0,0,0,0,0,0,12.9,1,43,3.08,MSS,Wide_Local_Excision,0.9,R0,4.6,0,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,89.94,1,89.94,1,0.0,3.6,Treatment_Toxicity,HC-ONC-009,1.0.0,42 |
| MEL-0000473,2018,46,Female,2,SSM,Trunk,0,0,9.0,1,0,1,2.62,0,1.0,T3a,1,Negative,0,0,0,N0,M0,1.55,IIB,0,V600E,1,0,0,1,0,0,0,0,31.0,1,79,7.09,MSS,Wide_Local_Excision,1.9,R0,4.3,0,Primary_Closure,0,23,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Ipilimumab,0,178.4,1,103.17,1,0.0,7.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000474,2017,60,Male,4,SSM,Trunk,0,0,7.3,0,0,0,0.87,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.37,IA,0,WT,0,0,0,1,0,0,0,0,25.9,1,64,2.14,MSS,Wide_Local_Excision,1.0,R0,3.7,0,Primary_Closure,0,39,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,75.07,1,75.07,1,0.0,5.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000475,2019,40,Male,2,SSM,LowerExtremity,0,0,1.0,0,0,1,1.98,0,0.0,T2a,0,Not_Performed,0,0,0,N0,M0,0.73,IIA,0,V600K,1,0,0,1,0,0,0,0,21.0,1,20,1.48,MSS,Wide_Local_Excision,1.6,R0,8.7,1,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,130.45,1,124.46,1,0.0,52.4,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000476,2022,71,Female,3,SSM,Trunk,0,0,7.8,0,0,0,0.61,0,0.0,T1a,0,Not_Performed,0,0,1,N2c,M0,0.72,IIIC,0,WT,0,0,0,0,0,0,0,0,33.8,1,41,0.7,MSS,Wide_Local_Excision,1.0,R0,5.3,0,Primary_Closure,0,14,0,1,Pembrolizumab_mono,1L,24,PD,5.96,1,1,0,Hepatic,0,0,0,0,0,0,1,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,22.8,1,Nodal_Basin,1,Pembrolizumab,0,57.38,0,21.81,1,0.0,26.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000477,2024,37,Female,1,SSM,HeadNeck,0,0,10.0,1,0,0,0.52,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.83,IA,0,V600E,1,0,0,0,1,0,0,0,17.6,1,42,1.47,MSS,Wide_Local_Excision,0.9,R0,26.5,1,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,1,89.36,1,0.0,5.1,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000478,2021,52,Female,3,SSM,Trunk,0,0,2.5,0,0,1,4.79,0,7.0,T4a,0,Not_Performed,0,0,0,N0,M0,0.5,IIC,0,V600E,1,0,0,0,0,1,0,0,4.0,0,23,3.52,MSS,Wide_Local_Excision,1.9,R0,5.9,0,Primary_Closure,0,34,0,1,Ipilimumab_mono,1L,33,CR,3.34,1,1,1,GI,0,0,0,0,0,1,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Nivolumab,0,183.38,1,183.38,1,4.18,8.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000479,2021,47,Male,3,SSM,UpperExtremity,0,0,9.5,1,0,2,0.61,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.42,IA,0,V600E,1,0,0,0,0,1,0,0,11.1,1,24,3.65,MSS,Wide_Local_Excision,1.0,R0,29.3,1,Primary_Closure,0,120,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,86.88,1,72.0,0,0.0,4.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000480,2019,59,Male,3,SSM,Trunk,0,0,1.0,1,0,0,2.68,0,6.0,T3a,1,Macrometastasis,1,1,0,N1b,M0,0.43,IIIB,0,WT,0,0,0,0,0,1,0,0,3.5,0,22,2.47,MSS,Wide_Local_Excision,2.1,R0,4.4,1,None,0,14,0,1,Ipilimumab_mono,1L,15,PR,2.78,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,10.3,0,None,0,None,0,198.78,0,25.6,0,26.02,26.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000481,2017,46,Female,2,SSM,UpperExtremity,0,0,8.4,0,0,2,1.3,0,0.0,T2a,1,Negative,0,0,0,N0,M0,1.26,IIA,0,V600E,1,0,0,0,0,0,0,0,25.4,1,9,3.1,MSS,Wide_Local_Excision,1.5,R0,1.9,0,Primary_Closure,0,42,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,160.84,0,159.85,1,0.0,6.7,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000482,2018,52,Female,4,SSM,Trunk,0,0,6.5,0,0,2,0.89,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.5,IA,0,WT,0,0,0,0,0,0,0,0,30.7,1,10,5.55,MSS,Wide_Local_Excision,1.0,R0,9.0,1,Skin_Graft,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,126.47,1,126.47,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000483,2019,53,Male,3,SSM,Trunk,1,0,1.8,0,0,0,1.16,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.61,IIA,0,V600E,1,0,0,0,1,1,0,0,31.9,1,10,2.12,MSS,Wide_Local_Excision,1.5,R0,4.1,0,Skin_Graft,0,37,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,63.52,1,63.52,1,0.0,3.6,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000484,2022,45,Female,2,SSM,UpperExtremity,0,0,7.4,1,0,0,0.48,0,1.0,T1b,1,Negative,0,0,0,N0,M0,1.72,IB,0,V600E,1,0,0,0,1,0,0,0,22.2,1,4,5.97,MSS,Wide_Local_Excision,1.0,R0,5.9,0,Primary_Closure,0,16,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,161.09,1,161.09,0,0.0,2.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000485,2020,64,Male,5,SSM,Trunk,0,0,8.8,1,0,1,1.19,1,1.0,T2b,1,Negative,0,0,0,N0,M1d_1,3.16,IV,1,WT,0,0,0,1,0,0,0,0,32.5,1,23,8.17,MSS,Wide_Local_Excision,1.3,R0,5.4,0,Primary_Closure,0,111,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,1,0,0,0,0,0,0,0,5,0,0,0.0,1,0.3,0,None,0,None,0,24.2,1,4.18,0,0.0,2.5,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000486,2022,60,Male,3,SSM,Trunk,0,0,7.2,0,0,1,0.56,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.85,IB,0,V600E,1,0,0,0,0,0,0,0,4.2,0,19,1.89,MSI_H,Wide_Local_Excision,1.2,R0,18.1,0,Primary_Closure,0,37,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,26.2,0,26.2,1,0.0,2.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000487,2014,55,Male,6,SSM,HeadNeck,0,0,7.7,0,0,0,0.91,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,1.13,IA,0,WT,0,0,0,0,0,1,0,0,13.8,1,43,1.36,MSS,Wide_Local_Excision,0.9,R0,7.1,1,Primary_Closure,0,106,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,63.03,0,63.03,0,0.0,8.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000488,2022,50,Male,6,SSM,Trunk,0,0,5.7,0,0,1,2.29,0,5.0,T3a,1,Micrometastasis,1,4,0,N2b,M0,1.11,IIIC,0,V600E,1,0,0,0,1,0,0,0,4.8,0,71,3.77,MSS,Wide_Local_Excision,2.0,R0,2.1,0,Primary_Closure,0,37,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,PR,15.19,1,1,BRAF_amplification,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,22.0,1,Nodal_Basin,1,Pembrolizumab,0,156.32,0,108.53,1,0.0,1.4,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000489,2019,69,Male,4,SSM,UpperExtremity,0,0,2.8,0,0,1,1.43,0,3.0,T2a,1,Negative,0,0,0,N0,M0,0.43,IIA,0,V600K,1,0,0,0,1,0,0,0,11.3,1,75,0.89,MSS,Wide_Local_Excision,1.1,R0,5.8,0,Skin_Graft,0,47,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,49.63,1,49.63,0,0.0,4.3,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000490,2024,53,Female,3,SSM,UpperExtremity,0,1,7.9,1,0,1,0.43,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.56,IA,0,V600K,1,0,0,0,0,0,0,0,54.7,1,83,1.55,MSS,Wide_Local_Excision,1.0,R0,6.8,0,Primary_Closure,0,14,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,139.6,1,139.6,0,0.0,17.8,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000491,2019,52,Male,3,NM,Trunk,0,0,10.0,0,0,1,6.35,0,4.0,T4a,1,Negative,0,0,1,N2c,M0,0.84,IIIC,0,WT,0,0,0,0,0,1,0,0,36.0,1,9,0.45,MSS,Wide_Local_Excision,1.8,R0,6.5,0,Primary_Closure,0,67,0,1,Pembrolizumab_mono,1L,28,PR,21.34,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,22.6,0,None,0,None,0,144.45,0,8.63,0,1.0,1.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000492,2019,58,Male,1,SSM,UpperExtremity,0,0,8.8,0,0,0,1.19,0,1.0,T2a,1,Negative,0,0,0,N0,M0,1.6,IIA,0,V600E,1,0,0,0,1,1,0,0,25.5,1,5,3.22,MSS,Wide_Local_Excision,1.3,R0,11.8,0,Primary_Closure,0,120,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,94.36,0,21.55,1,0.0,11.9,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000493,2015,84,Male,2,SSM,Trunk,0,0,2.5,0,0,0,0.82,0,4.0,T1b,1,Negative,0,0,0,N0,M1a_1,3.85,IV,1,V600E,1,0,0,0,0,0,0,0,13.0,1,51,6.2,MSS,Wide_Local_Excision,1.5,R0,1.0,0,Primary_Closure,0,77,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,1,Dabrafenib_Trametinib,1,CR,4.28,0,1,BRAF_amplification,0,1,1,0,0,1,0,0,0,2,1,0,0.0,1,0.4,0,None,0,None,0,53.87,1,38.7,0,0.0,14.2,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000494,2022,35,Male,3,SSM,LowerExtremity,0,0,3.5,1,0,0,2.02,1,5.0,T3b,1,Negative,0,0,0,N0,M0,0.61,IIB,0,WT,0,0,0,0,0,0,0,0,6.8,0,80,4.14,MSS,Wide_Local_Excision,2.0,R0,1.0,0,Skin_Graft,0,14,0,1,Pembrolizumab_mono,1L,8,SD,3.38,1,1,0,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,240.0,0,39.42,0,0.0,4.2,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000495,2021,69,Male,2,NM,Trunk,0,0,4.8,0,0,2,3.11,0,5.0,T3a,1,Negative,0,0,0,N0,M0,0.88,IIB,0,WT,0,0,0,0,1,1,0,0,17.4,1,95,3.83,MSS,Wide_Local_Excision,2.2,R1,0.0,0,Primary_Closure,0,45,1,1,Nivolumab_mono,1L,18,PD,11.33,1,1,1,Skin,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,72.22,0,72.22,1,0.0,28.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000496,2023,26,Female,4,SSM,Trunk,0,0,3.3,0,0,2,0.53,0,1.0,T1b,1,Negative,0,0,0,N0,M0,0.95,IB,0,WT,0,0,0,0,0,0,0,0,36.5,1,32,3.91,MSS,Wide_Local_Excision,1.2,R0,1.0,0,Skin_Graft,0,104,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,97.63,1,38.51,0,0.0,3.0,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000497,2015,60,Male,1,SSM,Trunk,1,0,6.6,0,0,1,4.37,0,1.0,T4a,1,Negative,0,0,0,N0,M0,0.97,IIC,0,WT,0,0,0,0,0,1,0,0,20.8,1,3,3.5,MSS,Wide_Local_Excision,2.2,R0,28.3,1,Flap,0,43,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,34.24,0,8.54,0,0.0,19.6,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000498,2016,82,Female,2,SSM,HeadNeck,0,0,7.3,0,0,0,1.19,0,2.0,T2a,1,Negative,0,0,0,N0,M0,0.53,IIA,0,V600K,1,0,0,0,0,0,0,0,4.2,0,29,3.27,MSS,Wide_Local_Excision,1.5,R0,13.5,0,Primary_Closure,0,30,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,85.37,1,85.37,1,0.0,2.9,Melanoma,HC-ONC-009,1.0.0,42 |
| MEL-0000499,2023,64,Female,2,SSM,LowerExtremity,1,0,3.6,0,0,1,1.13,1,0.0,T2b,1,Negative,0,0,0,N0,M0,0.6,IIB,0,V600K,1,0,0,0,0,0,0,0,16.3,1,35,3.44,MSS,Wide_Local_Excision,1.8,R0,15.2,1,Flap,0,44,0,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,1,Pembrolizumab,0,30.33,0,30.33,1,0.0,2.5,Censored,HC-ONC-009,1.0.0,42 |
| MEL-0000500,2014,59,Male,2,SSM,HeadNeck,1,0,8.1,0,0,0,0.9,0,0.0,T1a,0,Not_Performed,0,0,0,N0,M0,0.81,IA,0,WT,0,0,0,0,0,1,0,0,3.2,0,70,1.18,MSS,Wide_Local_Excision,1.2,R1,0.0,0,Primary_Closure,0,14,1,0,None,None,0,N/A,0.0,0,0,0,None,0,0,0,0,0,0,0,0,None,0,N/A,0.0,0,0,None,0,0,0,0,0,0,0,0,0,0,0,0,0.0,0,0.0,0,None,0,None,0,76.69,1,76.69,1,0.0,1.0,Melanoma,HC-ONC-009,1.0.0,42 |
|
|
